ID   TITIN_HUMAN             Reviewed;       34350 AA.
AC   Q8WZ42; A6NKB1; E7EQE6; E7ET18; K7ENY1; Q10465; Q10466; Q15598; Q2XUS3;
AC   Q32Q60; Q4U1Z6; Q4ZG20; Q6NSG0; Q6PDB1; Q6PJP0; Q7KYM2; Q7KYN4; Q7KYN5;
AC   Q7LDM3; Q7Z2X3; Q8TCG8; Q8WZ51; Q8WZ52; Q8WZ53; Q8WZB3; Q92761; Q92762;
AC   Q9UD97; Q9UP84; Q9Y6L9;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 4.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Titin;
DE            EC=2.7.11.1;
DE   AltName: Full=Connectin;
DE   AltName: Full=Rhabdomyosarcoma antigen MU-RMS-40.14;
GN   Name=TTN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   3336-12202 (ISOFORM 4), AND VARIANTS ILE-498; GLU-1201; MET-3261; ASN-3419;
RP   SER-3491; GLU-12679; ILE-19762; ILE-20718; ASN-23807; MET-24980 AND
RP   THR-27755.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7569978; DOI=10.1126/science.270.5234.293;
RA   Labeit S., Kolmerer B.;
RT   "Titins, giant proteins in charge of muscle ultrastructure and
RT   elasticity.";
RL   Science 270:293-296(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   LEU-1295; GLN-1572; ILE-2610; ASN-2831; SER-3491; PRO-4215; PHE-4283 AND
RP   ARG-12383.
RX   PubMed=10850961; DOI=10.1161/01.res.86.11.1114;
RA   Freiburg A., Trombitas K., Hell W., Cazorla O., Fougerousse F., Centner T.,
RA   Kolmerer B., Witt C., Beckmann J.S., Gregorio C.C., Granzier H., Labeit S.;
RT   "Series of exon-skipping events in the elastic spring region of titin as
RT   the structural basis for myofibrillar elastic diversity.";
RL   Circ. Res. 86:1114-1121(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, INTERACTION WITH OBSCN, AND VARIANTS LEU-1295; GLN-1572;
RP   ILE-2610; ASN-2831; SER-3491; PRO-4215 AND PHE-4283.
RX   PubMed=11717165; DOI=10.1161/hh2301.100981;
RA   Bang M.-L., Centner T., Fornoff F., Geach A.J., Gotthardt M., McNabb M.,
RA   Witt C.C., Labeit D., Gregorio C.C., Granzier H., Labeit S.;
RT   "The complete gene sequence of titin, expression of an unusual ~700 kDa
RT   titin isoform and its interaction with obscurin identify a novel Z-line to
RT   I-band linking system.";
RL   Circ. Res. 89:1065-1072(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-626 AND 34071-34350 (ISOFORM
RP   3).
RC   TISSUE=Muscle, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 405-709 (ISOFORMS 1 AND 2).
RC   TISSUE=Heart muscle;
RX   PubMed=8937992; DOI=10.1242/jcs.109.11.2747;
RA   Gautel M., Goulding D., Bullard B., Weber K., Furst D.O.;
RT   "The central Z-disk region of titin is assembled from a novel repeat in
RT   variable copy numbers.";
RL   J. Cell Sci. 109:2747-2754(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2023-2060, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart muscle;
RX   PubMed=7819249; DOI=10.1021/bi00002a021;
RA   Musco G., Tziatzos C., Schuck P., Pastore A.;
RT   "Dissecting titin into its structural motifs: identification of an alpha
RT   helix near the N-terminus.";
RL   Biochemistry 34:553-561(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3455-4473, AND VARIANTS PRO-4215 AND
RP   PHE-4283.
RX   PubMed=10051295; DOI=10.1161/01.cir.99.8.1022;
RA   Siu B.L., Niimura H., Osborne J.A., Fatkin D., MacRae C., Solomon S.,
RA   Benson D.W., Seidman J.G., Seidman C.E.;
RT   "Familial dilated cardiomyopathy locus maps to chromosome 2q31.";
RL   Circulation 99:1022-1026(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9806-12017 (ISOFORM 5).
RC   TISSUE=Heart ventricle;
RX   PubMed=12785098; DOI=10.1023/a:1023410523184;
RA   Greaser M.L., Berri M., Warren C.M., Mozdziak P.E.;
RT   "Species variations in cDNA sequence and exon splicing patterns in the
RT   extensible I-band region of cardiac titin: relation to passive tension.";
RL   J. Muscle Res. Cell Motil. 23:473-482(2002).
RN   [10]
RP   PROTEIN SEQUENCE OF 11773-11783; 17908-17931; 18656-18669; 26545-26553;
RP   28758-28774 AND 32920-32928, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12947-13797.
RC   TISSUE=Embryonic rhabdomyosarcoma;
RA   Behrends U., Gotz C., Mautner J.;
RT   "Serological identification of rhabdomyosarcoma antigens.";
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 14257-14543.
RX   PubMed=8351016; DOI=10.1212/wnl.43.8.1581;
RA   Gautel M., Lakey A., Barlow D.P., Holmes Z., Scales S., Leonard K.,
RA   Labeit S., Mygland A., Gilhus N.E., Aarli J.A.;
RT   "Titin antibodies in myasthenia gravis: identification of a major
RT   immunogenic region of titin.";
RL   Neurology 43:1581-1585(1993).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21021-22120, AND NUCLEOTIDE SEQUENCE [GENOMIC
RP   DNA] OF 23754-24284.
RX   PubMed=1582406; DOI=10.1002/j.1460-2075.1992.tb05222.x;
RA   Labeit S., Gautel M., Lakey A., Trinick J.;
RT   "Towards a molecular understanding of titin.";
RL   EMBO J. 11:1711-1716(1992).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29701-34350, AND PHOSPHORYLATION.
RX   PubMed=8404852; DOI=10.1002/j.1460-2075.1993.tb06061.x;
RA   Gautel M., Leonard K., Labeit S.;
RT   "Phosphorylation of KSF motifs in the C-terminal region of titin in
RT   differentiating myoblasts.";
RL   EMBO J. 12:3827-3834(1993).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33119-34350.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [16]
RP   INTERACTION WITH TCAP.
RX   PubMed=9645487; DOI=10.1016/s0014-5793(98)00501-8;
RA   Mues A., van der Ven P.F.M., Young P., Furst D.O., Gautel M.;
RT   "Two immunoglobulin-like domains of the Z-disc portion of titin interact in
RT   a conformation-dependent way with telethonin.";
RL   FEBS Lett. 428:111-114(1998).
RN   [17]
RP   INTERACTION WITH NEB.
RX   PubMed=12482578; DOI=10.1016/s0014-5793(02)03655-4;
RA   Ma K., Wang K.;
RT   "Interaction of nebulin SH3 domain with titin PEVK and myopalladin:
RT   implications for the signaling and assembly role of titin and nebulin.";
RL   FEBS Lett. 532:273-278(2002).
RN   [18]
RP   INTERACTION WITH FHL2.
RX   PubMed=12432079; DOI=10.1242/jcs.00181;
RA   Lange S., Auerbach D., McLoughlin P., Perriard E., Schafer B.W.,
RA   Perriard J.-C., Ehler E.;
RT   "Subcellular targeting of metabolic enzymes to titin in heart muscle may be
RT   mediated by DRAL/FHL-2.";
RL   J. Cell Sci. 115:4925-4936(2002).
RN   [19]
RP   INTERACTION WITH ANK1.
RX   PubMed=12444090; DOI=10.1074/jbc.m209012200;
RA   Kontrogianni-Konstantopoulos A., Bloch R.J.;
RT   "The hydrophilic domain of small ankyrin-1 interacts with the two N-
RT   terminal immunoglobulin domains of titin.";
RL   J. Biol. Chem. 278:3985-3991(2003).
RN   [20]
RP   INTERACTION WITH ANKRD1; ANKRD2; ANKRD23 AND CAPN3.
RX   PubMed=14583192; DOI=10.1016/j.jmb.2003.09.012;
RA   Miller M.K., Bang M.-L., Witt C.C., Labeit D., Trombitas C., Watanabe K.,
RA   Granzier H., McElhinny A.S., Gregorio C.C., Labeit S.;
RT   "The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family
RT   of titin filament-based stress response molecules.";
RL   J. Mol. Biol. 333:951-964(2003).
RN   [21]
RP   INTERACTION WITH CRYAB.
RX   PubMed=14676215; DOI=10.1074/jbc.m307473200;
RA   Bullard B., Ferguson C., Minajeva A., Leake M.C., Gautel M., Labeit D.,
RA   Ding L., Labeit S., Horwitz J., Leonard K.R., Linke W.A.;
RT   "Association of the chaperone alphaB-crystallin with titin in heart
RT   muscle.";
RL   J. Biol. Chem. 279:7917-7924(2004).
RN   [22]
RP   INTERACTION WITH TRIM63 AND TRIM55.
RX   PubMed=15967462; DOI=10.1016/j.jmb.2005.05.021;
RA   Witt S.H., Granzier H., Witt C.C., Labeit S.;
RT   "MURF-1 and MURF-2 target a specific subset of myofibrillar proteins
RT   redundantly: towards understanding MURF-dependent muscle ubiquitination.";
RL   J. Mol. Biol. 350:713-722(2005).
RN   [23]
RP   INTERACTION WITH LAMIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16410549; DOI=10.1242/jcs.02728;
RA   Zastrow M.S., Flaherty D.B., Benian G.M., Wilson K.L.;
RT   "Nuclear titin interacts with A- and B-type lamins in vitro and in vivo.";
RL   J. Cell Sci. 119:239-249(2006).
RN   [24]
RP   REVIEW.
RX   PubMed=16537787; DOI=10.1152/ajpheart.00816.2005;
RA   Hoshijima M.;
RT   "Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk,
RT   titin, and associated structures.";
RL   Am. J. Physiol. 290:H1313-H1325(2006).
RN   [25]
RP   INTERACTION WITH CMYA5.
RX   PubMed=20634290; DOI=10.1074/jbc.m110.108720;
RA   Sarparanta J., Blandin G., Charton K., Vihola A., Marchand S., Milic A.,
RA   Hackman P., Ehler E., Richard I., Udd B.;
RT   "Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to
RT   tibial and limb-girdle muscular dystrophies.";
RL   J. Biol. Chem. 285:30304-30315(2010).
RN   [26]
RP   STRUCTURE BY NMR OF 33483-33579.
RX   PubMed=7613868; DOI=10.1016/s0969-2126(01)00170-8;
RA   Pfuhl M., Pastore A.;
RT   "Tertiary structure of an immunoglobulin-like domain from the giant muscle
RT   protein titin: a new member of the I set.";
RL   Structure 3:391-401(1995).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 32172-32489, FUNCTION, ACTIVITY
RP   REGULATION, INTERACTION WITH CALM, PHOSPHORYLATION AT TYR-32341, AND
RP   MUTAGENESIS OF LYS-32207 AND TYR-32341.
RX   PubMed=9804419; DOI=10.1038/27603;
RA   Mayans O., van der Ven P.F.M., Wilm M., Mues A., Young P., Furst D.O.,
RA   Wilmanns M., Gautel M.;
RT   "Structural basis for activation of the titin kinase domain during
RT   myofibrillogenesis.";
RL   Nature 395:863-869(1998).
RN   [28]
RP   STRUCTURE BY NMR OF 22283-22385.
RX   PubMed=9782056; DOI=10.1016/s0969-2126(98)00129-4;
RA   Goll C.M., Pastore A., Nilges M.;
RT   "The three-dimensional structure of a type I module from titin: a prototype
RT   of intracellular fibronectin type III domains.";
RL   Structure 6:1291-1302(1998).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 2073-2171, AND DISULFIDE BOND.
RX   PubMed=11525170; DOI=10.1016/s0969-2126(01)00591-3;
RA   Mayans O., Wuerges J., Canela S., Gautel M., Wilmanns M.;
RT   "Structural evidence for a possible role of reversible disulphide bridge
RT   formation in the elasticity of the muscle protein titin.";
RL   Structure 9:331-340(2001).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 1-196 IN COMPLEX WITH TCAP.
RX   PubMed=16407954; DOI=10.1038/nature04343;
RA   Zou P., Pinotsis N., Lange S., Song Y.-H., Popov A., Mavridis I.,
RA   Mayans O.M., Gautel M., Wilmanns M.;
RT   "Palindromic assembly of the giant muscle protein titin in the sarcomeric
RT   Z-disk.";
RL   Nature 439:229-233(2006).
RN   [31]
RP   VARIANT CMH9 LEU-740.
RX   PubMed=10462489; DOI=10.1006/bbrc.1999.1221;
RA   Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., Kimura A.;
RT   "Structural analysis of the titin gene in hypertrophic cardiomyopathy:
RT   identification of a novel disease gene.";
RL   Biochem. Biophys. Res. Commun. 262:411-417(1999).
RN   [32]
RP   INVOLVEMENT IN LGMDR10, AND VARIANT TMD PRO-34315.
RX   PubMed=12145747; DOI=10.1086/342380;
RA   Hackman P., Vihola A., Haravuori H., Marchand S., Sarparanta J.,
RA   De Seze J., Labeit S., Witt C., Peltonen L., Richard I., Udd B.;
RT   "Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the
RT   gene encoding the giant skeletal-muscle protein titin.";
RL   Am. J. Hum. Genet. 71:492-500(2002).
RN   [33]
RP   VARIANTS CMD1G MET-54; VAL-743; TYR-3799 AND ASN-4465, VARIANTS CYS-328;
RP   GLN-4084 AND PRO-4215, CHARACTERIZATION OF VARIANTS CMD1G MET-54 AND
RP   VAL-743, AND FUNCTION.
RX   PubMed=11846417; DOI=10.1006/bbrc.2002.6448;
RA   Itoh-Satoh M., Hayashi T., Nishi H., Koga Y., Arimura T., Koyanagi T.,
RA   Takahashi M., Hohda S., Ueda K., Nouchi T., Hiroe M., Marumo F.,
RA   Imaizumi T., Yasunami M., Kimura A.;
RT   "Titin mutations as the molecular basis for dilated cardiomyopathy.";
RL   Biochem. Biophys. Res. Commun. 291:385-393(2002).
RN   [34]
RP   VARIANT CMD1G ARG-976.
RX   PubMed=11788824; DOI=10.1038/ng815;
RA   Gerull B., Gramlich M., Atherton J., McNabb M., Trombitas K.,
RA   Sasse-Klaassen S., Seidman J.G., Seidman C., Granzier H., Labeit S.,
RA   Frenneaux M., Thierfelder L.;
RT   "Mutations of TTN, encoding the giant muscle filament titin, cause familial
RT   dilated cardiomyopathy.";
RL   Nat. Genet. 30:201-204(2002).
RN   [35]
RP   VARIANT TMD ASN-34306.
RX   PubMed=12891679; DOI=10.1002/ana.10647;
RA   Van den Bergh P.Y.K., Bouquiaux O., Verellen C., Marchand S., Richard I.,
RA   Hackman P., Udd B.;
RT   "Tibial muscular dystrophy in a Belgian family.";
RL   Ann. Neurol. 54:248-251(2003).
RN   [36]
RP   VARIANT CMD1G GLN-32996.
RX   PubMed=16465475; DOI=10.1007/s10974-005-9018-5;
RA   Matsumoto Y., Hayashi T., Inagaki N., Takahashi M., Hiroi S., Nakamura T.,
RA   Arimura T., Nakamura K., Ashizawa N., Yasunami M., Ohe T., Yano K.,
RA   Kimura A.;
RT   "Functional analysis of titin/connectin N2-B mutations found in
RT   cardiomyopathy.";
RL   J. Muscle Res. Cell Motil. 26:367-374(2005).
RN   [37]
RP   VARIANT MFM9 TRP-279, CHARACTERIZATION OF VARIANT MFM9 TRP-279, AND
RP   INTERACTION WITH NBR1.
RX   PubMed=15802564; DOI=10.1126/science.1110463;
RA   Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E.,
RA   Kristensen J., Brandmeier B., Franzen G., Hedberg B., Gunnarsson L.G.,
RA   Hughes S.M., Marchand S., Sejersen T., Richard I., Edstroem L., Ehler E.,
RA   Udd B., Gautel M.;
RT   "The kinase domain of titin controls muscle gene expression and protein
RT   turnover.";
RL   Science 308:1599-1603(2005).
RN   [38]
RP   INVOLVEMENT IN SALMY.
RX   PubMed=17444505; DOI=10.1002/ana.21089;
RA   Carmignac V., Salih M.A.M., Quijano-Roy S., Marchand S., Al Rayess M.M.,
RA   Mukhtar M.M., Urtizberea J.A., Labeit S., Guicheney P., Leturcq F.,
RA   Gautel M., Fardeau M., Campbell K.P., Richard I., Estournet B.,
RA   Ferreiro A.;
RT   "C-terminal titin deletions cause a novel early-onset myopathy with fatal
RT   cardiomyopathy.";
RL   Ann. Neurol. 61:340-351(2007).
RN   [39]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-60; MET-115; CYS-328; THR-360; ILE-498;
RP   MET-799; ILE-811; HIS-922; ASP-937; THR-1081; ARG-1137; GLU-1201; ALA-1202;
RP   LEU-1295; ASP-1345; THR-1347; HIS-1350; LEU-1353; VAL-1393; CYS-1416;
RP   PRO-1441; VAL-1544; GLN-1572; GLY-1658; GLN-1664; ASP-1692; LEU-1744;
RP   GLY-1772; ILE-1907; HIS-1998; LEU-2107; THR-2118; THR-2164; TYR-2240;
RP   SER-2392; PHE-2432; ILE-2610; MET-2771; PHE-2823; ASN-2831; ILE-2930;
RP   ARG-3154; GLU-3191; LEU-3238; GLY-3250; MET-3261; GLN-3367; LYS-3482;
RP   LYS-3570; VAL-3590; VAL-3762; PHE-3877; LEU-3965; PRO-4215; TRP-4238;
RP   PHE-4283; THR-4291; ASP-4303; GLU-4427; GLU-12310; ALA-12469; CYS-12642;
RP   LYS-12657; GLU-12679; PHE-12720; CYS-12798; GLY-13049; LYS-13083;
RP   LEU-13096; ARG-13099; ALA-13297; MET-13399; THR-13418; VAL-13428;
RP   THR-13430; LYS-13434; ASN-13469; ASN-13495; SER-13785; HIS-13870;
RP   ILE-14109; GLN-14131; THR-14208; VAL-14728; THR-14999; THR-15021;
RP   VAL-15520; ILE-15555; GLN-15620; ILE-15629; CYS-15635; GLN-15700;
RP   PRO-15705; MET-15837; HIS-16058; ILE-16067; THR-16090; HIS-16195;
RP   CYS-16409; PRO-16424; MET-16629; ARG-16877; ASP-17060; VAL-17637;
RP   HIS-17838; ASN-17866; GLU-17906; ALA-18094; SER-18109; THR-18164;
RP   LEU-18221; THR-18222; GLN-18726; ALA-18835; LYS-18881; SER-18939;
RP   GLN-19000; GLN-19060; LYS-19091; SER-19224; ILE-19367; LYS-19392;
RP   SER-19480; GLY-19495; HIS-19665; ILE-19762; ARG-19947; MET-19956;
RP   GLN-19992; CYS-20057; LEU-20075; LYS-20179; THR-20198; VAL-20198;
RP   HIS-20331; THR-20408; LYS-20564; ILE-20718; PRO-20726; ASN-20892;
RP   ARG-20894; GLU-21125; SER-21403; CYS-21730; GLN-21747; ARG-21851;
RP   ARG-21851; ARG-21925; HIS-21995; VAL-22045; HIS-22149; ILE-22160;
RP   THR-22261; ASN-22306; HIS-22357; PRO-22408; HIS-22537; LEU-22584;
RP   PRO-22646; ALA-22670; ASP-22770; THR-22801; TRP-22823; GLN-22968;
RP   LEU-23074; PHE-23079; ASN-23282; TYR-23303; CYS-23306; SER-23515;
RP   GLN-23551; ASN-23807; ASN-23872; ALA-23891; HIS-23933; MET-23939;
RP   LEU-23952; GLY-24098; SER-24119; ILE-24133; ALA-24159; ALA-24239;
RP   LYS-24265; THR-24584; THR-24781; HIS-24799; HIS-24954; MET-24980;
RP   HIS-25659; THR-25679; ALA-25720; LYS-25821; LYS-25859; LYS-25879;
RP   VAL-25923; ILE-26045; GLU-26059; VAL-26134; CYS-26477; TYR-26843;
RP   ARG-27346; CYS-27652; VAL-27728; LEU-27754; THR-27755; VAL-27929;
RP   LEU-28132; GLN-28168; HIS-28538; THR-28572; THR-28948; VAL-28986;
RP   GLU-28993; VAL-28998; MET-29070; VAL-29090; CYS-29419; PRO-29479;
RP   LEU-29880; GLU-29976; GLY-30042; CYS-30107; PHE-30125; PRO-30211;
RP   THR-30412; SER-30617; ILE-30674; ILE-30809; ILE-30818; LYS-30825;
RP   THR-30856; ASP-30887; SER-30887; HIS-30897; HIS-30907; HIS-30946;
RP   PHE-31081; CYS-31107; GLY-31124; SER-31156; THR-31246; HIS-31330;
RP   ARG-31690; GLN-31724; ILE-31725; SER-31732; ILE-31886; CYS-32097;
RP   ASN-32171; ILE-32248; HIS-32281; HIS-32323; TRP-32411; VAL-32558;
RP   VAL-32610; VAL-32637; ALA-32922; ARG-32943; HIS-32953; LEU-33213;
RP   CYS-33242; MET-33387; ASP-33419; MET-33536; GLN-33568; LYS-33616;
RP   LEU-33620; VAL-33886; THR-33899; PRO-33904; ILE-33955 AND ALA-34115.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [40]
RP   VARIANTS VAL-16046 AND GLN-32742.
RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,
RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,
RA   Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [41]
RP   VARIANTS PRO-2963 AND GLN-14750.
RX   PubMed=25173926; DOI=10.1161/circgenetics.113.000486;
RA   Girolami F., Iascone M., Tomberli B., Bardi S., Benelli M., Marseglia G.,
RA   Pescucci C., Pezzoli L., Sana M.E., Basso C., Marziliano N., Merlini P.A.,
RA   Fornaro A., Cecchi F., Torricelli F., Olivotto I.;
RT   "Novel alpha-actinin 2 variant associated with familial hypertrophic
RT   cardiomyopathy and juvenile atrial arrhythmias: a massively parallel
RT   sequencing study.";
RL   Circ. Cardiovasc. Genet. 7:741-750(2014).
CC   -!- FUNCTION: Key component in the assembly and functioning of vertebrate
CC       striated muscles. By providing connections at the level of individual
CC       microfilaments, it contributes to the fine balance of forces between
CC       the two halves of the sarcomere. The size and extensibility of the
CC       cross-links are the main determinants of sarcomere extensibility
CC       properties of muscle. In non-muscle cells, seems to play a role in
CC       chromosome condensation and chromosome segregation during mitosis.
CC       Might link the lamina network to chromatin or nuclear actin, or both
CC       during interphase. {ECO:0000269|PubMed:11846417,
CC       ECO:0000269|PubMed:9804419}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Full activation of the protein kinase domain
CC       requires both phosphorylation of Tyr-32341, preventing it from blocking
CC       the catalytic aspartate residue, and binding of Ca/CALM to the C-
CC       terminal regulatory tail of the molecule which results in ATP binding
CC       to the kinase. {ECO:0000269|PubMed:9804419}.
CC   -!- SUBUNIT: Interacts with MYOM1, MYOM2, tropomyosin and myosin. Interacts
CC       with actin, primarily via the PEVK domains and with MYPN (By
CC       similarity). Interacts with FHL2, NEB, CRYAB, LMNA/lamin-A and
CC       LMNB/lamin-B. Interacts with TCAP/telethonin and/or ANK1 isoform
CC       Mu17/ank1.5, via the first two N-terminal immunoglobulin domains.
CC       Interacts with TRIM63 and TRIM55, through several domains including
CC       immunoglobulin domains 141 and 142. Interacts with ANKRD1, ANKRD2 and
CC       ANKRD23, via the region between immunoglobulin domains 77 and 78 and
CC       interacts with CAPN3, via immunoglobulin domain 79. Interacts with NBR1
CC       through the protein kinase domain. Interacts with CALM/calmodulin.
CC       Isoform 6 interacts with OBSCN isoform 3. Interacts with CMYA5.
CC       {ECO:0000250, ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:12432079,
CC       ECO:0000269|PubMed:12444090, ECO:0000269|PubMed:12482578,
CC       ECO:0000269|PubMed:14583192, ECO:0000269|PubMed:14676215,
CC       ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:15967462,
CC       ECO:0000269|PubMed:16407954, ECO:0000269|PubMed:16410549,
CC       ECO:0000269|PubMed:20634290, ECO:0000269|PubMed:9645487,
CC       ECO:0000269|PubMed:9804419}.
CC   -!- INTERACTION:
CC       Q8WZ42; P12814: ACTN1; NbExp=2; IntAct=EBI-681210, EBI-351710;
CC       Q8WZ42; P35609: ACTN2; NbExp=16; IntAct=EBI-681210, EBI-77797;
CC       Q8WZ42; P62158: CALM3; NbExp=2; IntAct=EBI-681210, EBI-397435;
CC       Q8WZ42; P20807: CAPN3; NbExp=4; IntAct=EBI-681210, EBI-5655000;
CC       Q8WZ42; O75953: DNAJB5; NbExp=4; IntAct=EBI-681210, EBI-5655937;
CC       Q8WZ42; O75923: DYSF; NbExp=17; IntAct=EBI-681210, EBI-2799016;
CC       Q8WZ42; P06733: ENO1; NbExp=3; IntAct=EBI-681210, EBI-353877;
CC       Q8WZ42; Q9H492: MAP1LC3A; NbExp=3; IntAct=EBI-681210, EBI-720768;
CC       Q8WZ42; Q9GZQ8: MAP1LC3B; NbExp=4; IntAct=EBI-681210, EBI-373144;
CC       Q8WZ42; Q14324: MYBPC2; NbExp=14; IntAct=EBI-681210, EBI-5653200;
CC       Q8WZ42; Q13203: MYBPH; NbExp=3; IntAct=EBI-681210, EBI-5655165;
CC       Q8WZ42; P20929: NEB; NbExp=6; IntAct=EBI-681210, EBI-1049657;
CC       Q8WZ42; Q5VST9: OBSCN; NbExp=15; IntAct=EBI-681210, EBI-941850;
CC       Q8WZ42; O75147: OBSL1; NbExp=13; IntAct=EBI-681210, EBI-1223896;
CC       Q8WZ42; O15061: SYNM; NbExp=3; IntAct=EBI-681210, EBI-7843148;
CC       Q8WZ42; O15273: TCAP; NbExp=9; IntAct=EBI-681210, EBI-954089;
CC       Q8WZ42; Q969Q1: TRIM63; NbExp=3; IntAct=EBI-681210, EBI-5661333;
CC       Q8WZ42; Q8WZ42: TTN; NbExp=16; IntAct=EBI-681210, EBI-681210;
CC       Q8WZ42-3; O15273: TCAP; NbExp=2; IntAct=EBI-15564183, EBI-954089;
CC       Q8WZ42-3; Q8WZ42-3: TTN; NbExp=9; IntAct=EBI-15564183, EBI-15564183;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:16410549}. Nucleus
CC       {ECO:0000269|PubMed:16410549}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC         Comment=A number of isoforms may be produced, ranging from 27000 to
CC         33000 residues in different striated muscle tissues, the size of the
CC         full-length protein may be up to 38138 residues.;
CC       Name=1;
CC         IsoId=Q8WZ42-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WZ42-2; Sequence=VSP_019138;
CC       Name=3; Synonyms=Small cardiac N2-B;
CC         IsoId=Q8WZ42-3; Sequence=VSP_019139, VSP_019145;
CC       Name=4; Synonyms=Soleus;
CC         IsoId=Q8WZ42-4; Sequence=VSP_019142, VSP_019151;
CC       Name=5;
CC         IsoId=Q8WZ42-5; Sequence=VSP_019147, VSP_019148, VSP_019149,
CC                                  VSP_019150, VSP_019152;
CC       Name=6; Synonyms=Small cardiac novex-3;
CC         IsoId=Q8WZ42-6; Sequence=VSP_019143, VSP_019146;
CC       Name=7; Synonyms=Cardiac novex-2;
CC         IsoId=Q8WZ42-7; Sequence=VSP_019141, VSP_019144;
CC       Name=8; Synonyms=Cardiac novex-1;
CC         IsoId=Q8WZ42-8; Sequence=VSP_019140;
CC       Name=9;
CC         IsoId=Q8WZ42-9; Sequence=VSP_019139, VSP_042903, VSP_019145;
CC       Name=10;
CC         IsoId=Q8WZ42-10; Sequence=VSP_019139, VSP_019140, VSP_019145;
CC       Name=11;
CC         IsoId=Q8WZ42-11; Sequence=VSP_019142;
CC       Name=12;
CC         IsoId=Q8WZ42-12; Sequence=VSP_045935, VSP_045929, VSP_045930,
CC                                   VSP_045931, VSP_045932, VSP_045933,
CC                                   VSP_045934;
CC       Name=13;
CC         IsoId=Q8WZ42-13; Sequence=VSP_047142;
CC   -!- TISSUE SPECIFICITY: Isoforms 3, 7 and 8 are expressed in cardiac
CC       muscle. Isoform 4 is expressed in vertebrate skeletal muscle. Isoform 6
CC       is expressed in skeletal muscle (at protein level).
CC       {ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:7819249}.
CC   -!- DOMAIN: ZIS1 and ZIS5 regions contain multiple SPXR consensus sites for
CC       ERK- and CDK-like protein kinases as well as multiple SP motifs. ZIS1
CC       could adopt a closed conformation which would block the TCAP-binding
CC       site.
CC   -!- DOMAIN: The PEVK region may serve as an entropic spring of a chain of
CC       structural folds and may also be an interaction site to other
CC       myofilament proteins to form interfilament connectivity in the
CC       sarcomere.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- DISEASE: Myopathy, myofibrillar, 9, with early respiratory failure
CC       (MFM9) [MIM:603689]: An autosomal dominant myopathy characterized by
CC       adulthood onset of weakness in proximal, distal, axial and respiratory
CC       muscles. Pelvic girdle weakness, foot drop and neck weakness are the
CC       main symptoms at onset, but ultimately the weakness usually involves
CC       the proximal compartment of both upper and lower limbs. Additional
CC       features include variable degrees of Achilles tendon contractures,
CC       spinal rigidity and muscle hypertrophy. Respiratory involvement often
CC       leads to requirement for non-invasive ventilation support.
CC       {ECO:0000269|PubMed:15802564}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic 9 (CMH9) [MIM:613765]: A
CC       hereditary heart disorder characterized by ventricular hypertrophy,
CC       which is usually asymmetric and often involves the interventricular
CC       septum. The symptoms include dyspnea, syncope, collapse, palpitations,
CC       and chest pain. They can be readily provoked by exercise. The disorder
CC       has inter- and intrafamilial variability ranging from benign to
CC       malignant forms with high risk of cardiac failure and sudden cardiac
CC       death. {ECO:0000269|PubMed:10462489}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]: A disorder
CC       characterized by ventricular dilation and impaired systolic function,
CC       resulting in congestive heart failure and arrhythmia. Patients are at
CC       risk of premature death. {ECO:0000269|PubMed:11788824,
CC       ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:16465475}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Tardive tibial muscular dystrophy (TMD) [MIM:600334]:
CC       Autosomal dominant, late-onset distal myopathy. Muscle weakness and
CC       atrophy are usually confined to the anterior compartment of the lower
CC       leg, in particular the tibialis anterior muscle. Clinical symptoms
CC       usually occur at age 35-45 years or much later.
CC       {ECO:0000269|PubMed:12145747, ECO:0000269|PubMed:12891679}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Muscular dystrophy, limb-girdle, autosomal recessive 10
CC       (LGMDR10) [MIM:608807]: An autosomal recessive degenerative myopathy
CC       characterized by progressive weakness of the pelvic and shoulder girdle
CC       muscles. Severe disability is observed within 20 years of onset.
CC       {ECO:0000269|PubMed:12145747}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Salih myopathy (SALMY) [MIM:611705]: An autosomal recessive,
CC       early-onset muscular disorder characterized by dilated cardiomyopathy,
CC       delayed motor development with generalized muscle weakness
CC       predominantly affecting proximal and distal lower limbs. Skeletal
CC       muscle biopsies show minicore-like lesions with mitochondrial depletion
CC       and sarcomere disorganization, centralized nuclei, and type 1 fiber
CC       predominance. Dystrophic changes become apparent in the second decade.
CC       Cardiac muscle biopsies show disruption of myocardial architecture,
CC       nuclear hypertrophy, and endomysial fibrosis. Sudden death may occurr
CC       due to cardiomyopathy. {ECO:0000269|PubMed:17444505}. Note=The disease
CC       is caused by variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: In some isoforms, after the PEVK repeat region there is
CC       a long PEVK duplicated region. On account of this region, it has been
CC       very difficult to sequence the whole protein. The length of this region
CC       (ranging from 183 to 2174 residues), may be a key elastic element of
CC       titin.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH58824.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 553.; Evidence={ECO:0000305};
CC       Sequence=AAH70170.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence starting in position 627.; Evidence={ECO:0000305};
CC       Sequence=CAA62188.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAD12455.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Titin entry;
CC       URL="https://en.wikipedia.org/wiki/Titin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X90568; CAA62188.1; ALT_FRAME; mRNA.
DR   EMBL; X90569; CAA62189.1; -; mRNA.
DR   EMBL; AJ277892; CAD12455.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AJ277892; CAD12456.1; -; Genomic_DNA.
DR   EMBL; AJ277892; CAD12457.1; -; Genomic_DNA.
DR   EMBL; AJ277892; CAD12458.1; -; Genomic_DNA.
DR   EMBL; AJ277892; CAD12459.1; -; Genomic_DNA.
DR   EMBL; AC009948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010680; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ695199; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023270; AAX88844.1; -; Genomic_DNA.
DR   EMBL; BC013396; AAH13396.1; -; mRNA.
DR   EMBL; BC058824; AAH58824.1; ALT_SEQ; mRNA.
DR   EMBL; BC070170; AAH70170.1; ALT_SEQ; mRNA.
DR   EMBL; BC107797; AAI07798.1; -; mRNA.
DR   EMBL; X98114; CAA66795.1; -; mRNA.
DR   EMBL; X98115; CAA66796.1; -; mRNA.
DR   EMBL; X83270; CAA58243.1; -; mRNA.
DR   EMBL; AF058332; AAD22603.1; -; Genomic_DNA.
DR   EMBL; AF058332; AAD22604.1; -; Genomic_DNA.
DR   EMBL; AF525413; AAP80791.1; -; mRNA.
DR   EMBL; DQ248309; ABB55264.1; -; mRNA.
DR   EMBL; X64698; CAA45939.1; -; mRNA.
DR   EMBL; X64699; CAA45940.1; -; Genomic_DNA.
DR   EMBL; X64697; CAA45938.1; -; mRNA.
DR   EMBL; X69490; CAA49245.1; -; mRNA.
DR   EMBL; AL713647; CAD28458.1; -; mRNA.
DR   CCDS; CCDS33337.1; -. [Q8WZ42-6]
DR   CCDS; CCDS54421.1; -. [Q8WZ42-3]
DR   CCDS; CCDS54422.1; -. [Q8WZ42-9]
DR   CCDS; CCDS54423.1; -. [Q8WZ42-10]
DR   CCDS; CCDS54424.1; -. [Q8WZ42-11]
DR   CCDS; CCDS59435.1; -. [Q8WZ42-12]
DR   CCDS; CCDS74610.1; -. [Q8WZ42-1]
DR   PIR; I38344; I38344.
DR   PIR; I38346; I38346.
DR   RefSeq; NP_001243779.1; NM_001256850.1. [Q8WZ42-1]
DR   RefSeq; NP_003310.4; NM_003319.4. [Q8WZ42-3]
DR   RefSeq; NP_596869.4; NM_133378.4. [Q8WZ42-11]
DR   RefSeq; NP_596870.2; NM_133379.4. [Q8WZ42-6]
DR   RefSeq; NP_597676.3; NM_133432.3. [Q8WZ42-10]
DR   PDB; 1BPV; NMR; -; A=22283-22385.
DR   PDB; 1G1C; X-ray; 2.10 A; A/B=2073-2171.
DR   PDB; 1NCT; NMR; -; A=33483-33579.
DR   PDB; 1NCU; NMR; -; A=33483-33579.
DR   PDB; 1TIT; NMR; -; A=12680-12765.
DR   PDB; 1TIU; NMR; -; A=12680-12765.
DR   PDB; 1TKI; X-ray; 2.00 A; A/B=32172-32492.
DR   PDB; 1TNM; NMR; -; A=33489-33579.
DR   PDB; 1TNN; NMR; -; A=33489-33579.
DR   PDB; 1WAA; X-ray; 1.80 A; A/B/C/D/E/F=12677-12765.
DR   PDB; 1YA5; X-ray; 2.44 A; A/B=1-196.
DR   PDB; 2A38; X-ray; 2.00 A; A/B/C=1-194.
DR   PDB; 2BK8; X-ray; 1.69 A; A=32497-32590.
DR   PDB; 2F8V; X-ray; 2.75 A; A/B/C/D=1-196.
DR   PDB; 2ILL; X-ray; 2.20 A; A=31854-32047.
DR   PDB; 2J8H; X-ray; 1.99 A; A=31854-32047.
DR   PDB; 2J8O; X-ray; 2.49 A; A/B=31854-32047.
DR   PDB; 2NZI; X-ray; 2.90 A; A/B=31854-32155.
DR   PDB; 2RQ8; NMR; -; A=12677-12765.
DR   PDB; 2WP3; X-ray; 1.48 A; T=34252-34350.
DR   PDB; 2WWK; X-ray; 1.70 A; T=34252-34350.
DR   PDB; 2WWM; X-ray; 2.30 A; D/T=34252-34350.
DR   PDB; 2Y9R; X-ray; 1.90 A; T=34252-34350.
DR   PDB; 3B43; X-ray; 3.30 A; A=7945-8511.
DR   PDB; 3KNB; X-ray; 1.40 A; A=34253-34350.
DR   PDB; 3LCY; X-ray; 2.50 A; A/B/C/D=31456-31649.
DR   PDB; 3LPW; X-ray; 1.65 A; A/B=22877-23070.
DR   PDB; 3PUC; X-ray; 0.96 A; A=33774-33871.
DR   PDB; 3Q5O; X-ray; 2.05 A; A/B=34253-34350.
DR   PDB; 3QP3; X-ray; 2.00 A; A/B/C=33294-33395.
DR   PDB; 4C4K; X-ray; 1.95 A; T=34252-34350.
DR   PDB; 4JNW; X-ray; 2.06 A; A/B=32172-32492.
DR   PDB; 4O00; X-ray; 1.85 A; A/B=14217-14319.
DR   PDB; 4QEG; X-ray; 2.00 A; A=2880-2967.
DR   PDB; 4UOW; X-ray; 3.30 A; 1/3/5/7/9/B/D/F/H/J/L/N/P/R/T/V/X/Z=7-99.
DR   PDB; 5BS0; X-ray; 2.40 A; C=24337-24345.
DR   PDB; 5JDD; X-ray; 1.53 A; A=2795-3053.
DR   PDB; 5JDE; X-ray; 1.90 A; A/B=2795-3053.
DR   PDB; 5JDJ; X-ray; 1.74 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=2880-2967.
DR   PDB; 5JOE; X-ray; 2.00 A; A=9582-9671.
DR   PDB; 6DL4; NMR; -; A=1821-1931.
DR   PDB; 6FWX; X-ray; 3.00 A; A/B=1-243.
DR   PDB; 6H4L; X-ray; 1.60 A; A=33294-33395.
DR   PDB; 6HCI; X-ray; 2.12 A; A/B/C/D=32712-32816.
DR   PDB; 6I0Y; EM; 3.20 A; z=12677-12765.
DR   PDB; 6SDB; X-ray; 2.80 A; A/B/C/D/E=3-196.
DR   PDB; 6YGN; X-ray; 2.40 A; A/B=32046-32594.
DR   PDB; 7AHS; X-ray; 2.05 A; A/B/C/D=9582-9851.
DR   PDB; 7NIP; NMR; -; A=9504-9544.
DR   PDBsum; 1BPV; -.
DR   PDBsum; 1G1C; -.
DR   PDBsum; 1NCT; -.
DR   PDBsum; 1NCU; -.
DR   PDBsum; 1TIT; -.
DR   PDBsum; 1TIU; -.
DR   PDBsum; 1TKI; -.
DR   PDBsum; 1TNM; -.
DR   PDBsum; 1TNN; -.
DR   PDBsum; 1WAA; -.
DR   PDBsum; 1YA5; -.
DR   PDBsum; 2A38; -.
DR   PDBsum; 2BK8; -.
DR   PDBsum; 2F8V; -.
DR   PDBsum; 2ILL; -.
DR   PDBsum; 2J8H; -.
DR   PDBsum; 2J8O; -.
DR   PDBsum; 2NZI; -.
DR   PDBsum; 2RQ8; -.
DR   PDBsum; 2WP3; -.
DR   PDBsum; 2WWK; -.
DR   PDBsum; 2WWM; -.
DR   PDBsum; 2Y9R; -.
DR   PDBsum; 3B43; -.
DR   PDBsum; 3KNB; -.
DR   PDBsum; 3LCY; -.
DR   PDBsum; 3LPW; -.
DR   PDBsum; 3PUC; -.
DR   PDBsum; 3Q5O; -.
DR   PDBsum; 3QP3; -.
DR   PDBsum; 4C4K; -.
DR   PDBsum; 4JNW; -.
DR   PDBsum; 4O00; -.
DR   PDBsum; 4QEG; -.
DR   PDBsum; 4UOW; -.
DR   PDBsum; 5BS0; -.
DR   PDBsum; 5JDD; -.
DR   PDBsum; 5JDE; -.
DR   PDBsum; 5JDJ; -.
DR   PDBsum; 5JOE; -.
DR   PDBsum; 6DL4; -.
DR   PDBsum; 6FWX; -.
DR   PDBsum; 6H4L; -.
DR   PDBsum; 6HCI; -.
DR   PDBsum; 6I0Y; -.
DR   PDBsum; 6SDB; -.
DR   PDBsum; 6YGN; -.
DR   PDBsum; 7AHS; -.
DR   PDBsum; 7NIP; -.
DR   SASBDB; Q8WZ42; -.
DR   SMR; Q8WZ42; -.
DR   BioGRID; 113124; 191.
DR   ComplexPortal; CPX-101; Titin-Telethonin complex.
DR   CORUM; Q8WZ42; -.
DR   DIP; DIP-33449N; -.
DR   IntAct; Q8WZ42; 141.
DR   MINT; Q8WZ42; -.
DR   STRING; 9606.ENSP00000467141; -.
DR   MoonDB; Q8WZ42; Predicted.
DR   CarbonylDB; Q8WZ42; -.
DR   GlyGen; Q8WZ42; 11 sites, 2 O-linked glycans (11 sites).
DR   iPTMnet; Q8WZ42; -.
DR   MetOSite; Q8WZ42; -.
DR   PhosphoSitePlus; Q8WZ42; -.
DR   SwissPalm; Q8WZ42; -.
DR   BioMuta; TTN; -.
DR   EPD; Q8WZ42; -.
DR   jPOST; Q8WZ42; -.
DR   MassIVE; Q8WZ42; -.
DR   MaxQB; Q8WZ42; -.
DR   PaxDb; Q8WZ42; -.
DR   PeptideAtlas; Q8WZ42; -.
DR   PRIDE; Q8WZ42; -.
DR   ProteomicsDB; 75209; -. [Q8WZ42-1]
DR   ProteomicsDB; 75210; -. [Q8WZ42-10]
DR   ProteomicsDB; 75211; -. [Q8WZ42-11]
DR   ProteomicsDB; 75212; -. [Q8WZ42-2]
DR   ProteomicsDB; 75213; -. [Q8WZ42-3]
DR   ProteomicsDB; 75214; -. [Q8WZ42-4]
DR   ProteomicsDB; 75215; -. [Q8WZ42-5]
DR   ProteomicsDB; 75216; -. [Q8WZ42-6]
DR   ProteomicsDB; 75217; -. [Q8WZ42-7]
DR   ProteomicsDB; 75218; -. [Q8WZ42-8]
DR   ProteomicsDB; 75219; -. [Q8WZ42-9]
DR   ABCD; Q8WZ42; 2 sequenced antibodies.
DR   Antibodypedia; 2056; 211 antibodies from 27 providers.
DR   DNASU; 7273; -.
DR   Ensembl; ENST00000342992.11; ENSP00000343764.6; ENSG00000155657.29. [Q8WZ42-11]
DR   Ensembl; ENST00000359218.10; ENSP00000352154.5; ENSG00000155657.29. [Q8WZ42-10]
DR   Ensembl; ENST00000360870.10; ENSP00000354117.4; ENSG00000155657.29. [Q8WZ42-6]
DR   Ensembl; ENST00000460472.6; ENSP00000434586.1; ENSG00000155657.29. [Q8WZ42-3]
DR   Ensembl; ENST00000591111.5; ENSP00000465570.1; ENSG00000155657.29. [Q8WZ42-1]
DR   GeneID; 7273; -.
DR   KEGG; hsa:7273; -.
DR   UCSC; uc002unb.4; human. [Q8WZ42-1]
DR   CTD; 7273; -.
DR   DisGeNET; 7273; -.
DR   GeneCards; TTN; -.
DR   GeneReviews; TTN; -.
DR   HGNC; HGNC:12403; TTN.
DR   HPA; ENSG00000155657; Tissue enhanced (heart muscle, skeletal muscle, tongue).
DR   MalaCards; TTN; -.
DR   MIM; 188840; gene.
DR   MIM; 600334; phenotype.
DR   MIM; 603689; phenotype.
DR   MIM; 604145; phenotype.
DR   MIM; 608807; phenotype.
DR   MIM; 611705; phenotype.
DR   MIM; 613765; phenotype.
DR   neXtProt; NX_Q8WZ42; -.
DR   OpenTargets; ENSG00000155657; -.
DR   Orphanet; 169186; Autosomal recessive centronuclear myopathy.
DR   Orphanet; 466921; Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome.
DR   Orphanet; 324604; Classic multiminicore myopathy.
DR   Orphanet; 289377; Early-onset myopathy with fatal cardiomyopathy.
DR   Orphanet; 334; Familial atrial fibrillation.
DR   Orphanet; 293899; Familial isolated arrhythmogenic ventricular dysplasia, biventricular form.
DR   Orphanet; 293888; Familial isolated arrhythmogenic ventricular dysplasia, left dominant form.
DR   Orphanet; 293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 178464; Hereditary myopathy with early respiratory failure.
DR   Orphanet; 155; NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
DR   Orphanet; 609; Tibial muscular dystrophy.
DR   Orphanet; 140922; Titin-related limb-girdle muscular dystrophy R10.
DR   PharmGKB; PA37067; -.
DR   VEuPathDB; HostDB:ENSG00000155657; -.
DR   eggNOG; KOG0613; Eukaryota.
DR   eggNOG; KOG4475; Eukaryota.
DR   GeneTree; ENSGT01060000248587; -.
DR   HOGENOM; CLU_000001_1_0_1; -.
DR   InParanoid; Q8WZ42; -.
DR   OMA; VYEGDSC; -.
DR   TreeFam; TF316477; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q8WZ42; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   SignaLink; Q8WZ42; -.
DR   SIGNOR; Q8WZ42; -.
DR   BioGRID-ORCS; 7273; 10 hits in 1103 CRISPR screens.
DR   ChiTaRS; TTN; human.
DR   EvolutionaryTrace; Q8WZ42; -.
DR   GeneWiki; Titin; -.
DR   GenomeRNAi; 7273; -.
DR   Pharos; Q8WZ42; Tbio.
DR   PRO; PR:Q8WZ42; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000155657; Expressed in gluteal muscle and 162 other tissues.
DR   ExpressionAtlas; Q8WZ42; baseline and differential.
DR   Genevisible; Q8WZ42; HS.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0031674; C:I band; IDA:BHF-UCL.
DR   GO; GO:0031430; C:M band; IDA:BHF-UCL.
DR   GO; GO:0005865; C:striated muscle thin filament; IDA:BHF-UCL.
DR   GO; GO:1990733; C:titin-telethonin complex; IPI:ComplexPortal.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; IDA:BHF-UCL.
DR   GO; GO:0042805; F:actinin binding; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IPI:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051371; F:muscle alpha-actinin binding; IPI:BHF-UCL.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0043621; F:protein self-association; IDA:BHF-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0008307; F:structural constituent of muscle; IMP:BHF-UCL.
DR   GO; GO:0097493; F:structural molecule activity conferring elasticity; IDA:BHF-UCL.
DR   GO; GO:0031433; F:telethonin binding; IPI:BHF-UCL.
DR   GO; GO:0055013; P:cardiac muscle cell development; IMP:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; IMP:BHF-UCL.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0055003; P:cardiac myofibril assembly; IMP:BHF-UCL.
DR   GO; GO:0035995; P:detection of muscle stretch; IDA:MGI.
DR   GO; GO:0007076; P:mitotic chromosome condensation; IEP:BHF-UCL.
DR   GO; GO:0006936; P:muscle contraction; TAS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:CAFA.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:CAFA.
DR   GO; GO:0010737; P:protein kinase A signaling; IMP:CAFA.
DR   GO; GO:0050790; P:regulation of catalytic activity; IMP:BHF-UCL.
DR   GO; GO:0045859; P:regulation of protein kinase activity; IMP:BHF-UCL.
DR   GO; GO:0051592; P:response to calcium ion; IDA:BHF-UCL.
DR   GO; GO:0045214; P:sarcomere organization; IMP:BHF-UCL.
DR   GO; GO:0048769; P:sarcomerogenesis; IMP:BHF-UCL.
DR   GO; GO:0030241; P:skeletal muscle myosin thick filament assembly; IMP:BHF-UCL.
DR   GO; GO:0030240; P:skeletal muscle thin filament assembly; IMP:BHF-UCL.
DR   GO; GO:0006941; P:striated muscle contraction; TAS:UniProtKB.
DR   CDD; cd00063; FN3; 132.
DR   DisProt; DP00072; -.
DR   Gene3D; 2.60.40.10; -; 299.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR040849; MyBP-C_THB.
DR   InterPro; IPR004168; PPAK_motif.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR015129; Titin_Z_rpt.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   Pfam; PF00041; fn3; 132.
DR   Pfam; PF07679; I-set; 162.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF02818; PPAK; 9.
DR   Pfam; PF18362; THB; 1.
DR   Pfam; PF09042; Titin_Z; 6.
DR   SMART; SM00060; FN3; 132.
DR   SMART; SM00409; IG; 167.
DR   SMART; SM00408; IGc2; 148.
DR   SMART; SM00406; IGv; 23.
DR   SUPFAM; SSF48726; SSF48726; 167.
DR   SUPFAM; SSF49265; SSF49265; 74.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50853; FN3; 132.
DR   PROSITE; PS50835; IG_LIKE; 143.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calcium;
KW   Calmodulin-binding; Cardiomyopathy; Coiled coil; Cytoplasm;
KW   Direct protein sequencing; Disease variant; Disulfide bond;
KW   Immunoglobulin domain; Kinase; Limb-girdle muscular dystrophy; Magnesium;
KW   Metal-binding; Myofibrillar myopathy; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..34350
FT                   /note="Titin"
FT                   /id="PRO_0000239311"
FT   DOMAIN          6..96
FT                   /note="Ig-like 1"
FT   DOMAIN          104..192
FT                   /note="Ig-like 2"
FT   REPEAT          417..462
FT                   /note="Z-repeat 1"
FT   REPEAT          466..511
FT                   /note="Z-repeat 2"
FT   REPEAT          512..554
FT                   /note="Z-repeat 3"
FT   REPEAT          555..600
FT                   /note="Z-repeat 4"
FT   REPEAT          601..646
FT                   /note="Z-repeat 5"
FT   REPEAT          647..691
FT                   /note="Z-repeat 6"
FT   REPEAT          692..740
FT                   /note="Z-repeat 7"
FT   DOMAIN          943..1031
FT                   /note="Ig-like 3"
FT   DOMAIN          1082..1172
FT                   /note="Ig-like 4"
FT   DOMAIN          1291..1382
FT                   /note="Ig-like 5"
FT   DOMAIN          1457..1546
FT                   /note="Ig-like 6"
FT   DOMAIN          1556..1646
FT                   /note="Ig-like 7"
FT   DOMAIN          1703..1793
FT                   /note="Ig-like 8"
FT   DOMAIN          1841..1928
FT                   /note="Ig-like 9"
FT   DOMAIN          2078..2167
FT                   /note="Ig-like 10"
FT   DOMAIN          2171..2262
FT                   /note="Ig-like 11"
FT   DOMAIN          2264..2354
FT                   /note="Ig-like 12"
FT   DOMAIN          2353..2443
FT                   /note="Ig-like 13"
FT   DOMAIN          2430..2529
FT                   /note="Ig-like 14"
FT   DOMAIN          2620..2703
FT                   /note="Ig-like 15"
FT   DOMAIN          2880..2965
FT                   /note="Ig-like 16"
FT   DOMAIN          2968..3050
FT                   /note="Ig-like 17"
FT   DOMAIN          3058..3141
FT                   /note="Ig-like 18"
FT   DOMAIN          3239..3327
FT                   /note="Ig-like 19"
FT   DOMAIN          3344..3432
FT                   /note="Ig-like 20"
FT   DOMAIN          3503..3586
FT                   /note="Ig-like 21"
FT   DOMAIN          3621..3712
FT                   /note="Ig-like 22"
FT   DOMAIN          4289..4376
FT                   /note="Ig-like 23"
FT   DOMAIN          4383..4471
FT                   /note="Ig-like 24"
FT   DOMAIN          4478..4566
FT                   /note="Ig-like 25"
FT   DOMAIN          4571..4659
FT                   /note="Ig-like 26"
FT   DOMAIN          4664..4753
FT                   /note="Ig-like 27"
FT   DOMAIN          4758..4846
FT                   /note="Ig-like 28"
FT   DOMAIN          4851..4936
FT                   /note="Ig-like 29"
FT   DOMAIN          4943..5032
FT                   /note="Ig-like 30"
FT   DOMAIN          5040..5128
FT                   /note="Ig-like 31"
FT   DOMAIN          5133..5221
FT                   /note="Ig-like 32"
FT   DOMAIN          5225..5314
FT                   /note="Ig-like 33"
FT   DOMAIN          5320..5408
FT                   /note="Ig-like 34"
FT   DOMAIN          5413..5501
FT                   /note="Ig-like 35"
FT   DOMAIN          5505..5594
FT                   /note="Ig-like 36"
FT   DOMAIN          5602..5690
FT                   /note="Ig-like 37"
FT   DOMAIN          5695..5783
FT                   /note="Ig-like 38"
FT   DOMAIN          5788..5877
FT                   /note="Ig-like 39"
FT   DOMAIN          5882..5970
FT                   /note="Ig-like 40"
FT   DOMAIN          5975..6063
FT                   /note="Ig-like 41"
FT   DOMAIN          6067..6156
FT                   /note="Ig-like 42"
FT   DOMAIN          6164..6252
FT                   /note="Ig-like 43"
FT   DOMAIN          6257..6347
FT                   /note="Ig-like 44"
FT   DOMAIN          6350..6440
FT                   /note="Ig-like 45"
FT   DOMAIN          6444..6534
FT                   /note="Ig-like 46"
FT   DOMAIN          6537..6626
FT                   /note="Ig-like 47"
FT   DOMAIN          6630..6721
FT                   /note="Ig-like 48"
FT   DOMAIN          6727..6815
FT                   /note="Ig-like 49"
FT   DOMAIN          6820..6908
FT                   /note="Ig-like 50"
FT   DOMAIN          6912..7001
FT                   /note="Ig-like 51"
FT   DOMAIN          7005..7093
FT                   /note="Ig-like 52"
FT   DOMAIN          7102..7190
FT                   /note="Ig-like 53"
FT   DOMAIN          7198..7286
FT                   /note="Ig-like 54"
FT   DOMAIN          7291..7380
FT                   /note="Ig-like 55"
FT   DOMAIN          7385..7473
FT                   /note="Ig-like 56"
FT   DOMAIN          7478..7567
FT                   /note="Ig-like 57"
FT   DOMAIN          7571..7662
FT                   /note="Ig-like 58"
FT   DOMAIN          7668..7756
FT                   /note="Ig-like 59"
FT   DOMAIN          7761..7849
FT                   /note="Ig-like 60"
FT   DOMAIN          7853..7942
FT                   /note="Ig-like 61"
FT   DOMAIN          7946..8035
FT                   /note="Ig-like 62"
FT   DOMAIN          8042..8133
FT                   /note="Ig-like 63"
FT   DOMAIN          8138..8229
FT                   /note="Ig-like 64"
FT   DOMAIN          8232..8321
FT                   /note="Ig-like 65"
FT   DOMAIN          8326..8414
FT                   /note="Ig-like 66"
FT   DOMAIN          8419..8508
FT                   /note="Ig-like 67"
FT   DOMAIN          8512..8603
FT                   /note="Ig-like 68"
FT   DOMAIN          8609..8697
FT                   /note="Ig-like 69"
FT   DOMAIN          8702..8790
FT                   /note="Ig-like 70"
FT   DOMAIN          8794..8883
FT                   /note="Ig-like 71"
FT   DOMAIN          8888..8976
FT                   /note="Ig-like 72"
FT   DOMAIN          8984..9074
FT                   /note="Ig-like 73"
FT   DOMAIN          9079..9168
FT                   /note="Ig-like 74"
FT   DOMAIN          9176..9265
FT                   /note="Ig-like 75"
FT   DOMAIN          9272..9361
FT                   /note="Ig-like 76"
FT   DOMAIN          9366..9470
FT                   /note="Ig-like 77"
FT   DOMAIN          9660..9755
FT                   /note="Ig-like 78"
FT   DOMAIN          9760..9851
FT                   /note="Ig-like 79"
FT   REPEAT          10216..10242
FT                   /note="PEVK 1"
FT   REPEAT          10244..10270
FT                   /note="PEVK 2"
FT   REPEAT          10272..10298
FT                   /note="PEVK 3"
FT   REPEAT          10300..10326
FT                   /note="PEVK 4"
FT   REPEAT          10327..10353
FT                   /note="PEVK 5"
FT   REPEAT          10355..10381
FT                   /note="PEVK 6"
FT   REPEAT          10508..10534
FT                   /note="PEVK 7"
FT   REPEAT          10536..10562
FT                   /note="PEVK 8"
FT   REPEAT          10592..10618
FT                   /note="PEVK 9"
FT   REPEAT          10878..10904
FT                   /note="PEVK 10"
FT   REPEAT          10906..10930
FT                   /note="PEVK 11"
FT   REPEAT          10932..10958
FT                   /note="PEVK 12"
FT   REPEAT          10960..10986
FT                   /note="PEVK 13"
FT   REPEAT          10987..11014
FT                   /note="PEVK 14"
FT   REPEAT          11363..11396
FT                   /note="PEVK 15"
FT   REPEAT          11397..11421
FT                   /note="PEVK 16"
FT   REPEAT          11453..11479
FT                   /note="PEVK 17"
FT   REPEAT          11481..11507
FT                   /note="PEVK 18"
FT   REPEAT          11509..11535
FT                   /note="PEVK 19"
FT   REPEAT          11537..11563
FT                   /note="PEVK 20"
FT   REPEAT          11565..11591
FT                   /note="PEVK 21"
FT   REPEAT          11657..11683
FT                   /note="PEVK 22"
FT   REPEAT          11703..11729
FT                   /note="PEVK 23"
FT   REPEAT          11745..11771
FT                   /note="PEVK 24"
FT   REPEAT          11775..11801
FT                   /note="PEVK 25"
FT   REPEAT          11836..11862
FT                   /note="PEVK 26"
FT   REPEAT          11864..11890
FT                   /note="PEVK 27"
FT   REPEAT          11893..11919
FT                   /note="PEVK 28"
FT   REPEAT          11929..11955
FT                   /note="PEVK 29"
FT   REPEAT          11966..11992
FT                   /note="PEVK 30"
FT   REPEAT          11996..12022
FT                   /note="PEVK 31"
FT   DOMAIN          12041..12133
FT                   /note="Ig-like 80"
FT   DOMAIN          12138..12222
FT                   /note="Ig-like 81"
FT   DOMAIN          12233..12318
FT                   /note="Ig-like 82"
FT   DOMAIN          12499..12584
FT                   /note="Ig-like 83"
FT   DOMAIN          12590..12672
FT                   /note="Ig-like 84"
FT   DOMAIN          12766..12850
FT                   /note="Ig-like 85"
FT   DOMAIN          12945..13032
FT                   /note="Ig-like 86"
FT   DOMAIN          13120..13206
FT                   /note="Ig-like 87"
FT   DOMAIN          13210..13295
FT                   /note="Ig-like 88"
FT   DOMAIN          13299..13384
FT                   /note="Ig-like 89"
FT   DOMAIN          13388..13478
FT                   /note="Ig-like 90"
FT   DOMAIN          13479..13562
FT                   /note="Ig-like 91"
FT   DOMAIN          13565..13655
FT                   /note="Ig-like 92"
FT   DOMAIN          13659..13748
FT                   /note="Ig-like 93"
FT   DOMAIN          13749..13833
FT                   /note="Ig-like 94"
FT   DOMAIN          13927..14012
FT                   /note="Ig-like 95"
FT   DOMAIN          14019..14114
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14120..14215
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14221..14316
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14417..14513
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14517..14614
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14615..14708
FT                   /note="Ig-like 96"
FT   DOMAIN          14713..14806
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14812..14907
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          14913..15007
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15010..15107
FT                   /note="Fibronectin type-III 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15113..15207
FT                   /note="Fibronectin type-III 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15214..15310
FT                   /note="Fibronectin type-III 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15314..15402
FT                   /note="Ig-like 97"
FT   DOMAIN          15409..15503
FT                   /note="Fibronectin type-III 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15509..15604
FT                   /note="Fibronectin type-III 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15608..15724
FT                   /note="Ig-like 98"
FT   DOMAIN          15731..15826
FT                   /note="Fibronectin type-III 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15832..15926
FT                   /note="Fibronectin type-III 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          15929..16025
FT                   /note="Fibronectin type-III 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16029..16119
FT                   /note="Ig-like 99"
FT   DOMAIN          16126..16218
FT                   /note="Fibronectin type-III 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16224..16318
FT                   /note="Fibronectin type-III 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16322..16420
FT                   /note="Ig-like 100"
FT   DOMAIN          16427..16522
FT                   /note="Fibronectin type-III 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16528..16628
FT                   /note="Fibronectin type-III 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16634..16734
FT                   /note="Fibronectin type-III 21"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16727..16834
FT                   /note="Ig-like 101"
FT   DOMAIN          16841..16934
FT                   /note="Fibronectin type-III 22"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          16941..17041
FT                   /note="Fibronectin type-III 23"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17044..17139
FT                   /note="Ig-like 102"
FT   DOMAIN          17147..17240
FT                   /note="Fibronectin type-III 24"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17246..17345
FT                   /note="Fibronectin type-III 25"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17348..17445
FT                   /note="Fibronectin type-III 26"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17449..17536
FT                   /note="Ig-like 103"
FT   DOMAIN          17545..17640
FT                   /note="Fibronectin type-III 27"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17646..17741
FT                   /note="Fibronectin type-III 28"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17745..17834
FT                   /note="Ig-like 104"
FT   DOMAIN          17842..17935
FT                   /note="Fibronectin type-III 29"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          17941..18036
FT                   /note="Fibronectin type-III 30"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18042..18139
FT                   /note="Fibronectin type-III 31"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18143..18228
FT                   /note="Ig-like 105"
FT   DOMAIN          18239..18333
FT                   /note="Fibronectin type-III 32"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18339..18431
FT                   /note="Fibronectin type-III 33"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18435..18526
FT                   /note="Ig-like 106"
FT   DOMAIN          18533..18632
FT                   /note="Fibronectin type-III 34"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18633..18727
FT                   /note="Fibronectin type-III 35"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18733..18829
FT                   /note="Fibronectin type-III 36"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          18833..18924
FT                   /note="Ig-like 107"
FT   DOMAIN          18931..19025
FT                   /note="Fibronectin type-III 37"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19030..19124
FT                   /note="Fibronectin type-III 38"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19128..19219
FT                   /note="Ig-like 108"
FT   DOMAIN          19226..19321
FT                   /note="Fibronectin type-III 39"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19325..19420
FT                   /note="Fibronectin type-III 40"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19426..19527
FT                   /note="Fibronectin type-III 41"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19531..19617
FT                   /note="Ig-like 109"
FT   DOMAIN          19628..19722
FT                   /note="Fibronectin type-III 42"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19728..19823
FT                   /note="Fibronectin type-III 43"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          19826..19914
FT                   /note="Ig-like 110"
FT   DOMAIN          19921..20017
FT                   /note="Fibronectin type-III 44"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20018..20116
FT                   /note="Fibronectin type-III 45"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20119..20217
FT                   /note="Fibronectin type-III 46"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20220..20311
FT                   /note="Ig-like 111"
FT   DOMAIN          20318..20411
FT                   /note="Fibronectin type-III 47"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20417..20512
FT                   /note="Fibronectin type-III 48"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20518..20613
FT                   /note="Fibronectin type-III 49"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20716..20813
FT                   /note="Fibronectin type-III 50"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20814..20908
FT                   /note="Fibronectin type-III 51"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          20893..20996
FT                   /note="Ig-like 112"
FT   DOMAIN          21006..21101
FT                   /note="Fibronectin type-III 52"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21105..21200
FT                   /note="Fibronectin type-III 53"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21203..21299
FT                   /note="Fibronectin type-III 54"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21303..21395
FT                   /note="Ig-like 113"
FT   DOMAIN          21402..21495
FT                   /note="Fibronectin type-III 55"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21501..21596
FT                   /note="Fibronectin type-III 56"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21602..21697
FT                   /note="Fibronectin type-III 57"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21701..21793
FT                   /note="Ig-like 114"
FT   DOMAIN          21797..21891
FT                   /note="Fibronectin type-III 58"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21894..21986
FT                   /note="Fibronectin type-III 59"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          21990..22083
FT                   /note="Ig-like 115"
FT   DOMAIN          22088..22182
FT                   /note="Fibronectin type-III 60"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22188..22283
FT                   /note="Fibronectin type-III 61"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22286..22382
FT                   /note="Fibronectin type-III 62"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22386..22477
FT                   /note="Ig-like 116"
FT   DOMAIN          22484..22578
FT                   /note="Fibronectin type-III 63"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22584..22679
FT                   /note="Fibronectin type-III 64"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22685..22781
FT                   /note="Fibronectin type-III 65"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22785..22874
FT                   /note="Ig-like 117"
FT   DOMAIN          22881..22976
FT                   /note="Fibronectin type-III 66"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          22978..23071
FT                   /note="Fibronectin type-III 67"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23075..23163
FT                   /note="Ig-like 118"
FT   DOMAIN          23170..23264
FT                   /note="Fibronectin type-III 68"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23270..23364
FT                   /note="Fibronectin type-III 69"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23368..23463
FT                   /note="Fibronectin type-III 70"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23468..23555
FT                   /note="Ig-like 119"
FT   DOMAIN          23566..23660
FT                   /note="Fibronectin type-III 71"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23666..23761
FT                   /note="Fibronectin type-III 72"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23767..23863
FT                   /note="Fibronectin type-III 73"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          23867..23954
FT                   /note="Ig-like 120"
FT   DOMAIN          23963..24057
FT                   /note="Fibronectin type-III 74"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24060..24153
FT                   /note="Fibronectin type-III 75"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24157..24241
FT                   /note="Ig-like 121"
FT   DOMAIN          24252..24346
FT                   /note="Fibronectin type-III 76"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24352..24446
FT                   /note="Fibronectin type-III 77"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24450..24546
FT                   /note="Fibronectin type-III 78"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24550..24641
FT                   /note="Ig-like 122"
FT   DOMAIN          24648..24742
FT                   /note="Fibronectin type-III 79"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24748..24843
FT                   /note="Fibronectin type-III 80"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24849..24945
FT                   /note="Fibronectin type-III 81"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          24949..25038
FT                   /note="Ig-like 123"
FT   DOMAIN          25045..25139
FT                   /note="Fibronectin type-III 82"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25142..25235
FT                   /note="Fibronectin type-III 83"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25239..25325
FT                   /note="Ig-like 124"
FT   DOMAIN          25335..25428
FT                   /note="Fibronectin type-III 84"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25434..25529
FT                   /note="Fibronectin type-III 85"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25532..25627
FT                   /note="Fibronectin type-III 86"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25632..25722
FT                   /note="Ig-like 125"
FT   DOMAIN          25731..25825
FT                   /note="Fibronectin type-III 87"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25831..25926
FT                   /note="Fibronectin type-III 88"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          25932..26028
FT                   /note="Fibronectin type-III 89"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26032..26121
FT                   /note="Ig-like 126"
FT   DOMAIN          26128..26222
FT                   /note="Fibronectin type-III 90"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26225..26318
FT                   /note="Fibronectin type-III 91"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26322..26410
FT                   /note="Ig-like 127"
FT   DOMAIN          26417..26510
FT                   /note="Fibronectin type-III 92"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26516..26611
FT                   /note="Fibronectin type-III 93"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26614..26710
FT                   /note="Fibronectin type-III 94"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26714..26801
FT                   /note="Ig-like 128"
FT   DOMAIN          26812..26906
FT                   /note="Fibronectin type-III 95"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          26912..27007
FT                   /note="Fibronectin type-III 96"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27013..27107
FT                   /note="Fibronectin type-III 97"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27101..27196
FT                   /note="Ig-like 129"
FT   DOMAIN          27205..27296
FT                   /note="Fibronectin type-III 98"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27302..27392
FT                   /note="Fibronectin type-III 99"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27499..27593
FT                   /note="Fibronectin type-III 100"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27599..27694
FT                   /note="Fibronectin type-III 101"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27697..27793
FT                   /note="Fibronectin type-III 102"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27797..27888
FT                   /note="Ig-like 130"
FT   DOMAIN          27895..27989
FT                   /note="Fibronectin type-III 103"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          27995..28090
FT                   /note="Fibronectin type-III 104"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28096..28192
FT                   /note="Fibronectin type-III 105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28196..28286
FT                   /note="Ig-like 131"
FT   DOMAIN          28295..28389
FT                   /note="Fibronectin type-III 106"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28392..28484
FT                   /note="Fibronectin type-III 107"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28488..28577
FT                   /note="Ig-like 132"
FT   DOMAIN          28583..28680
FT                   /note="Fibronectin type-III 108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28686..28781
FT                   /note="Fibronectin type-III 109"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28784..28879
FT                   /note="Fibronectin type-III 110"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          28882..28974
FT                   /note="Ig-like 133"
FT   DOMAIN          28979..29071
FT                   /note="Fibronectin type-III 111"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29081..29177
FT                   /note="Fibronectin type-III 112"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29180..29278
FT                   /note="Fibronectin type-III 113"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29282..29367
FT                   /note="Ig-like 134"
FT   DOMAIN          29378..29473
FT                   /note="Fibronectin type-III 114"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29475..29568
FT                   /note="Fibronectin type-III 115"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29568..29663
FT                   /note="Ig-like 135"
FT   DOMAIN          29670..29764
FT                   /note="Fibronectin type-III 116"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29770..29865
FT                   /note="Fibronectin type-III 117"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29868..29967
FT                   /note="Fibronectin type-III 118"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          29971..30059
FT                   /note="Ig-like 136"
FT   DOMAIN          30070..30163
FT                   /note="Fibronectin type-III 119"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30169..30265
FT                   /note="Fibronectin type-III 120"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30271..30367
FT                   /note="Fibronectin type-III 121"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30371..30460
FT                   /note="Ig-like 137"
FT   DOMAIN          30467..30561
FT                   /note="Fibronectin type-III 122"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30564..30658
FT                   /note="Fibronectin type-III 123"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30663..30754
FT                   /note="Ig-like 138"
FT   DOMAIN          30761..30855
FT                   /note="Fibronectin type-III 124"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30861..30956
FT                   /note="Fibronectin type-III 125"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          30962..31058
FT                   /note="Fibronectin type-III 126"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31061..31150
FT                   /note="Ig-like 139"
FT   DOMAIN          31158..31254
FT                   /note="Fibronectin type-III 127"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31258..31354
FT                   /note="Fibronectin type-III 128"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31360..31455
FT                   /note="Fibronectin type-III 129"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31460..31548
FT                   /note="Ig-like 140"
FT   DOMAIN          31653..31748
FT                   /note="Fibronectin type-III 130"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31754..31849
FT                   /note="Fibronectin type-III 131"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          31855..31945
FT                   /note="Ig-like 141"
FT   DOMAIN          31955..32046
FT                   /note="Ig-like 142"
FT   DOMAIN          32051..32144
FT                   /note="Fibronectin type-III 132"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          32178..32432
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          32496..32584
FT                   /note="Ig-like 143"
FT   DOMAIN          32617..32710
FT                   /note="Ig-like 144"
FT   DOMAIN          32722..32811
FT                   /note="Ig-like 145"
FT   DOMAIN          33301..33391
FT                   /note="Ig-like 146"
FT   DOMAIN          33488..33576
FT                   /note="Ig-like 147"
FT   DOMAIN          33645..33732
FT                   /note="Ig-like 148"
FT   DOMAIN          33779..33867
FT                   /note="Ig-like 149"
FT   DOMAIN          33963..34052
FT                   /note="Ig-like 150"
FT   DOMAIN          34061..34149
FT                   /note="Ig-like 151"
FT   DOMAIN          34256..34344
FT                   /note="Ig-like 152"
FT   REGION          244..313
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          253..341
FT                   /note="ZIS1"
FT   REGION          333..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..886
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1408..1443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1410..1440
FT                   /note="ZIS5"
FT   REGION          4241..4272
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          9920..9945
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10039..10070
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10087..10109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10207..10280
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10314..10361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10412..10457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10499..10566
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10583..10617
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10661..10743
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          10882..11102
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          11158..11193
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          11362..11636
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          11666..12032
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          14216..14236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          14891..14921
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          15911..15939
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          16614..16654
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          18614..18637
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          18716..18743
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          19304..19331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          27090..27110
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          31238..31267
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          33213..33256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          33432..33463
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          33584..33638
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          33749..33777
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          529..561
FT                   /evidence="ECO:0000255"
FT   COILED          2025..2052
FT                   /evidence="ECO:0000255"
FT   COILED          3462..3487
FT                   /evidence="ECO:0000255"
FT   COILED          9534..9577
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        252..266
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..288
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        4247..4266
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        9920..9936
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10044..10070
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10207..10221
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10222..10246
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10247..10261
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10330..10350
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10439..10457
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10505..10566
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10666..10704
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10719..10736
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10882..10948
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        10991..11016
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11032..11098
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11162..11187
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11384..11417
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11592..11609
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11610..11630
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11680..11694
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11770..11804
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11816..11841
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11850..11904
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11917..11933
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11935..11949
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11984..11999
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        12008..12024
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        14221..14236
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15922..15936
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        16621..16638
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        19315..19331
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31249..31263
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33221..33240
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33432..33460
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33597..33617
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33749..33767
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        32298
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         32184..32192
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         32207
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         267
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         6920
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         9122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         11503
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         12007
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         12009
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         12022
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         30443
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         32341
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:9804419"
FT   MOD_RES         33245
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         33247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         33602
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         33614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        964..1015
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1724..1777
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        2109..2134
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:11525170"
FT   DISULFID        2196..2246
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        3259..3311
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        4404..4455
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        4499..4550
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        4592..4643
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        4686..4737
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        4779..4830
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        5061..5112
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        5248..5299
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        5623..5674
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        5810..5861
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        5903..5954
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        6185..6236
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        6372..6423
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        6465..6516
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        6748..6799
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7027..7078
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7123..7174
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7219..7270
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7313..7364
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7406..7457
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7689..7740
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        7968..8019
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8064..8115
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8160..8211
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8254..8305
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8347..8398
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8630..8681
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        8909..8960
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        9005..9056
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        9101..9152
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        9294..9345
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        9693..9743
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        12067..12117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        12611..12660
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        12966..13016
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        13233..13283
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        13322..13372
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        13411..13461
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        13771..13821
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        31481..31532
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        32516..32568
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        33664..33718
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         555..646
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8937992"
FT                   /id="VSP_019138"
FT   VAR_SEQ         556..601
FT                   /note="Missing (in isoform 3, isoform 9 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7569978"
FT                   /id="VSP_019139"
FT   VAR_SEQ         3434
FT                   /note="E -> EGFSKFEENTSNSQWHVSLSVSFKKEPLGQKPSFIQPLSSLRVHNGE
FT                   TVRFHARVSGIPKPEIQWFHNQQLILPTKDVVFHFEESTGMALMLIVDAYSEHAGQYSC
FT                   KAANSAGEATCAATLTVTPKVQALDRQSSGKDVRESAKSQAVADSSFTKEESKISQKEI
FT                   KSFQGSSYEYEVQVFESVSQSSIHTAASVQDTQLCHTASLSQIAESTELSKECAKESTG
FT                   EAPKIFLHLQDVTVKCGDTAQFLCVLKDDSFIDVTWTHEGAKIEESERLKQSQNGNIQF
FT                   LTICNVQLVDQGLYSCIVHNDCGERTTSAVLSVEG (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045935"
FT   VAR_SEQ         3434
FT                   /note="E -> EGFSKFEENTSNSQWHVSLSVSFKKEPLGQKPSFIQPLSSLRVHNGE
FT                   TVRFHARVSGIPKPEIQWFHNQQLILPTKDVVFHFEESTGMALMLIVDAYSEHAGQYSC
FT                   KAANSAGEATCAATLTVTPK (in isoform 8 and isoform 10)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_019140"
FT   VAR_SEQ         3434
FT                   /note="E -> EVQALDRQSSGKDVRESAKSQAVADSSFTKEESKISQKEIKSFQGSS
FT                   YEYEVQVFESVSQSSIHTAASVQDTQLCHTASLSQIAESTELSKECAKESTGEAPKIFL
FT                   HLQDVTVKCGDTAQFLCVLKDDSFIDVTWTHEGAKIEESERLKQSQNGNIQFLTICNVQ
FT                   LVDQGLYSCIVHNDCGERTTSAVLSVEG (in isoform 9)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042903"
FT   VAR_SEQ         3435..3645
FT                   /note="APESILHERIEQEIEMEMKEFSSSFLSAEEEGLHSAELQLSKINETLELLSE
FT                   SPVYPTKFDSEKEGTGPIFIKEVSNADISMGDVATLSVTVIGIPKPKIQWFFNGVLLTP
FT                   SADYKFVFDGDDHSLIILFTKLEDEGEYTCMASNDYGKTICSAYLKINSKGEGHKDTET
FT                   ESAVAKSLEKLGGPCPPHFLKELKPIRCAQGLPAIFEYTVV -> VQALDRQSSGKDVR
FT                   ESTKSQAVADSSFTKEESKISQKEIKSFQGSSYEYEVQVFESVSQSSIHTAASVQDTQL
FT                   CHTASLSQIAESTELSKECAKESTGEAPKIFLHLQDVTVKCGDTAQFLCVLKDDSFIDV
FT                   TWTHEGAKIEESERLKQSQNGNIQFLTICNVQLVDQGLYSCIVHNDCGERTTSAVLSVE
FT                   GAPESILHERIEQEIEMEMK (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_019141"
FT   VAR_SEQ         3454..4380
FT                   /note="Missing (in isoform 4 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:7569978"
FT                   /id="VSP_019142"
FT   VAR_SEQ         3455..5604
FT                   /note="FSSSFLSAEEEGLHSAELQLSKINETLELLSESPVYPTKFDSEKEGTGPIFI
FT                   KEVSNADISMGDVATLSVTVIGIPKPKIQWFFNGVLLTPSADYKFVFDGDDHSLIILFT
FT                   KLEDEGEYTCMASNDYGKTICSAYLKINSKGEGHKDTETESAVAKSLEKLGGPCPPHFL
FT                   KELKPIRCAQGLPAIFEYTVVGEPAPTVTWFKENKQLCTSVYYTIIHNPNGSGTFIVND
FT                   PQREDSGLYICKAENMLGESTCAAELLVLLEDTDMTDTPCKAKSTPEAPEDFPQTPLKG
FT                   PAVEALDSEQEIATFVKDTILKAALITEENQQLSYEHIAKANELSSQLPLGAQELQSIL
FT                   EQDKLTPESTREFLCINGSIHFQPLKEPSPNLQLQIVQSQKTFSKEGILMPEEPETQAV
FT                   LSDTEKIFPSAMSIEQINSLTVEPLKTLLAEPEGNYPQSSIEPPMHSYLTSVAEEVLSP
FT                   KEKTVSDTNREQRVTLQKQEAQSALILSQSLAEGHVESLQSPDVMISQVNYEPLVPSEH
FT                   SCTEGGKILIESANPLENAGQDSAVRIEEGKSLRFPLALEEKQVLLKEEHSDNVVMPPD
FT                   QIIESKREPVAIKKVQEVQGRDLLSKESLLSGIPEEQRLNLKIQICRALQAAVASEQPG
FT                   LFSEWLRNIEKVEVEAVNITQEPRHIMCMYLVTSAKSVTEEVTIIIEDVDPQMANLKME
FT                   LRDALCAIIYEEIDILTAEGPRIQQGAKTSLQEEMDSFSGSQKVEPITEPEVESKYLIS
FT                   TEEVSYFNVQSRVKYLDATPVTKGVASAVVSDEKQDESLKPSEEKEESSSESGTEEVAT
FT                   VKIQEAEGGLIKEDGPMIHTPLVDTVSEEGDIVHLTTSITNAKEVNWYFENKLVPSDEK
FT                   FKCLQDQNTYTLVIDKVNTEDHQGEYVCEALNDSGKTATSAKLTVVKRAAPVIKRKIEP
FT                   LEVALGHLAKFTCEIQSAPNVRFQWFKAGREIYESDKCSIRSSKYISSLEILRTQVVDC
FT                   GEYTCKASNEYGSVSCTATLTVTEAYPPTFLSRPKSLTTFVGKAAKFICTVTGTPVIET
FT                   IWQKDGAALSPSPNWRISDAENKHILELSNLTIQDRGVYSCKASNKFGADICQAELIII
FT                   DKPHFIKELEPVQSAINKKVHLECQVDEDRKVTVTWSKDGQKLPPGKDYKICFEDKIAT
FT                   LEIPLAKLKDSGTYVCTASNEAGSSSCSATVTVREPPSFVKKVDPSYLMLPGESARLHC
FT                   KLKGSPVIQVTWFKNNKELSESNTVRMYFVNSEAILDITDVKVEDSGSYSCEAVNDVGS
FT                   DSCSTEIVIKEPPSFIKTLEPADIVRGTNALLQCEVSGTGPFEISWFKDKKQIRSSKKY
FT                   RLFSQKSLVCLEIFSFNSADVGEYECVVANEVGKCGCMATHLLKEPPTFVKKVDDLIAL
FT                   GGQTVTLQAAVRGSEPISVTWMKGQEVIREDGKIKMSFSNGVAVLIIPDVQISFGGKYT
FT                   CLAENEAGSQTSVGELIVKEPAKIIERAELIQVTAGDPATLEYTVAGTPELKPKWYKDG
FT                   RPLVASKKYRISFKNNVAQLKFYSAELHDSGQYTFEISNEVGSSSCETTFTVLDRDIAP
FT                   FFTKPLRNVDSVVNGTCRLDCKIAGSLPMRVSWFKDGKEIAASDRYRIAFVEGTASLEI
FT                   IRVDMNDAGNFTCRATNSVGSKDSSGALIVQEPPSFVTKPGSKDVLPGSAVCLKSTFQG
FT                   STPLTIRWFKGNKELVSGGSCYITKEALESSLELYLVKTSDSGTYTCKVSNVAGGVECS
FT                   ANLFVKEPATFVEKLEPSQLLKKGDATQLACKVTGTPPIKITWFANDREIKESSKHRMS
FT                   FVESTAVLRLTDVGIEDSGEYMCEAQNEAGSDHCSSIVIVKESPYFTKEFKPIEVLKEY
FT                   DVMLLAEVAGTPPFEITWFKDNTILRSGRKYKTFIQDHLVSLQILKFVAADAGEYQCRV
FT                   TNEVGSSICSARVTLREPPSFIKKIESTSSLRGGTAAFQATLKGSLPITVTWLKDSDEI
FT                   TEDDNIRMTFENNVASLYLSGIEVKHDGKYVCQAKNDAGIQRCSALLSVKEPATITEEA
FT                   VSIDVTQGDPATLQVKFSGTKEITAKWFKDGQELTLGSKYKISVTDTVSILKIISTEKK
FT                   DSGEYTFEVQNDVGRSSCKARINVLDLIIPPSF -> LFSEGESEHSERDTRDAFSDSE
FT                   DIDHKSMAAKRYASRISSTSSWPEYFKPSFTQKLTFKYVLEGEPVVFTCRLIACPTPEM
FT                   TWFHNNRPIPTGLRRIIKAESDLHHHSSSLEIKRVQDRDSGSYRLLAINSEGSAESTAS
FT                   LLVIQKGQDEKYLEFLKRAERTHENVEALVERGEDRIKVDLRFTGSPFNKKQDVEQKGM
FT                   MRTIHFKTMSSAKKTDYMYDEEYLESKSDIRGWLNVGESFLDKETKVKLQRLREARKTL
FT                   MEKKKLSLLDTSSEISSRTLRSEASDKDILFSREDMKIRSMSDLAESYKVDHSAESIVQ
FT                   NPHALSNQMDQNIESEELPTSFQTIVDEEIFQTEIRMSQEALVKESLPKDHLYGEILVN
FT                   ENTQARGQLEEIMANTTIGESSTYITNVCEKEEVYETPENVSQAITPHASESFGTLVNV
FT                   EESEEIASERIKKDDLRELQLSASTRIDEFKTEQKEENMRFFENSFRKRPQRCPPSFLQ
FT                   EIESQEVYEGDSCNFVCHFQGYPQPIVTWYNNDMPIPRNQNFIIHSLENYSILTLSSVH
FT                   HQNEGSITCVLFNQYGTVKTTSMLKVKAKQKHDVKAHKVPVFHDYLDEEEELALVFDQA
FT                   KGAHPSMSQEGQTNLHLLKTNPPVPPSGDTELLSFPVEIQVTAATPIPEQDKESKEVFQ
FT                   TEELEPKAMPQDQVTQSPKHRFVFLSDITNEPPKMLQEMPKHARCREGDSIILECLISG
FT                   EPQPVVTWFQNGVLLKQNQKFQFEEVNCSHQLYIKDVNSQDSGKYKCVAENNSGAVESV
FT                   SDLTVEPVTYRENSQFENIGEIYGKYSRDQQLQDQGESVRAHFYDYPAGPFTPWTNVKE
FT                   YSVRDYFQSLETIEQIDQKEQVRCIPSREKIPRFVHGASRTIKISKPIRAEFIQCQAEG
FT                   KERHVSEKSKLHQAEGTVYPFVDDFSDVTIKKEIRNNFGKLGRSEKENVQECAQSDYLP
FT                   NIHSERISDSYNTKDSSAIVYEESLGEEIHYPGKKVKHRIIEFEKLHVEKGVLEKRPTR
FT                   TSIVNPPQKKIDDKAFSLKQRESRSSNLNANMYQAEKMSPNTESDSSNIAINLKLLSSQ
FT                   THKEFDAQEREQQEKISLIDKPAISKRAEHESPITFDLKQFHTQIKHTDVKFQELDSGQ
FT                   PEEAYFKIQHPADTENIVFDLKQMYSHIGDPALEFQGQETREQQEIHYKEKIPSPETLQ
FT                   PDTHNISKSVQNNVFASQEISSSQELSNRTMVEKSSIDENSISLEKEVRHVQEQNLDIL
FT                   KTDLSLKSFSEEIYSESCALLPTSSADIEETDLSEKSCPLENGGRSSISHLKKAASEEK
FT                   PLGVGEMEEECTLEPELAAFPKQDGGTQEYTDATLEDHRGDVQEADTLHRQLSLSQCFP
FT                   LLMTEEQQNPGEQISTNIHASGEEKCYEEVQVQNEASFSTLEGEMIETSFSQNIPKLDE
FT                   AHTTEAAESETSLTQYLLAAGKREVPETKDTRDQAKLVQSESITSMEVEEVTFNTVYEY
FT                   YNQKQESLGRPLSPESDISIGVGSTTSEEISELDQFYTPPSSVEYFESPKSPDLYFNPS
FT                   DITKQSSIHSGGETVERYSTPLGEVAERYSTPSEGEVGERYSTPPGETLERYSTPPGET
FT                   LERYSTPPGETLERYSTPPGETLERYSTPPGETLERYSTPPGEALERYSIPTGGPNPTG
FT                   TFKTYPSKIEREDGTPNEHFYTPTEERGSAYEIWRSDSFGTPNEAIEPKDNEMPPSFIE
FT                   PLTKRKVYENTTLGFIVEVEGLPVPGVKWYRNKSLLEPDERIKMERVGNVCSLEISNIQ
FT                   KGEGGEYMCHAVNIIGEAKSFANVDIMPQEERVVALPPPVTHQHVMEFDLEHTTSSRTP
FT                   SPQEIVLEVELSEKDVKEFEKQVKIVTVPEFTPDHKSMIVSLDVLPFNFVDPNMDSREG
FT                   EDKELKIDLEVFEMPPRFIMPICDFKIPENSDAVFKCSVIGIPTPEVKWYKEYMCIEPD
FT                   NIKYVISEEKGSHTLKIRNVCLSDSATYRCRAVNCVGEAICRGFLTMGDSEIFAVIAKK
FT                   SKVTLSSLMEELVLKSNYTDSFFEFQVVEGPPRFIKGISDCYAPIGTAAYFQCLVRGSP
FT                   RPTVYWYKDGKLVQGRRFTVEESGTGFHNLFITSLVKSDEGEYRCVATNKSGMAESFAA
FT                   LTLT (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_019143"
FT   VAR_SEQ         3646..4380
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_019144"
FT   VAR_SEQ         4474..11851
FT                   /note="Missing (in isoform 3, isoform 9 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7569978"
FT                   /id="VSP_019145"
FT   VAR_SEQ         5605..34350
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_019146"
FT   VAR_SEQ         10382..10645
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12785098"
FT                   /id="VSP_019147"
FT   VAR_SEQ         10742..10931
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12785098"
FT                   /id="VSP_019148"
FT   VAR_SEQ         11015..11163
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12785098"
FT                   /id="VSP_019149"
FT   VAR_SEQ         11117
FT                   /note="I -> VPKKPVPEKKVPVPAPKKVEPPPPPKVPEI (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045929"
FT   VAR_SEQ         11133
FT                   /note="E -> EAPPAKVSVVPKKPEPEKKVPPPGLKKAV (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045930"
FT   VAR_SEQ         11223..11852
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12785098"
FT                   /id="VSP_019150"
FT   VAR_SEQ         11421
FT                   /note="K -> KAPEVPKKIVPEEKVREAVLKKPEVPPAKVPGMPKKSVQEEKSPIVI
FT                   SEDTEMYIYEASEEAVLEEKVLVTQPQKTKPKLAKVPEPPKKVVPEDKIYVTIPKKRET
FT                   PATKEPDTTRGIFPEVEPPEAIPEIPEHPPTEEFEVFKEVIPEGETPIVKRRKTPSPTV
FT                   PESPREIVPVKETPMAAPLEIEIPPTKAPEAMKEVVPEMKIFEDVPEEPETPRMKTPEA
FT                   PQEIIPAKTVPSKKREPPSVKVPEALQEIVPEKKTLVVPLRKPEVLPDEVPEALREVVP
FT                   EKKVHPPQRAEVVPVKVHEAPKEIIPEKKVSVVPPKKPEVPPVKVPEASKEVIREEKVP
FT                   LAPPKEPEVPPVKVPEPPKEVVPEKKAPVAPPKEPEVPPVKVPEAPKEVVPEKKVPVPP
FT                   PKKPEVPPTKVPEVPKAAVPEKKLPEAIPPKPESPPPE (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045931"
FT   VAR_SEQ         11450
FT                   /note="P -> PKVPEAPKEVVLEKKASVAVPKKPEAPRAKVPEAAQEVVPEKKIPKA
FT                   PIKKPEAPAVTVPEVPQEATEKEIPVAPPKKPEAPIVPVPEAQEVVPEKKVPKAPPTKP
FT                   EAPPATVPEVPQEIVPEKKTLVLPKKPEVPPVTVPEAPKEVVLEKKVPSAPPKKPEVPP
FT                   V (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045932"
FT   VAR_SEQ         11507
FT                   /note="E -> EVPEVLPPKEVVPEKKVPVPPAKKPEAPPPKVPEAPKEVVLEKKASV
FT                   AVPKKPEAPRAKVPEAAQEVVPEKKIPKAPIKKPEAPAVTVPEVPQEAAEKEIPVAPPK
FT                   KPEAPIVPVPEAQEVVPEKKVPKAPPTKPEAPPATVPEVPQEIVPEKKTLVLPKKPEVP
FT                   PVTVPEAPKEVVLEKKVPSTPPKKPEVPPVKVPEAPKEVVPEKKVPVPPPKKPEVPPTK
FT                   VPEVPKAAVPEKKVPEAIPPKPESPPPEVPEVLPPKEVVPEKKVPVPPAKKPEAPPPKV
FT                   PEAPKEVVLEKKVSVAVPKKPEAPRAKVPEAAQEVVPEKKIPKAPIKKPEAPAVTVPEV
FT                   PQEAAEKEIPVAPPKKPEAPIVPVPEAQEVVPEKKVPKAPPTKPEAPPATVPEVPQEIV
FT                   PEKKTLVLPKKPEVPPVTVPEAPKEVVLEKKVPLAPPKKPEVPPVKVPEAPKEVVPEKK
FT                   VPVTPPKKPEVPPVKVPEAPIEVVPEKKMPLAPPKKPEVPPVKVPEAPKEVVPEKKVPS
FT                   APPKKPEVPPVK (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045933"
FT   VAR_SEQ         11507
FT                   /note="E -> EVFEEPEESPSAPPKKPEVPPVR (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:7569978"
FT                   /id="VSP_019151"
FT   VAR_SEQ         11790
FT                   /note="P -> PKEPEMPKKVVPVKKVPTVKKPETPAAKVPEVPKKLVPVKKEPVPVT
FT                   KKPEVLPEKVPKVPEKIIPEKEVSVPIPAEPEVPPAEVEETPEEIIYEEKASITIGRKE
FT                   TPPVEEREIEKYIKPEEPEPEPQPEEIPV (in isoform 13)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047142"
FT   VAR_SEQ         11793
FT                   /note="P -> PEMPKKVVPVKKVPTVKKPETPAAKVPEVPKKLVPVKKEPVPVTKKP
FT                   EVLPEKVPKVPEKIIPEKEVSVPIPAEPEVPPAEVEETPEEIIYEEKASITIGRKETPP
FT                   VEEREIEKYIKPEEPEPEPQPEEIPVKEP (in isoform 12)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045934"
FT   VAR_SEQ         11985..12201
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12785098"
FT                   /id="VSP_019152"
FT   VARIANT         54
FT                   /note="V -> M (in CMD1G; affects interaction with
FT                   TCAP/telethonin; dbSNP:rs139517732)"
FT                   /evidence="ECO:0000269|PubMed:11846417"
FT                   /id="VAR_026685"
FT   VARIANT         60
FT                   /note="D -> Y (in dbSNP:rs35683768)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040078"
FT   VARIANT         115
FT                   /note="V -> M (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs564777385)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040079"
FT   VARIANT         279
FT                   /note="R -> W (in MFM9; disrupts NBR1-binding;
FT                   dbSNP:rs138060032)"
FT                   /evidence="ECO:0000269|PubMed:15802564"
FT                   /id="VAR_026634"
FT   VARIANT         328
FT                   /note="R -> C (in dbSNP:rs16866538)"
FT                   /evidence="ECO:0000269|PubMed:11846417,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_026686"
FT   VARIANT         360
FT                   /note="R -> T (in dbSNP:rs56128843)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040080"
FT   VARIANT         498
FT                   /note="V -> I (in dbSNP:rs72647851)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040081"
FT   VARIANT         740
FT                   /note="R -> L (in CMH9; dbSNP:rs28933405)"
FT                   /evidence="ECO:0000269|PubMed:10462489"
FT                   /id="VAR_026687"
FT   VARIANT         743
FT                   /note="A -> V (in CMD1G; affects interaction with
FT                   TCAP/telethonin; dbSNP:rs267607157)"
FT                   /evidence="ECO:0000269|PubMed:11846417"
FT                   /id="VAR_026688"
FT   VARIANT         799
FT                   /note="T -> M (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs149061352)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040082"
FT   VARIANT         811
FT                   /note="T -> I (in dbSNP:rs35813871)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040083"
FT   VARIANT         922
FT                   /note="R -> H (in dbSNP:rs56046320)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040084"
FT   VARIANT         937
FT                   /note="E -> D (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040085"
FT   VARIANT         976
FT                   /note="W -> R (in CMD1G; dbSNP:rs267607155)"
FT                   /evidence="ECO:0000269|PubMed:11788824"
FT                   /id="VAR_026689"
FT   VARIANT         1081
FT                   /note="A -> T (in dbSNP:rs55914517)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040086"
FT   VARIANT         1137
FT                   /note="G -> R (in dbSNP:rs72647870)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040087"
FT   VARIANT         1201
FT                   /note="K -> E (in dbSNP:rs10497520)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040088"
FT   VARIANT         1202
FT                   /note="V -> A (in dbSNP:rs150667217)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040089"
FT   VARIANT         1249
FT                   /note="S -> L (in dbSNP:rs1552280)"
FT                   /id="VAR_056081"
FT   VARIANT         1295
FT                   /note="S -> L (in dbSNP:rs1552280)"
FT                   /evidence="ECO:0000269|PubMed:10850961,
FT                   ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040090"
FT   VARIANT         1345
FT                   /note="G -> D (in dbSNP:rs36021856)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040091"
FT   VARIANT         1347
FT                   /note="A -> T (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs267599092)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040092"
FT   VARIANT         1350
FT                   /note="R -> H (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs539470256)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040093"
FT   VARIANT         1353
FT                   /note="V -> L (in dbSNP:rs36062108)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040094"
FT   VARIANT         1393
FT                   /note="I -> V (in dbSNP:rs16866531)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040095"
FT   VARIANT         1416
FT                   /note="R -> C (in dbSNP:rs72647875)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040096"
FT   VARIANT         1441
FT                   /note="R -> P (in dbSNP:rs72647876)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040097"
FT   VARIANT         1544
FT                   /note="I -> V (in dbSNP:rs72647877)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040098"
FT   VARIANT         1572
FT                   /note="R -> Q (in dbSNP:rs12476289)"
FT                   /evidence="ECO:0000269|PubMed:10850961,
FT                   ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040099"
FT   VARIANT         1658
FT                   /note="R -> G (in dbSNP:rs56270960)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040100"
FT   VARIANT         1664
FT                   /note="R -> Q (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation; dbSNP:rs375029799)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040101"
FT   VARIANT         1692
FT                   /note="G -> D (in a lung squamous cell carcinoma sample;
FT                   somatic mutation; dbSNP:rs370004591)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040102"
FT   VARIANT         1744
FT                   /note="P -> L (in dbSNP:rs75686037)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040103"
FT   VARIANT         1772
FT                   /note="S -> G (in dbSNP:rs150725992)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040104"
FT   VARIANT         1907
FT                   /note="T -> I (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040105"
FT   VARIANT         1998
FT                   /note="R -> H (in dbSNP:rs144135510)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040106"
FT   VARIANT         2107
FT                   /note="P -> L (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040107"
FT   VARIANT         2118
FT                   /note="I -> T (in dbSNP:rs56404770)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040108"
FT   VARIANT         2164
FT                   /note="A -> T (in dbSNP:rs56285559)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040109"
FT   VARIANT         2240
FT                   /note="D -> Y"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040110"
FT   VARIANT         2392
FT                   /note="G -> S (in dbSNP:rs4894048)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040111"
FT   VARIANT         2432
FT                   /note="L -> F (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation; dbSNP:rs571572592)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040112"
FT   VARIANT         2610
FT                   /note="M -> I (in dbSNP:rs56142888)"
FT                   /evidence="ECO:0000269|PubMed:10850961,
FT                   ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040113"
FT   VARIANT         2771
FT                   /note="I -> M (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation; dbSNP:rs576644663)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040114"
FT   VARIANT         2823
FT                   /note="V -> F (in dbSNP:rs33917087)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040115"
FT   VARIANT         2831
FT                   /note="S -> N (in dbSNP:rs2306636)"
FT                   /evidence="ECO:0000269|PubMed:10850961,
FT                   ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040116"
FT   VARIANT         2930
FT                   /note="V -> I (in dbSNP:rs56373393)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040117"
FT   VARIANT         2963
FT                   /note="T -> P (in dbSNP:rs200875815)"
FT                   /evidence="ECO:0000269|PubMed:25173926"
FT                   /id="VAR_074293"
FT   VARIANT         3026
FT                   /note="N -> I (in dbSNP:rs11900987)"
FT                   /id="VAR_056082"
FT   VARIANT         3154
FT                   /note="K -> R (in dbSNP:rs4893853)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040118"
FT   VARIANT         3191
FT                   /note="Q -> E (in dbSNP:rs33997263)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040119"
FT   VARIANT         3238
FT                   /note="P -> L (in a bladder carcinoma sample; somatic
FT                   mutation; dbSNP:rs397517792)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040120"
FT   VARIANT         3250
FT                   /note="V -> G (in dbSNP:rs55634230)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040121"
FT   VARIANT         3261
FT                   /note="V -> M (in dbSNP:rs2291311)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040122"
FT   VARIANT         3367
FT                   /note="R -> Q (in dbSNP:rs34819099)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040123"
FT   VARIANT         3419
FT                   /note="S -> N (in dbSNP:rs2291310)"
FT                   /evidence="ECO:0000269|PubMed:7569978"
FT                   /id="VAR_056083"
FT   VARIANT         3482
FT                   /note="E -> K (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040124"
FT   VARIANT         3491
FT                   /note="P -> S (in dbSNP:rs2627037)"
FT                   /evidence="ECO:0000269|PubMed:10850961,
FT                   ECO:0000269|PubMed:11717165, ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040125"
FT   VARIANT         3570
FT                   /note="E -> K (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040126"
FT   VARIANT         3590
FT                   /note="L -> V (in dbSNP:rs55853696)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040127"
FT   VARIANT         3637
FT                   /note="P -> S (in dbSNP:rs757223770)"
FT                   /id="VAR_056084"
FT   VARIANT         3762
FT                   /note="I -> V (in dbSNP:rs34070843)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040128"
FT   VARIANT         3799
FT                   /note="S -> Y (in CMD1G)"
FT                   /evidence="ECO:0000269|PubMed:11846417"
FT                   /id="VAR_026690"
FT   VARIANT         3877
FT                   /note="I -> F (in dbSNP:rs34618570)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040129"
FT   VARIANT         3965
FT                   /note="I -> L (in dbSNP:rs56244420)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040130"
FT   VARIANT         4084
FT                   /note="R -> Q (in dbSNP:rs200431386)"
FT                   /evidence="ECO:0000269|PubMed:11846417"
FT                   /id="VAR_026691"
FT   VARIANT         4215
FT                   /note="T -> P (in dbSNP:rs2562829)"
FT                   /evidence="ECO:0000269|PubMed:10051295,
FT                   ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165,
FT                   ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_026635"
FT   VARIANT         4238
FT                   /note="G -> W (in dbSNP:rs56030296)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040131"
FT   VARIANT         4283
FT                   /note="L -> F (in dbSNP:rs1883085)"
FT                   /evidence="ECO:0000269|PubMed:10051295,
FT                   ECO:0000269|PubMed:10850961, ECO:0000269|PubMed:11717165,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_026636"
FT   VARIANT         4291
FT                   /note="I -> T (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040132"
FT   VARIANT         4303
FT                   /note="G -> D (in dbSNP:rs55857742)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040133"
FT   VARIANT         4427
FT                   /note="D -> E (in dbSNP:rs55906845)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040134"
FT   VARIANT         4465
FT                   /note="S -> N (in CMD1G; dbSNP:rs281864908)"
FT                   /evidence="ECO:0000269|PubMed:11846417"
FT                   /id="VAR_026692"
FT   VARIANT         8288
FT                   /note="A -> V (in dbSNP:rs16866412)"
FT                   /id="VAR_056085"
FT   VARIANT         8474
FT                   /note="I -> T (in dbSNP:rs4893852)"
FT                   /id="VAR_056086"
FT   VARIANT         12310
FT                   /note="G -> E (in dbSNP:rs55723264)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040135"
FT   VARIANT         12383
FT                   /note="H -> R (in dbSNP:rs2288563)"
FT                   /evidence="ECO:0000269|PubMed:10850961"
FT                   /id="VAR_040136"
FT   VARIANT         12469
FT                   /note="V -> A (in dbSNP:rs34706299)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040137"
FT   VARIANT         12642
FT                   /note="R -> C (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs199684560)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040138"
FT   VARIANT         12657
FT                   /note="E -> K (in a Wilms tumor; somatic mutation;
FT                   dbSNP:rs778634417)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040139"
FT   VARIANT         12679
FT                   /note="K -> E (in dbSNP:rs6723526)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040140"
FT   VARIANT         12720
FT                   /note="S -> F (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040141"
FT   VARIANT         12798
FT                   /note="R -> C (in dbSNP:rs200914097)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040142"
FT   VARIANT         13049
FT                   /note="E -> G"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040143"
FT   VARIANT         13083
FT                   /note="E -> K (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs1458591077)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040144"
FT   VARIANT         13096
FT                   /note="R -> L (in dbSNP:rs373298007)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040145"
FT   VARIANT         13099
FT                   /note="Q -> R (in a lung small cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040146"
FT   VARIANT         13297
FT                   /note="V -> A (in dbSNP:rs571522834)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040147"
FT   VARIANT         13399
FT                   /note="I -> M (in dbSNP:rs74580375)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040148"
FT   VARIANT         13418
FT                   /note="A -> T (in dbSNP:rs144668626)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040149"
FT   VARIANT         13428
FT                   /note="E -> V (in dbSNP:rs114331773)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040150"
FT   VARIANT         13430
FT                   /note="I -> T (in dbSNP:rs184078045)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040151"
FT   VARIANT         13434
FT                   /note="R -> K (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040152"
FT   VARIANT         13469
FT                   /note="D -> N (in dbSNP:rs17354992)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040153"
FT   VARIANT         13495
FT                   /note="K -> N (in dbSNP:rs72677225)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040154"
FT   VARIANT         13785
FT                   /note="N -> S (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040155"
FT   VARIANT         13870
FT                   /note="Q -> H (in a lung small cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040156"
FT   VARIANT         14109
FT                   /note="V -> I (in dbSNP:rs72677232)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040157"
FT   VARIANT         14131
FT                   /note="R -> Q (in dbSNP:rs72677233)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040158"
FT   VARIANT         14208
FT                   /note="P -> T (in dbSNP:rs146181477)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040159"
FT   VARIANT         14728
FT                   /note="L -> V (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040160"
FT   VARIANT         14750
FT                   /note="R -> Q (in dbSNP:rs200944827)"
FT                   /evidence="ECO:0000269|PubMed:25173926"
FT                   /id="VAR_074294"
FT   VARIANT         14999
FT                   /note="S -> T (in dbSNP:rs55663050)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040161"
FT   VARIANT         15021
FT                   /note="N -> T (in dbSNP:rs36043230)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040162"
FT   VARIANT         15520
FT                   /note="A -> V (in dbSNP:rs16866412)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040163"
FT   VARIANT         15555
FT                   /note="R -> I (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs751398376)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040164"
FT   VARIANT         15620
FT                   /note="R -> Q (in dbSNP:rs201825412)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040165"
FT   VARIANT         15629
FT                   /note="S -> I (in dbSNP:rs200650668)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040166"
FT   VARIANT         15635
FT                   /note="Y -> C (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040167"
FT   VARIANT         15700
FT                   /note="R -> Q (in dbSNP:rs370390570)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040168"
FT   VARIANT         15705
FT                   /note="L -> P (in dbSNP:rs755155531)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040169"
FT   VARIANT         15837
FT                   /note="I -> M (in dbSNP:rs554368924)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040170"
FT   VARIANT         16046
FT                   /note="G -> V (in dbSNP:rs780672348)"
FT                   /evidence="ECO:0000269|PubMed:23033978"
FT                   /id="VAR_069432"
FT   VARIANT         16058
FT                   /note="R -> H (in dbSNP:rs72646808)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040171"
FT   VARIANT         16067
FT                   /note="K -> I (in dbSNP:rs2303832)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040172"
FT   VARIANT         16090
FT                   /note="I -> T (in dbSNP:rs72646809)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040173"
FT   VARIANT         16195
FT                   /note="R -> H (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs373526624)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040174"
FT   VARIANT         16409
FT                   /note="R -> C (in dbSNP:rs55734111)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040175"
FT   VARIANT         16424
FT                   /note="R -> P"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040176"
FT   VARIANT         16575
FT                   /note="V -> M (in dbSNP:rs3813243)"
FT                   /id="VAR_056087"
FT   VARIANT         16629
FT                   /note="I -> M (in dbSNP:rs55809450)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040177"
FT   VARIANT         16877
FT                   /note="K -> R (in dbSNP:rs72646823)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040178"
FT   VARIANT         17060
FT                   /note="N -> D (in dbSNP:rs1001238)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040179"
FT   VARIANT         17637
FT                   /note="I -> V (in dbSNP:rs56025724)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040180"
FT   VARIANT         17838
FT                   /note="R -> H (in dbSNP:rs2288569)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040181"
FT   VARIANT         17866
FT                   /note="D -> N"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040182"
FT   VARIANT         17906
FT                   /note="G -> E (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs374713701)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040183"
FT   VARIANT         18094
FT                   /note="E -> A (in dbSNP:rs769852851)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040184"
FT   VARIANT         18109
FT                   /note="G -> S (in dbSNP:rs200732032)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040185"
FT   VARIANT         18164
FT                   /note="R -> T (in an ovarian serous carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040186"
FT   VARIANT         18221
FT                   /note="P -> L (in dbSNP:rs16866406)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040187"
FT   VARIANT         18222
FT                   /note="A -> T"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040188"
FT   VARIANT         18726
FT                   /note="R -> Q (in dbSNP:rs141973925)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040189"
FT   VARIANT         18835
FT                   /note="V -> A (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation; dbSNP:rs1336054298)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040190"
FT   VARIANT         18881
FT                   /note="R -> K (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs1204056923)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040191"
FT   VARIANT         18939
FT                   /note="N -> S (in dbSNP:rs1470758075)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040192"
FT   VARIANT         19000
FT                   /note="R -> Q (in dbSNP:rs199895260)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040193"
FT   VARIANT         19060
FT                   /note="L -> Q (in a lung large cell carcinoma sample;
FT                   somatic mutation; dbSNP:rs1383995916)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040194"
FT   VARIANT         19091
FT                   /note="R -> K (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040195"
FT   VARIANT         19224
FT                   /note="P -> S (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040196"
FT   VARIANT         19367
FT                   /note="T -> I (in dbSNP:rs72646850)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040197"
FT   VARIANT         19392
FT                   /note="E -> K (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040198"
FT   VARIANT         19480
FT                   /note="A -> S (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040199"
FT   VARIANT         19495
FT                   /note="D -> G (in dbSNP:rs773075736)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040200"
FT   VARIANT         19665
FT                   /note="R -> H (in dbSNP:rs202240487)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040201"
FT   VARIANT         19762
FT                   /note="T -> I (in dbSNP:rs2042996)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040202"
FT   VARIANT         19947
FT                   /note="G -> R (in dbSNP:rs181717727)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040203"
FT   VARIANT         19956
FT                   /note="V -> M (in dbSNP:rs150661999)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040204"
FT   VARIANT         19992
FT                   /note="R -> Q (in dbSNP:rs141965360)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040205"
FT   VARIANT         20057
FT                   /note="R -> C (in dbSNP:rs72646861)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040206"
FT   VARIANT         20075
FT                   /note="S -> L (in dbSNP:rs13021201)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040207"
FT   VARIANT         20179
FT                   /note="T -> K"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040208"
FT   VARIANT         20198
FT                   /note="A -> T (in dbSNP:rs56378177)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040209"
FT   VARIANT         20198
FT                   /note="A -> V (in dbSNP:rs55948748)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040210"
FT   VARIANT         20331
FT                   /note="R -> H (in dbSNP:rs200217934)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040211"
FT   VARIANT         20359
FT                   /note="R -> K (in dbSNP:rs9808036)"
FT                   /id="VAR_056088"
FT   VARIANT         20408
FT                   /note="A -> T (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040212"
FT   VARIANT         20564
FT                   /note="R -> K (in dbSNP:rs72646869)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040213"
FT   VARIANT         20718
FT                   /note="V -> I (in dbSNP:rs2303838)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040214"
FT   VARIANT         20726
FT                   /note="S -> P (in dbSNP:rs72646873)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040215"
FT   VARIANT         20892
FT                   /note="T -> N"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040216"
FT   VARIANT         20894
FT                   /note="S -> R (in dbSNP:rs750847940)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040217"
FT   VARIANT         21125
FT                   /note="D -> E (in dbSNP:rs534340303)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040218"
FT   VARIANT         21403
FT                   /note="P -> S (in dbSNP:rs55980498)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040219"
FT   VARIANT         21730
FT                   /note="R -> C (in dbSNP:rs56141309)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040220"
FT   VARIANT         21747
FT                   /note="R -> Q (in dbSNP:rs55853138)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040221"
FT   VARIANT         21851
FT                   /note="C -> R (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs55713867)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040222"
FT   VARIANT         21925
FT                   /note="G -> R (in dbSNP:rs55801134)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040223"
FT   VARIANT         21995
FT                   /note="R -> H (in dbSNP:rs56071233)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040224"
FT   VARIANT         22045
FT                   /note="A -> V (in dbSNP:rs55903402)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040225"
FT   VARIANT         22149
FT                   /note="R -> H (in dbSNP:rs55677134)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040226"
FT   VARIANT         22160
FT                   /note="V -> I (in dbSNP:rs55885640)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040227"
FT   VARIANT         22261
FT                   /note="I -> T (in dbSNP:rs55837610)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040228"
FT   VARIANT         22306
FT                   /note="K -> N (in dbSNP:rs56019808)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040229"
FT   VARIANT         22357
FT                   /note="R -> H (in dbSNP:rs10164753)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040230"
FT   VARIANT         22408
FT                   /note="L -> P (in dbSNP:rs56399205)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040231"
FT   VARIANT         22537
FT                   /note="Q -> H (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040232"
FT   VARIANT         22584
FT                   /note="P -> L (in dbSNP:rs55992239)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040233"
FT   VARIANT         22646
FT                   /note="L -> P (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040234"
FT   VARIANT         22670
FT                   /note="T -> A (in dbSNP:rs56201325)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040235"
FT   VARIANT         22770
FT                   /note="A -> D (in dbSNP:rs55991022)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040236"
FT   VARIANT         22801
FT                   /note="A -> T (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs764005465)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040237"
FT   VARIANT         22823
FT                   /note="R -> W (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs369098292)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040238"
FT   VARIANT         22968
FT                   /note="E -> Q (in dbSNP:rs55762754)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040239"
FT   VARIANT         23074
FT                   /note="P -> L (in dbSNP:rs55713856)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040240"
FT   VARIANT         23079
FT                   /note="L -> F (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040241"
FT   VARIANT         23282
FT                   /note="D -> N (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040242"
FT   VARIANT         23303
FT                   /note="H -> Y (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040243"
FT   VARIANT         23306
FT                   /note="R -> C (in dbSNP:rs744426)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040244"
FT   VARIANT         23515
FT                   /note="A -> S (in a lung squamous cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040245"
FT   VARIANT         23551
FT                   /note="E -> Q (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040246"
FT   VARIANT         23807
FT                   /note="S -> N (in dbSNP:rs3813243)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040247"
FT   VARIANT         23872
FT                   /note="D -> N (in an ovarian serous carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040248"
FT   VARIANT         23891
FT                   /note="V -> A (in dbSNP:rs55984930)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040249"
FT   VARIANT         23933
FT                   /note="Y -> H (in dbSNP:rs3813245)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040250"
FT   VARIANT         23939
FT                   /note="T -> M (in dbSNP:rs56372592)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040251"
FT   VARIANT         23952
FT                   /note="F -> L (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040252"
FT   VARIANT         24098
FT                   /note="A -> G (in dbSNP:rs56391938)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040253"
FT   VARIANT         24098
FT                   /note="A -> T (in dbSNP:rs4894028)"
FT                   /id="VAR_056089"
FT   VARIANT         24119
FT                   /note="N -> S (in dbSNP:rs3813246)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040254"
FT   VARIANT         24133
FT                   /note="V -> I (in dbSNP:rs56340968)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040255"
FT   VARIANT         24159
FT                   /note="V -> A (in a head and neck squamous cell carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040256"
FT   VARIANT         24239
FT                   /note="T -> A (in dbSNP:rs56018860)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040257"
FT   VARIANT         24265
FT                   /note="E -> K (in dbSNP:rs56341835)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040258"
FT   VARIANT         24584
FT                   /note="I -> T (in dbSNP:rs12463674)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040259"
FT   VARIANT         24781
FT                   /note="I -> T (in dbSNP:rs3731745)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040260"
FT   VARIANT         24799
FT                   /note="R -> H (in dbSNP:rs56044609)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040261"
FT   VARIANT         24954
FT                   /note="D -> H (in dbSNP:rs56307213)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040262"
FT   VARIANT         24980
FT                   /note="T -> M (in dbSNP:rs3731746)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040263"
FT   VARIANT         25659
FT                   /note="R -> H (in dbSNP:rs55850344)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040264"
FT   VARIANT         25679
FT                   /note="A -> T (in dbSNP:rs56365600)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040265"
FT   VARIANT         25720
FT                   /note="P -> A (in dbSNP:rs56137800)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040266"
FT   VARIANT         25821
FT                   /note="T -> K (in dbSNP:rs55933739)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040267"
FT   VARIANT         25859
FT                   /note="E -> K (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs375422359)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040268"
FT   VARIANT         25879
FT                   /note="N -> K (in dbSNP:rs56264840)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040269"
FT   VARIANT         25923
FT                   /note="A -> V (in dbSNP:rs55634791)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040270"
FT   VARIANT         26045
FT                   /note="V -> I (in dbSNP:rs56309296)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040271"
FT   VARIANT         26059
FT                   /note="K -> E (in a lung small cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040272"
FT   VARIANT         26134
FT                   /note="I -> V (in dbSNP:rs3829746)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040273"
FT   VARIANT         26477
FT                   /note="R -> C (in dbSNP:rs56057221)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040274"
FT   VARIANT         26843
FT                   /note="D -> Y (in dbSNP:rs56330345)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040275"
FT   VARIANT         27346
FT                   /note="K -> R (in dbSNP:rs1186947794)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040276"
FT   VARIANT         27652
FT                   /note="R -> C (in dbSNP:rs191482653)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040277"
FT   VARIANT         27728
FT                   /note="G -> V (in dbSNP:rs55898359)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040278"
FT   VARIANT         27754
FT                   /note="F -> L (in dbSNP:rs55940667)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040279"
FT   VARIANT         27755
FT                   /note="I -> T (in dbSNP:rs9808377)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:7569978"
FT                   /id="VAR_040280"
FT   VARIANT         27929
FT                   /note="I -> V (in dbSNP:rs139506970)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040281"
FT   VARIANT         28132
FT                   /note="I -> L (in dbSNP:rs77853750)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040282"
FT   VARIANT         28168
FT                   /note="R -> Q (in dbSNP:rs72648238)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040283"
FT   VARIANT         28538
FT                   /note="R -> H (in dbSNP:rs149567378)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040284"
FT   VARIANT         28572
FT                   /note="I -> T (in dbSNP:rs114026724)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040285"
FT   VARIANT         28948
FT                   /note="A -> T (in dbSNP:rs148617456)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040286"
FT   VARIANT         28986
FT                   /note="I -> V (in dbSNP:rs535151633)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040287"
FT   VARIANT         28993
FT                   /note="G -> E (in dbSNP:rs376628842)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040288"
FT   VARIANT         28998
FT                   /note="L -> V (in dbSNP:rs373049260)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040289"
FT   VARIANT         29070
FT                   /note="V -> M (in dbSNP:rs747122)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040290"
FT   VARIANT         29090
FT                   /note="I -> V (in dbSNP:rs16866391)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040291"
FT   VARIANT         29419
FT                   /note="R -> C (in dbSNP:rs750303653)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040292"
FT   VARIANT         29479
FT                   /note="L -> P (in dbSNP:rs1310673663)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040293"
FT   VARIANT         29880
FT                   /note="S -> L (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040294"
FT   VARIANT         29976
FT                   /note="D -> E (in dbSNP:rs72648256)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040295"
FT   VARIANT         30042
FT                   /note="S -> G (in dbSNP:rs72648257)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040296"
FT   VARIANT         30107
FT                   /note="R -> C (in dbSNP:rs142525903)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040297"
FT   VARIANT         30125
FT                   /note="S -> F (in dbSNP:rs191484894)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040298"
FT   VARIANT         30211
FT                   /note="L -> P (in dbSNP:rs62621206)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040299"
FT   VARIANT         30412
FT                   /note="I -> T (in dbSNP:rs62621236)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040300"
FT   VARIANT         30617
FT                   /note="T -> S (in a renal chromophobe cancer sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040301"
FT   VARIANT         30674
FT                   /note="T -> I (in dbSNP:rs56027402)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040302"
FT   VARIANT         30809
FT                   /note="V -> I (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs397517769)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040303"
FT   VARIANT         30818
FT                   /note="F -> I (in dbSNP:rs56009327)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040304"
FT   VARIANT         30825
FT                   /note="E -> K (in dbSNP:rs55915651)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040305"
FT   VARIANT         30856
FT                   /note="I -> T (in dbSNP:rs55660660)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040306"
FT   VARIANT         30887
FT                   /note="G -> D (in dbSNP:rs56066673)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040307"
FT   VARIANT         30887
FT                   /note="G -> S (in dbSNP:rs56233675)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040308"
FT   VARIANT         30897
FT                   /note="R -> H (in dbSNP:rs3731749)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040309"
FT   VARIANT         30907
FT                   /note="R -> H (in dbSNP:rs55676195)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040310"
FT   VARIANT         30946
FT                   /note="R -> H (in dbSNP:rs55704830)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040311"
FT   VARIANT         31081
FT                   /note="I -> F (in dbSNP:rs72648270)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040312"
FT   VARIANT         31107
FT                   /note="R -> C (in dbSNP:rs72648272)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040313"
FT   VARIANT         31124
FT                   /note="A -> G (in dbSNP:rs72648273)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040314"
FT   VARIANT         31156
FT                   /note="N -> S (in dbSNP:rs149001703)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040315"
FT   VARIANT         31246
FT                   /note="P -> T (in dbSNP:rs55653324)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040316"
FT   VARIANT         31330
FT                   /note="R -> H (in dbSNP:rs4894028)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040317"
FT   VARIANT         31690
FT                   /note="C -> R (in dbSNP:rs56061641)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040318"
FT   VARIANT         31724
FT                   /note="R -> Q (in dbSNP:rs55742743)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040319"
FT   VARIANT         31725
FT                   /note="V -> I (in dbSNP:rs55675869)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040320"
FT   VARIANT         31732
FT                   /note="G -> S (in dbSNP:rs55880786)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040321"
FT   VARIANT         31886
FT                   /note="V -> I (in dbSNP:rs2278196)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040322"
FT   VARIANT         32097
FT                   /note="R -> C (in dbSNP:rs56273463)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040323"
FT   VARIANT         32171
FT                   /note="T -> N (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040324"
FT   VARIANT         32248
FT                   /note="V -> I (in dbSNP:rs34924609)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040325"
FT   VARIANT         32281
FT                   /note="Q -> H (in dbSNP:rs55886356)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040326"
FT   VARIANT         32323
FT                   /note="R -> H (in dbSNP:rs55669553)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040327"
FT   VARIANT         32411
FT                   /note="R -> W (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs756924372)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040328"
FT   VARIANT         32558
FT                   /note="I -> V (in dbSNP:rs56347248)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040329"
FT   VARIANT         32610
FT                   /note="M -> V (in dbSNP:rs56173891)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040330"
FT   VARIANT         32637
FT                   /note="G -> V (in dbSNP:rs3731752)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040331"
FT   VARIANT         32742
FT                   /note="E -> Q (in dbSNP:rs148525155)"
FT                   /evidence="ECO:0000269|PubMed:23033978"
FT                   /id="VAR_069433"
FT   VARIANT         32922
FT                   /note="V -> A (in dbSNP:rs55945684)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040332"
FT   VARIANT         32943
FT                   /note="L -> R (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040333"
FT   VARIANT         32953
FT                   /note="R -> H (in dbSNP:rs3829747)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040334"
FT   VARIANT         32996
FT                   /note="R -> Q (in CMD1G; dbSNP:rs199642423)"
FT                   /evidence="ECO:0000269|PubMed:16465475"
FT                   /id="VAR_026693"
FT   VARIANT         33213
FT                   /note="V -> L (in dbSNP:rs55866005)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040335"
FT   VARIANT         33242
FT                   /note="R -> C (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs1003158162)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040336"
FT   VARIANT         33387
FT                   /note="T -> M (in dbSNP:rs56001826)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040337"
FT   VARIANT         33419
FT                   /note="E -> D (in dbSNP:rs56308529)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040338"
FT   VARIANT         33536
FT                   /note="V -> M (in dbSNP:rs55865284)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040339"
FT   VARIANT         33568
FT                   /note="K -> Q (in dbSNP:rs56365812)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040340"
FT   VARIANT         33616
FT                   /note="E -> K (in dbSNP:rs56324595)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040341"
FT   VARIANT         33620
FT                   /note="P -> L (in dbSNP:rs16866380)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040342"
FT   VARIANT         33886
FT                   /note="E -> V (in dbSNP:rs55725279)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040343"
FT   VARIANT         33899
FT                   /note="I -> T (in dbSNP:rs55880440)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040344"
FT   VARIANT         33904
FT                   /note="L -> P (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040345"
FT   VARIANT         33955
FT                   /note="T -> I (in dbSNP:rs55842557)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040346"
FT   VARIANT         34115
FT                   /note="V -> A (in dbSNP:rs16866378)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040347"
FT   VARIANT         34306
FT                   /note="I -> N (in TMD; dbSNP:rs281864928)"
FT                   /evidence="ECO:0000269|PubMed:12891679"
FT                   /id="VAR_026694"
FT   VARIANT         34315
FT                   /note="L -> P (in TMD; dbSNP:rs267607156)"
FT                   /evidence="ECO:0000269|PubMed:12145747"
FT                   /id="VAR_026695"
FT   MUTAGEN         32207
FT                   /note="K->A: Disrupts catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:9804419"
FT   MUTAGEN         32341
FT                   /note="Y->E: No phosphorylation on tyrosine."
FT                   /evidence="ECO:0000269|PubMed:9804419"
FT   CONFLICT        132
FT                   /note="T -> N (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        255
FT                   /note="P -> H (in Ref. 3; CAD12455/CAD12456/CAD12457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1472..1474
FT                   /note="QTA -> ANC (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1730
FT                   /note="G -> S (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3919
FT                   /note="P -> L (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4525
FT                   /note="R -> K (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        6619
FT                   /note="R -> E (in Ref. 1; CAA62189 and 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7145
FT                   /note="D -> H (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7441
FT                   /note="S -> N (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8038
FT                   /note="A -> E (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8225
FT                   /note="Q -> H (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        8850
FT                   /note="A -> P (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9693
FT                   /note="C -> V (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9892
FT                   /note="I -> V (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10205
FT                   /note="I -> V (in Ref. 3; CAD12456 and 9; AAP80791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10305
FT                   /note="G -> R (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10566
FT                   /note="R -> K (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        10779
FT                   /note="R -> H (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11424
FT                   /note="E -> D (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11511
FT                   /note="A -> V (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11626
FT                   /note="K -> N (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        11838
FT                   /note="K -> N (in Ref. 1; CAA62189)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12994
FT                   /note="A -> T (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13795..13797
FT                   /note="YKF -> IQI (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14590
FT                   /note="A -> T (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        14792
FT                   /note="V -> A (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        15974
FT                   /note="E -> K (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        16234..16235
FT                   /note="TK -> QR (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        17238
FT                   /note="R -> H (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        17423
FT                   /note="R -> S (in Ref. 3; CAD12456)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        19734
FT                   /note="V -> A (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        20517
FT                   /note="G -> A (in Ref. 1; CAA62188 and 3; CAD12455)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        20622
FT                   /note="L -> H (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        20775
FT                   /note="A -> P (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        21625
FT                   /note="Y -> I (in Ref. 13; CAA45939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        21795..21800
FT                   /note="PGPVLN -> ARPSPQ (in Ref. 13; CAA45939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22176
FT                   /note="C -> W (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22816
FT                   /note="A -> D (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22837
FT                   /note="T -> A (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        24176
FT                   /note="I -> M (in Ref. 1; CAA62188 and 13; CAA45940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        24181
FT                   /note="S -> F (in Ref. 13; CAA45940)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25731
FT                   /note="P -> S (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        26573
FT                   /note="M -> V (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        26846..26848
FT                   /note="IVE -> HRK (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        27879
FT                   /note="G -> A (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        28936
FT                   /note="D -> N (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29222
FT                   /note="A -> T (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29518
FT                   /note="F -> L (in Ref. 1; CAA62188)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29701
FT                   /note="T -> P (in Ref. 14; CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29873
FT                   /note="E -> G (in Ref. 14; CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        29878
FT                   /note="T -> Q (in Ref. 14; CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30209
FT                   /note="K -> E (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30256
FT                   /note="A -> R (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30496
FT                   /note="V -> I (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30534
FT                   /note="Y -> H (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        30748
FT                   /note="S -> L (in Ref. 14; CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        31303
FT                   /note="W -> V (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32060
FT                   /note="V -> A (in Ref. 1; CAA62188 and 14;
FT                   CAA45938/CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33084
FT                   /note="D -> N (in Ref. 1; CAA62188 and 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33120
FT                   /note="R -> W (in Ref. 15; CAD28458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33382
FT                   /note="A -> R (in Ref. 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33424
FT                   /note="S -> P (in Ref. 1; CAA62188 and 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33526
FT                   /note="Q -> R (in Ref. 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33633
FT                   /note="T -> I (in Ref. 1; CAA62188 and 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33716
FT                   /note="Y -> V (in Ref. 15; CAD28458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33995
FT                   /note="V -> A (in Ref. 15; CAD28458)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        34071
FT                   /note="N -> G (in Ref. 5; AAI07798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        34082
FT                   /note="C -> R (in Ref. 14; CAA49245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        34253
FT                   /note="G -> R (in Ref. 5; AAI07798)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..10
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          15..18
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          23..33
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          36..45
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   TURN            48..50
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          55..59
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          62..69
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   HELIX           72..74
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          76..84
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          87..98
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          102..108
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          113..116
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          119..131
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          134..139
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:1YA5"
FT   STRAND          147..155
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          158..166
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          172..180
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          183..194
FT                   /evidence="ECO:0007829|PDB:2A38"
FT   STRAND          199..205
FT                   /evidence="ECO:0007829|PDB:6FWX"
FT   STRAND          209..213
FT                   /evidence="ECO:0007829|PDB:6FWX"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:6FWX"
FT   STRAND          236..241
FT                   /evidence="ECO:0007829|PDB:6FWX"
FT   STRAND          1850..1852
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1858..1863
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1866..1869
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1871..1876
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   TURN            1891..1893
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1894..1899
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1908..1916
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          1919..1929
FT                   /evidence="ECO:0007829|PDB:6DL4"
FT   STRAND          2076..2082
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2087..2090
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2095..2105
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2108..2113
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2122..2130
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2133..2138
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   HELIX           2143..2145
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2147..2155
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2158..2169
FT                   /evidence="ECO:0007829|PDB:1G1C"
FT   STRAND          2797..2799
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2804..2807
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2812..2820
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2826..2829
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2838..2845
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2848..2853
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   HELIX           2858..2860
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2862..2868
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2871..2880
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2884..2886
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2891..2894
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2899..2907
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2914..2916
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2924..2932
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2935..2940
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   HELIX           2945..2947
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2949..2955
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2958..2967
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2971..2973
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2978..2981
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          2986..2994
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          3000..3003
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          3012..3019
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          3022..3027
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   HELIX           3032..3034
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          3036..3042
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   STRAND          3045..3053
FT                   /evidence="ECO:0007829|PDB:5JDD"
FT   HELIX           9506..9510
FT                   /evidence="ECO:0007829|PDB:7NIP"
FT   HELIX           9518..9525
FT                   /evidence="ECO:0007829|PDB:7NIP"
FT   HELIX           9530..9543
FT                   /evidence="ECO:0007829|PDB:7NIP"
FT   STRAND          9582..9587
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9592..9595
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9600..9608
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9616..9619
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9628..9635
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9638..9643
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   HELIX           9648..9650
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9652..9658
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9661..9670
FT                   /evidence="ECO:0007829|PDB:5JOE"
FT   STRAND          9674..9676
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9681..9684
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9689..9697
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9703..9706
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9717..9722
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9725..9732
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   HELIX           9735..9737
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9739..9745
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9748..9757
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9763..9765
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9770..9772
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9778..9786
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9790..9795
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9803..9811
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9814..9819
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   HELIX           9824..9826
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9828..9835
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          9841..9850
FT                   /evidence="ECO:0007829|PDB:7AHS"
FT   STRAND          12680..12682
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12687..12690
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12691..12693
FT                   /evidence="ECO:0007829|PDB:6I0Y"
FT   STRAND          12695..12705
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12709..12712
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12719..12722
FT                   /evidence="ECO:0007829|PDB:1TIU"
FT   STRAND          12723..12728
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12731..12736
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   HELIX           12741..12743
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12745..12751
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          12754..12763
FT                   /evidence="ECO:0007829|PDB:1WAA"
FT   STRAND          14223..14228
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          14232..14240
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          14252..14259
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          14275..14281
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          14288..14296
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          14308..14314
FT                   /evidence="ECO:0007829|PDB:4O00"
FT   STRAND          22291..22296
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22299..22303
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22319..22324
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22340..22345
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22354..22361
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22367..22377
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   HELIX           22381..22384
FT                   /evidence="ECO:0007829|PDB:1BPV"
FT   STRAND          22883..22890
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22895..22900
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22912..22919
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22926..22932
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22934..22939
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22947..22956
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22970..22972
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22982..22987
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          22992..22996
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          23009..23016
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          23023..23035
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          23043..23052
FT                   /evidence="ECO:0007829|PDB:3LPW"
FT   STRAND          31458..31464
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31469..31472
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31475..31487
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31490..31495
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31498..31500
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31504..31520
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   HELIX           31524..31526
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31528..31535
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31540..31555
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31563..31568
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31573..31583
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31586..31591
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31600..31606
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31608..31617
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   HELIX           31620..31623
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31625..31632
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31637..31647
FT                   /evidence="ECO:0007829|PDB:3LCY"
FT   STRAND          31856..31859
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31864..31867
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31872..31879
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31885..31890
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31893..31895
FT                   /evidence="ECO:0007829|PDB:2J8O"
FT   STRAND          31899..31907
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   TURN            31908..31910
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31911..31916
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   HELIX           31921..31923
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31925..31933
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31936..31952
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   HELIX           31956..31959
FT                   /evidence="ECO:0007829|PDB:2NZI"
FT   STRAND          31961..31967
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31973..31982
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31985..31992
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          31997..32000
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          32002..32005
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          32007..32013
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   HELIX           32020..32022
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          32024..32032
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          32035..32046
FT                   /evidence="ECO:0007829|PDB:2J8H"
FT   STRAND          32053..32061
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   STRAND          32063..32070
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   STRAND          32076..32078
FT                   /evidence="ECO:0007829|PDB:2NZI"
FT   STRAND          32082..32089
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   STRAND          32095..32111
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   STRAND          32117..32125
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   HELIX           32142..32154
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   STRAND          32167..32170
FT                   /evidence="ECO:0007829|PDB:6YGN"
FT   TURN            32175..32177
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32178..32186
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32188..32197
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   TURN            32198..32201
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32202..32209
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32214..32228
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32237..32243
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32246..32251
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32259..32263
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32265..32267
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32272..32291
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32301..32303
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32304..32310
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32314..32316
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32330..32336
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32338..32340
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32343..32346
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32353..32369
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32379..32388
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32395..32398
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32403..32410
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32417..32419
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32423..32428
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32430..32433
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32436..32438
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32447..32457
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   HELIX           32466..32472
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32474..32476
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32483..32489
FT                   /evidence="ECO:0007829|PDB:1TKI"
FT   STRAND          32504..32506
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32512..32520
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32526..32531
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32538..32547
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32550..32555
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   HELIX           32560..32562
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32564..32571
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32576..32585
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   TURN            32586..32588
FT                   /evidence="ECO:0007829|PDB:2BK8"
FT   STRAND          32720..32726
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32731..32734
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32739..32749
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32752..32757
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   TURN            32765..32767
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32768..32773
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   TURN            32774..32776
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32777..32784
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   HELIX           32787..32789
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32791..32799
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   STRAND          32802..32813
FT                   /evidence="ECO:0007829|PDB:6HCI"
FT   TURN            33294..33297
FT                   /evidence="ECO:0007829|PDB:3QP3"
FT   STRAND          33299..33305
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33310..33313
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33318..33328
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33331..33336
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33345..33352
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33355..33360
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   HELIX           33365..33367
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33369..33377
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33380..33391
FT                   /evidence="ECO:0007829|PDB:6H4L"
FT   STRAND          33489..33492
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33497..33503
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33509..33512
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33514..33516
FT                   /evidence="ECO:0007829|PDB:1TNM"
FT   STRAND          33523..33526
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33532..33538
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33540..33547
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33556..33560
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33571..33577
FT                   /evidence="ECO:0007829|PDB:1NCT"
FT   STRAND          33777..33783
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33788..33794
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33796..33806
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33809..33814
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33821..33830
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33833..33838
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   HELIX           33843..33845
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33847..33855
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          33858..33869
FT                   /evidence="ECO:0007829|PDB:3PUC"
FT   STRAND          34060..34071
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34078..34088
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34091..34096
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   TURN            34104..34106
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34107..34112
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34115..34122
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   HELIX           34125..34127
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34129..34136
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34138..34148
FT                   /evidence="ECO:0007829|PDB:4UOW"
FT   STRAND          34254..34258
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34263..34268
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34271..34283
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34286..34291
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   HELIX           34300..34302
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34304..34308
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34310..34319
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   HELIX           34322..34324
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34326..34334
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   STRAND          34337..34348
FT                   /evidence="ECO:0007829|PDB:3KNB"
FT   CONFLICT        Q8WZ42-6:3732
FT                   /note="L -> F (in Ref. 3; CAD12457)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        Q8WZ42-6:5139
FT                   /note="R -> M (in Ref. 3; CAD12457)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   34350 AA;  3816030 MW;  DEB216410AD560D9 CRC64;
     MTTQAPTFTQ PLQSVVVLEG STATFEAHIS GFPVPEVSWF RDGQVISTST LPGVQISFSD
     GRAKLTIPAV TKANSGRYSL KATNGSGQAT STAELLVKAE TAPPNFVQRL QSMTVRQGSQ
     VRLQVRVTGI PTPVVKFYRD GAEIQSSLDF QISQEGDLYS LLIAEAYPED SGTYSVNATN
     SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR IEKKIEAHFD ARSIATVEMV
     IDGAAGQQLP HKTPPRIPPK PKSRSPTPPS IAAKAQLARQ QSPSPIRHSP SPVRHVRAPT
     PSPVRSVSPA ARISTSPIRS VRSPLLMRKT QASTVATGPE VPPPWKQEGY VASSSEAEMR
     ETTLTTSTQI RTEERWEGRY GVQEQVTISG AAGAAASVSA SASYAAEAVA TGAKEVKQDA
     DKSAAVATVV AAVDMARVRE PVISAVEQTA QRTTTTAVHI QPAQEQVRKE AEKTAVTKVV
     VAADKAKEQE LKSRTKEVIT TKQEQMHVTH EQIRKETEKT FVPKVVISAA KAKEQETRIS
     EEITKKQKQV TQEAIRQETE ITAASMVVVA TAKSTKLETV PGAQEETTTQ QDQMHLSYEK
     IMKETRKTVV PKVIVATPKV KEQDLVSRGR EGITTKREQV QITQEKMRKE AEKTALSTIA
     VATAKAKEQE TILRTRETMA TRQEQIQVTH GKVDVGKKAE AVATVVAAVD QARVREPREP
     GHLEESYAQQ TTLEYGYKER ISAAKVAEPP QRPASEPHVV PKAVKPRVIQ APSETHIKTT
     DQKGMHISSQ IKKTTDLTTE RLVHVDKRPR TASPHFTVSK ISVPKTEHGY EASIAGSAIA
     TLQKELSATS SAQKITKSVK APTVKPSETR VRAEPTPLPQ FPFADTPDTY KSEAGVEVKK
     EVGVSITGTT VREERFEVLH GREAKVTETA RVPAPVEIPV TPPTLVSGLK NVTVIEGESV
     TLECHISGYP SPTVTWYRED YQIESSIDFQ ITFQSGIARL MIREAFAEDS GRFTCSAVNE
     AGTVSTSCYL AVQVSEEFEK ETTAVTEKFT TEEKRFVESR DVVMTDTSLT EEQAGPGEPA
     APYFITKPVV QKLVEGGSVV FGCQVGGNPK PHVYWKKSGV PLTTGYRYKV SYNKQTGECK
     LVISMTFADD AGEYTIVVRN KHGETSASAS LLEEADYELL MKSQQEMLYQ TQVTAFVQEP
     KVGETAPGFV YSEYEKEYEK EQALIRKKMA KDTVVVRTYV EDQEFHISSF EERLIKEIEY
     RIIKTTLEEL LEEDGEEKMA VDISESEAVE SGFDSRIKNY RILEGMGVTF HCKMSGYPLP
     KIAWYKDGKR IKHGERYQMD FLQDGRASLR IPVVLPEDEG IYTAFASNIK GNAICSGKLY
     VEPAAPLGAP TYIPTLEPVS RIRSLSPRSV SRSPIRMSPA RMSPARMSPA RMSPARMSPG
     RRLEETDESQ LERLYKPVFV LKPVSFKCLE GQTARFDLKV VGRPMPETFW FHDGQQIVND
     YTHKVVIKED GTQSLIIVPA TPSDSGEWTV VAQNRAGRSS ISVILTVEAV EHQVKPMFVE
     KLKNVNIKEG SRLEMKVRAT GNPNPDIVWL KNSDIIVPHK YPKIRIEGTK GEAALKIDST
     VSQDSAWYTA TAINKAGRDT TRCKVNVEVE FAEPEPERKL IIPRGTYRAK EIAAPELEPL
     HLRYGQEQWE EGDLYDKEKQ QKPFFKKKLT SLRLKRFGPA HFECRLTPIG DPTMVVEWLH
     DGKPLEAANR LRMINEFGYC SLDYGVAYSR DSGIITCRAT NKYGTDHTSA TLIVKDEKSL
     VEESQLPEGR KGLQRIEELE RMAHEGALTG VTTDQKEKQK PDIVLYPEPV RVLEGETARF
     RCRVTGYPQP KVNWYLNGQL IRKSKRFRVR YDGIHYLDIV DCKSYDTGEV KVTAENPEGV
     IEHKVKLEIQ QREDFRSVLR RAPEPRPEFH VHEPGKLQFE VQKVDRPVDT TETKEVVKLK
     RAERITHEKV PEESEELRSK FKRRTEEGYY EAITAVELKS RKKDESYEEL LRKTKDELLH
     WTKELTEEEK KALAEEGKIT IPTFKPDKIE LSPSMEAPKI FERIQSQTVG QGSDAHFRVR
     VVGKPDPECE WYKNGVKIER SDRIYWYWPE DNVCELVIRD VTAEDSASIM VKAINIAGET
     SSHAFLLVQA KQLITFTQEL QDVVAKEKDT MATFECETSE PFVKVKWYKD GMEVHEGDKY
     RMHSDRKVHF LSILTIDTSD AEDYSCVLVE DENVKTTAKL IVEGAVVEFV KELQDIEVPE
     SYSGELECIV SPENIEGKWY HNDVELKSNG KYTITSRRGR QNLTVKDVTK EDQGEYSFVI
     DGKKTTCKLK MKPRPIAILQ GLSDQKVCEG DIVQLEVKVS LESVEGVWMK DGQEVQPSDR
     VHIVIDKQSH MLLIEDMTKE DAGNYSFTIP ALGLSTSGRV SVYSVDVITP LKDVNVIEGT
     KAVLECKVSV PDVTSVKWYL NDEQIKPDDR VQAIVKGTKQ RLVINRTHAS DEGPYKLIVG
     RVETNCNLSV EKIKIIRGLR DLTCTETQNV VFEVELSHSG IDVLWNFKDK EIKPSSKYKI
     EAHGKIYKLT VLNMMKDDEG KYTFYAGENM TSGKLTVAGG AISKPLTDQT VAESQEAVFE
     CEVANPDSKG EWLRDGKHLP LTNNIRSESD GHKRRLIIAA TKLDDIGEYT YKVATSKTSA
     KLKVEAVKIK KTLKNLTVTE TQDAVFTVEL THPNVKGVQW IKNGVVLESN EKYAISVKGT
     IYSLRIKNCA IVDESVYGFR LGRLGASARL HVETVKIIKK PKDVTALENA TVAFEVSVSH
     DTVPVKWFHK SVEIKPSDKH RLVSERKVHK LMLQNISPSD AGEYTAVVGQ LECKAKLFVE
     TLHITKTMKN IEVPETKTAS FECEVSHFNV PSMWLKNGVE IEMSEKFKIV VQGKLHQLII
     MNTSTEDSAE YTFVCGNDQV SATLTVTPIM ITSMLKDINA EEKDTITFEV TVNYEGISYK
     WLKNGVEIKS TDKCQMRTKK LTHSLNIRNV HFGDAADYTF VAGKATSTAT LYVEARHIEF
     RKHIKDIKVL EKKRAMFECE VSEPDITVQW MKDDQELQIT DRIKIQKEKY VHRLLIPSTR
     MSDAGKYTVV AGGNVSTAKL FVEGRDVRIR SIKKEVQVIE KQRAVVEFEV NEDDVDAHWY
     KDGIEINFQV QERHKYVVER RIHRMFISET RQSDAGEYTF VAGRNRSSVT LYVNAPEPPQ
     VLQELQPVTV QSGKPARFCA VISGRPQPKI SWYKEEQLLS TGFKCKFLHD GQEYTLLLIE
     AFPEDAAVYT CEAKNDYGVA TTSASLSVEV PEVVSPDQEM PVYPPAIITP LQDTVTSEGQ
     PARFQCRVSG TDLKVSWYSK DKKIKPSRFF RMTQFEDTYQ LEIAEAYPED EGTYTFVASN
     AVGQVSSTAN LSLEAPESIL HERIEQEIEM EMKEFSSSFL SAEEEGLHSA ELQLSKINET
     LELLSESPVY PTKFDSEKEG TGPIFIKEVS NADISMGDVA TLSVTVIGIP KPKIQWFFNG
     VLLTPSADYK FVFDGDDHSL IILFTKLEDE GEYTCMASND YGKTICSAYL KINSKGEGHK
     DTETESAVAK SLEKLGGPCP PHFLKELKPI RCAQGLPAIF EYTVVGEPAP TVTWFKENKQ
     LCTSVYYTII HNPNGSGTFI VNDPQREDSG LYICKAENML GESTCAAELL VLLEDTDMTD
     TPCKAKSTPE APEDFPQTPL KGPAVEALDS EQEIATFVKD TILKAALITE ENQQLSYEHI
     AKANELSSQL PLGAQELQSI LEQDKLTPES TREFLCINGS IHFQPLKEPS PNLQLQIVQS
     QKTFSKEGIL MPEEPETQAV LSDTEKIFPS AMSIEQINSL TVEPLKTLLA EPEGNYPQSS
     IEPPMHSYLT SVAEEVLSPK EKTVSDTNRE QRVTLQKQEA QSALILSQSL AEGHVESLQS
     PDVMISQVNY EPLVPSEHSC TEGGKILIES ANPLENAGQD SAVRIEEGKS LRFPLALEEK
     QVLLKEEHSD NVVMPPDQII ESKREPVAIK KVQEVQGRDL LSKESLLSGI PEEQRLNLKI
     QICRALQAAV ASEQPGLFSE WLRNIEKVEV EAVNITQEPR HIMCMYLVTS AKSVTEEVTI
     IIEDVDPQMA NLKMELRDAL CAIIYEEIDI LTAEGPRIQQ GAKTSLQEEM DSFSGSQKVE
     PITEPEVESK YLISTEEVSY FNVQSRVKYL DATPVTKGVA SAVVSDEKQD ESLKPSEEKE
     ESSSESGTEE VATVKIQEAE GGLIKEDGPM IHTPLVDTVS EEGDIVHLTT SITNAKEVNW
     YFENKLVPSD EKFKCLQDQN TYTLVIDKVN TEDHQGEYVC EALNDSGKTA TSAKLTVVKR
     AAPVIKRKIE PLEVALGHLA KFTCEIQSAP NVRFQWFKAG REIYESDKCS IRSSKYISSL
     EILRTQVVDC GEYTCKASNE YGSVSCTATL TVTEAYPPTF LSRPKSLTTF VGKAAKFICT
     VTGTPVIETI WQKDGAALSP SPNWRISDAE NKHILELSNL TIQDRGVYSC KASNKFGADI
     CQAELIIIDK PHFIKELEPV QSAINKKVHL ECQVDEDRKV TVTWSKDGQK LPPGKDYKIC
     FEDKIATLEI PLAKLKDSGT YVCTASNEAG SSSCSATVTV REPPSFVKKV DPSYLMLPGE
     SARLHCKLKG SPVIQVTWFK NNKELSESNT VRMYFVNSEA ILDITDVKVE DSGSYSCEAV
     NDVGSDSCST EIVIKEPPSF IKTLEPADIV RGTNALLQCE VSGTGPFEIS WFKDKKQIRS
     SKKYRLFSQK SLVCLEIFSF NSADVGEYEC VVANEVGKCG CMATHLLKEP PTFVKKVDDL
     IALGGQTVTL QAAVRGSEPI SVTWMKGQEV IREDGKIKMS FSNGVAVLII PDVQISFGGK
     YTCLAENEAG SQTSVGELIV KEPAKIIERA ELIQVTAGDP ATLEYTVAGT PELKPKWYKD
     GRPLVASKKY RISFKNNVAQ LKFYSAELHD SGQYTFEISN EVGSSSCETT FTVLDRDIAP
     FFTKPLRNVD SVVNGTCRLD CKIAGSLPMR VSWFKDGKEI AASDRYRIAF VEGTASLEII
     RVDMNDAGNF TCRATNSVGS KDSSGALIVQ EPPSFVTKPG SKDVLPGSAV CLKSTFQGST
     PLTIRWFKGN KELVSGGSCY ITKEALESSL ELYLVKTSDS GTYTCKVSNV AGGVECSANL
     FVKEPATFVE KLEPSQLLKK GDATQLACKV TGTPPIKITW FANDREIKES SKHRMSFVES
     TAVLRLTDVG IEDSGEYMCE AQNEAGSDHC SSIVIVKESP YFTKEFKPIE VLKEYDVMLL
     AEVAGTPPFE ITWFKDNTIL RSGRKYKTFI QDHLVSLQIL KFVAADAGEY QCRVTNEVGS
     SICSARVTLR EPPSFIKKIE STSSLRGGTA AFQATLKGSL PITVTWLKDS DEITEDDNIR
     MTFENNVASL YLSGIEVKHD GKYVCQAKND AGIQRCSALL SVKEPATITE EAVSIDVTQG
     DPATLQVKFS GTKEITAKWF KDGQELTLGS KYKISVTDTV SILKIISTEK KDSGEYTFEV
     QNDVGRSSCK ARINVLDLII PPSFTKKLKK MDSIKGSFID LECIVAGSHP ISIQWFKDDQ
     EISASEKYKF SFHDNTAFLE ISQLEGTDSG TYTCSATNKA GHNQCSGHLT VKEPPYFVEK
     PQSQDVNPNT RVQLKALVGG TAPMTIKWFK DNKELHSGAA RSVWKDDTST SLELFAAKAT
     DSGTYICQLS NDVGTATSKA TLFVKEPPQF IKKPSPVLVL RNGQSTTFEC QITGTPKIRV
     SWYLDGNEIT AIQKHGISFI DGLATFQISG ARVENSGTYV CEARNDAGTA SCSIELKVKE
     PPTFIRELKP VEVVKYSDVE LECEVTGTPP FEVTWLKNNR EIRSSKKYTL TDRVSVFNLH
     ITKCDPSDTG EYQCIVSNEG GSCSCSTRVA LKEPPSFIKK IENTTTVLKS SATFQSTVAG
     SPPISITWLK DDQILDEDDN VYISFVDSVA TLQIRSVDNG HSGRYTCQAK NESGVERCYA
     FLLVQEPAQI VEKAKSVDVT EKDPMTLECV VAGTPELKVK WLKDGKQIVP SRYFSMSFEN
     NVASFRIQSV MKQDSGQYTF KVENDFGSSS CDAYLRVLDQ NIPPSFTKKL TKMDKVLGSS
     IHMECKVSGS LPISAQWFKD GKEISTSAKY RLVCHERSVS LEVNNLELED TANYTCKVSN
     VAGDDACSGI LTVKEPPSFL VKPGRQQAIP DSTVEFKAIL KGTPPFKIKW FKDDVELVSG
     PKCFIGLEGS TSFLNLYSVD ASKTGQYTCH VTNDVGSDSC TTMLLVTEPP KFVKKLEASK
     IVKAGDSSRL ECKIAGSPEI RVVWFRNEHE LPASDKYRMT FIDSVAVIQM NNLSTEDSGD
     FICEAQNPAG STSCSTKVIV KEPPVFSSFP PIVETLKNAE VSLECELSGT PPFEVVWYKD
     KRQLRSSKKY KIASKNFHTS IHILNVDTSD IGEYHCKAQN EVGSDTCVCT VKLKEPPRFV
     SKLNSLTVVA GEPAELQASI EGAQPIFVQW LKEKEEVIRE SENIRITFVE NVATLQFAKA
     EPANAGKYIC QIKNDGGMRE NMATLMVLEP AVIVEKAGPM TVTVGETCTL ECKVAGTPEL
     SVEWYKDGKL LTSSQKHKFS FYNKISSLRI LSVERQDAGT YTFQVQNNVG KSSCTAVVDV
     SDRAVPPSFT RRLKNTGGVL GASCILECKV AGSSPISVAW FHEKTKIVSG AKYQTTFSDN
     VCTLQLNSLD SSDMGNYTCV AANVAGSDEC RAVLTVQEPP SFVKEPEPLE VLPGKNVTFT
     SVIRGTPPFK VNWFRGAREL VKGDRCNIYF EDTVAELELF NIDISQSGEY TCVVSNNAGQ
     ASCTTRLFVK EPAAFLKRLS DHSVEPGKSI ILESTYTGTL PISVTWKKDG FNITTSEKCN
     IVTTEKTCIL EILNSTKRDA GQYSCEIENE AGRDVCGALV STLEPPYFVT ELEPLEAAVG
     DSVSLQCQVA GTPEITVSWY KGDTKLRPTP EYRTYFTNNV ATLVFNKVNI NDSGEYTCKA
     ENSIGTASSK TVFRIQERQL PPSFARQLKD IEQTVGLPVT LTCRLNGSAP IQVCWYRDGV
     LLRDDENLQT SFVDNVATLK ILQTDLSHSG QYSCSASNPL GTASSSARLT AREPKKSPFF
     DIKPVSIDVI AGESADFECH VTGAQPMRIT WSKDNKEIRP GGNYTITCVG NTPHLRILKV
     GKGDSGQYTC QATNDVGKDM CSAQLSVKEP PKFVKKLEAS KVAKQGESIQ LECKISGSPE
     IKVSWFRNDS ELHESWKYNM SFINSVALLT INEASAEDSG DYICEAHNGV GDASCSTALT
     VKAPPVFTQK PSPVGALKGS DVILQCEISG TPPFEVVWVK DRKQVRNSKK FKITSKHFDT
     SLHILNLEAS DVGEYHCKAT NEVGSDTCSC SVKFKEPPRF VKKLSDTSTL IGDAVELRAI
     VEGFQPISVV WLKDRGEVIR ESENTRISFI DNIATLQLGS PEASNSGKYI CQIKNDAGMR
     ECSAVLTVLE PARIIEKPEP MTVTTGNPFA LECVVTGTPE LSAKWFKDGR ELSADSKHHI
     TFINKVASLK IPCAEMSDKG LYSFEVKNSV GKSNCTVSVH VSDRIVPPSF IRKLKDVNAI
     LGASVVLECR VSGSAPISVG WFQDGNEIVS GPKCQSSFSE NVCTLNLSLL EPSDTGIYTC
     VAANVAGSDE CSAVLTVQEP PSFEQTPDSV EVLPGMSLTF TSVIRGTPPF KVKWFKGSRE
     LVPGESCNIS LEDFVTELEL FEVQPLESGD YSCLVTNDAG SASCTTHLFV KEPATFVKRL
     ADFSVETGSP IVLEATYTGT PPISVSWIKD EYLISQSERC SITMTEKSTI LEILESTIED
     YAQYSCLIEN EAGQDICEAL VSVLEPPYFI EPLEHVEAVI GEPATLQCKV DGTPEIRISW
     YKEHTKLRSA PAYKMQFKNN VASLVINKVD HSDVGEYSCK ADNSVGAVAS SAVLVIKARK
     LPPFFARKLK DVHETLGFPV AFECRINGSE PLQVSWYKDG VLLKDDANLQ TSFVHNVATL
     QILQTDQSHI GQYNCSASNP LGTASSSAKL ILSEHEVPPF FDLKPVSVDL ALGESGTFKC
     HVTGTAPIKI TWAKDNREIR PGGNYKMTLV ENTATLTVLK VGKGDAGQYT CYASNIAGKD
     SCSAQLGVQE PPRFIKKLEP SRIVKQDEFT RYECKIGGSP EIKVLWYKDE TEIQESSKFR
     MSFVDSVAVL EMHNLSVEDS GDYTCEAHNA AGSASSSTSL KVKEPPIFRK KPHPIETLKG
     ADVHLECELQ GTPPFHVSWY KDKRELRSGK KYKIMSENFL TSIHILNVDA ADIGEYQCKA
     TNDVGSDTCV GSIALKAPPR FVKKLSDIST VVGKEVQLQT TIEGAEPISV VWFKDKGEIV
     RESDNIWISY SENIATLQFS RVEPANAGKY TCQIKNDAGM QECFATLSVL EPATIVEKPE
     SIKVTTGDTC TLECTVAGTP ELSTKWFKDG KELTSDNKYK ISFFNKVSGL KIINVAPSDS
     GVYSFEVQNP VGKDSCTASL QVSDRTVPPS FTRKLKETNG LSGSSVVMEC KVYGSPPISV
     SWFHEGNEIS SGRKYQTTLT DNTCALTVNM LEESDSGDYT CIATNMAGSD ECSAPLTVRE
     PPSFVQKPDP MDVLTGTNVT FTSIVKGTPP FSVSWFKGSS ELVPGDRCNV SLEDSVAELE
     LFDVDTSQSG EYTCIVSNEA GKASCTTHLY IKAPAKFVKR LNDYSIEKGK PLILEGTFTG
     TPPISVTWKK NGINVTPSQR CNITTTEKSA ILEIPSSTVE DAGQYNCYIE NASGKDSCSA
     QILILEPPYF VKQLEPVKVS VGDSASLQCQ LAGTPEIGVS WYKGDTKLRP TTTYKMHFRN
     NVATLVFNQV DINDSGEYIC KAENSVGEVS ASTFLTVQEQ KLPPSFSRQL RDVQETVGLP
     VVFDCAISGS EPISVSWYKD GKPLKDSPNV QTSFLDNTAT LNIFKTDRSL AGQYSCTATN
     PIGSASSSAR LILTEGKNPP FFDIRLAPVD AVVGESADFE CHVTGTQPIK VSWAKDSREI
     RSGGKYQISY LENSAHLTVL KVDKGDSGQY TCYAVNEVGK DSCTAQLNIK ERLIPPSFTK
     RLSETVEETE GNSFKLEGRV AGSQPITVAW YKNNIEIQPT SNCEITFKNN TLVLQVRKAG
     MNDAGLYTCK VSNDAGSALC TSSIVIKEPK KPPVFDQHLT PVTVSEGEYV QLSCHVQGSE
     PIRIQWLKAG REIKPSDRCS FSFASGTAVL ELRDVAKADS GDYVCKASNV AGSDTTKSKV
     TIKDKPAVAP ATKKAAVDGR LFFVSEPQSI RVVEKTTATF IAKVGGDPIP NVKWTKGKWR
     QLNQGGRVFI HQKGDEAKLE IRDTTKTDSG LYRCVAFNEH GEIESNVNLQ VDERKKQEKI
     EGDLRAMLKK TPILKKGAGE EEEIDIMELL KNVDPKEYEK YARMYGITDF RGLLQAFELL
     KQSQEEETHR LEIEEIERSE RDEKEFEELV SFIQQRLSQT EPVTLIKDIE NQTVLKDNDA
     VFEIDIKINY PEIKLSWYKG TEKLEPSDKF EISIDGDRHT LRVKNCQLKD QGNYRLVCGP
     HIASAKLTVI EPAWERHLQD VTLKEGQTCT MTCQFSVPNV KSEWFRNGRI LKPQGRHKTE
     VEHKVHKLTI ADVRAEDQGQ YTCKYEDLET SAELRIEAEP IQFTKRIQNI VVSEHQSATF
     ECEVSFDDAI VTWYKGPTEL TESQKYNFRN DGRCHYMTIH NVTPDDEGVY SVIARLEPRG
     EARSTAELYL TTKEIKLELK PPDIPDSRVP IPTMPIRAVP PEEIPPVVAP PIPLLLPTPE
     EKKPPPKRIE VTKKAVKKDA KKVVAKPKEM TPREEIVKKP PPPTTLIPAK APEIIDVSSK
     AEEVKIMTIT RKKEVQKEKE AVYEKKQAVH KEKRVFIESF EEPYDELEVE PYTEPFEQPY
     YEEPDEDYEE IKVEAKKEVH EEWEEDFEEG QEYYEREEGY DEGEEEWEEA YQEREVIQVQ
     KEVYEESHER KVPAKVPEKK APPPPKVIKK PVIEKIEKTS RRMEEEKVQV TKVPEVSKKI
     VPQKPSRTPV QEEVIEVKVP AVHTKKMVIS EEKMFFASHT EEEVSVTVPE VQKEIVTEEK
     IHVAISKRVE PPPKVPELPE KPAPEEVAPV PIPKKVEPPA PKVPEVPKKP VPEEKKPVPV
     PKKEPAAPPK VPEVPKKPVP EEKIPVPVAK KKEAPPAKVP EVQKGVVTEE KITIVTQREE
     SPPPAVPEIP KKKVPEERKP VPRKEEEVPP PPKVPALPKK PVPEEKVAVP VPVAKKAPPP
     RAEVSKKTVV EEKRFVAEEK LSFAVPQRVE VTRHEVSAEE EWSYSEEEEG VSISVYREEE
     REEEEEAEVT EYEVMEEPEE YVVEEKLHII SKRVEAEPAE VTERQEKKIV LKPKIPAKIE
     EPPPAKVPEA PKKIVPEKKV PAPVPKKEKV PPPKVPEEPK KPVPEKKVPP KVIKMEEPLP
     AKVTERHMQI TQEEKVLVAV TKKEAPPKAR VPEEPKRAVP EEKVLKLKPK REEEPPAKVT
     EFRKRVVKEE KVSIEAPKRE PQPIKEVTIM EEKERAYTLE EEAVSVQREE EYEEYEEYDY
     KEFEEYEPTE EYDQYEEYEE REYERYEEHE EYITEPEKPI PVKPVPEEPV PTKPKAPPAK
     VLKKAVPEEK VPVPIPKKLK PPPPKVPEEP KKVFEEKIRI SITKREKEQV TEPAAKVPMK
     PKRVVAEEKV PVPRKEVAPP VRVPEVPKEL EPEEVAFEEE VVTHVEEYLV EEEEEYIHEE
     EEFITEEEVV PVIPVKVPEV PRKPVPEEKK PVPVPKKKEA PPAKVPEVPK KPEEKVPVLI
     PKKEKPPPAK VPEVPKKPVP EEKVPVPVPK KVEAPPAKVP EVPKKPVPEK KVPVPAPKKV
     EAPPAKVPEV PKKLIPEEKK PTPVPKKVEA PPPKVPKKRE PVPVPVALPQ EEEVLFEEEI
     VPEEEVLPEE EEVLPEEEEV LPEEEEVLPE EEEIPPEEEE VPPEEEYVPE EEEFVPEEEV
     LPEVKPKVPV PAPVPEIKKK VTEKKVVIPK KEEAPPAKVP EVPKKVEEKR IILPKEEEVL
     PVEVTEEPEE EPISEEEIPE EPPSIEEVEE VAPPRVPEVI KKAVPEAPTP VPKKVEAPPA
     KVSKKIPEEK VPVPVQKKEA PPAKVPEVPK KVPEKKVLVP KKEAVPPAKG RTVLEEKVSV
     AFRQEVVVKE RLELEVVEAE VEEIPEEEEF HEVEEYFEEG EFHEVEEFIK LEQHRVEEEH
     RVEKVHRVIE VFEAEEVEVF EKPKAPPKGP EISEKIIPPK KPPTKVVPRK EPPAKVPEVP
     KKIVVEEKVR VPEEPRVPPT KVPEVLPPKE VVPEKKVPVP PAKKPEAPPP KVPEAPKEVV
     PEKKVPVPPP KKPEVPPTKV PEVPKAAVPE KKVPEAIPPK PESPPPEVPE APKEVVPEKK
     VPAAPPKKPE VTPVKVPEAP KEVVPEKKVP VPPPKKPEVP PTKVPEVPKV AVPEKKVPEA
     IPPKPESPPP EVFEEPEEVA LEEPPAEVVE EPEPAAPPQV TVPPKKPVPE KKAPAVVAKK
     PELPPVKVPE VPKEVVPEKK VPLVVPKKPE APPAKVPEVP KEVVPEKKVA VPKKPEVPPA
     KVPEVPKKPV LEEKPAVPVP ERAESPPPEV YEEPEEIAPE EEIAPEEEKP VPVAEEEEPE
     VPPPAVPEEP KKIIPEKKVP VIKKPEAPPP KEPEPEKVIE KPKLKPRPPP PPPAPPKEDV
     KEKIFQLKAI PKKKVPEKPQ VPEKVELTPL KVPGGEKKVR KLLPERKPEP KEEVVLKSVL
     RKRPEEEEPK VEPKKLEKVK KPAVPEPPPP KPVEEVEVPT VTKRERKIPE PTKVPEIKPA
     IPLPAPEPKP KPEAEVKTIK PPPVEPEPTP IAAPVTVPVV GKKAEAKAPK EEAAKPKGPI
     KGVPKKTPSP IEAERRKLRP GSGGEKPPDE APFTYQLKAV PLKFVKEIKD IILTESEFVG
     SSAIFECLVS PSTAITTWMK DGSNIRESPK HRFIADGKDR KLHIIDVQLS DAGEYTCVLR
     LGNKEKTSTA KLVVEELPVR FVKTLEEEVT VVKGQPLYLS CELNKERDVV WRKDGKIVVE
     KPGRIVPGVI GLMRALTIND ADDTDAGTYT VTVENANNLE CSSCVKVVEV IRDWLVKPIR
     DQHVKPKGTA IFACDIAKDT PNIKWFKGYD EIPAEPNDKT EILRDGNHLY LKIKNAMPED
     IAEYAVEIEG KRYPAKLTLG EREVELLKPI EDVTIYEKES ASFDAEISEA DIPGQWKLKG
     ELLRPSPTCE IKAEGGKRFL TLHKVKLDQA GEVLYQALNA ITTAILTVKE IELDFAVPLK
     DVTVPERRQA RFECVLTREA NVIWSKGPDI IKSSDKFDII ADGKKHILVI NDSQFDDEGV
     YTAEVEGKKT SARLFVTGIR LKFMSPLEDQ TVKEGETATF VCELSHEKMH VVWFKNDAKL
     HTSRTVLISS EGKTHKLEMK EVTLDDISQI KAQVKELSST AQLKVLEADP YFTVKLHDKT
     AVEKDEITLK CEVSKDVPVK WFKDGEEIVP SPKYSIKADG LRRILKIKKA DLKDKGEYVC
     DCGTDKTKAN VTVEARLIKV EKPLYGVEVF VGETAHFEIE LSEPDVHGQW KLKGQPLTAS
     PDCEIIEDGK KHILILHNCQ LGMTGEVSFQ AANAKSAANL KVKELPLIFI TPLSDVKVFE
     KDEAKFECEV SREPKTFRWL KGTQEITGDD RFELIKDGTK HSMVIKSAAF EDEAKYMFEA
     EDKHTSGKLI IEGIRLKFLT PLKDVTAKEK ESAVFTVELS HDNIRVKWFK NDQRLHTTRS
     VSMQDEGKTH SITFKDLSID DTSQIRVEAM GMSSEAKLTV LEGDPYFTGK LQDYTGVEKD
     EVILQCEISK ADAPVKWFKD GKEIKPSKNA VIKADGKKRM LILKKALKSD IGQYTCDCGT
     DKTSGKLDIE DREIKLVRPL HSVEVMETET ARFETEISED DIHANWKLKG EALLQTPDCE
     IKEEGKIHSL VLHNCRLDQT GGVDFQAANV KSSAHLRVKP RVIGLLRPLK DVTVTAGETA
     TFDCELSYED IPVEWYLKGK KLEPSDKVVP RSEGKVHTLT LRDVKLEDAG EVQLTAKDFK
     THANLFVKEP PVEFTKPLED QTVEEGATAV LECEVSRENA KVKWFKNGTE ILKSKKYEIV
     ADGRVRKLVI HDCTPEDIKT YTCDAKDFKT SCNLNVVPPH VEFLRPLTDL QVREKEMARF
     ECELSRENAK VKWFKDGAEI KKGKKYDIIS KGAVRILVIN KCLLDDEAEY SCEVRTARTS
     GMLTVLEEEA VFTKNLANIE VSETDTIKLV CEVSKPGAEV IWYKGDEEII ETGRYEILTE
     GRKRILVIQN AHLEDAGNYN CRLPSSRTDG KVKVHELAAE FISKPQNLEI LEGEKAEFVC
     SISKESFPVQ WKRDDKTLES GDKYDVIADG KKRVLVVKDA TLQDMGTYVV MVGAARAAAH
     LTVIEKLRIV VPLKDTRVKE QQEVVFNCEV NTEGAKAKWF RNEEAIFDSS KYIILQKDLV
     YTLRIRDAHL DDQANYNVSL TNHRGENVKS AANLIVEEED LRIVEPLKDI ETMEKKSVTF
     WCKVNRLNVT LKWTKNGEEV PFDNRVSYRV DKYKHMLTIK DCGFPDEGEY IVTAGQDKSV
     AELLIIEAPT EFVEHLEDQT VTEFDDAVFS CQLSREKANV KWYRNGREIK EGKKYKFEKD
     GSIHRLIIKD CRLDDECEYA CGVEDRKSRA RLFVEEIPVE IIRPPQDILE APGADVVFLA
     ELNKDKVEVQ WLRNNMVVVQ GDKHQMMSEG KIHRLQICDI KPRDQGEYRF IAKDKEARAK
     LELAAAPKIK TADQDLVVDV GKPLTMVVPY DAYPKAEAEW FKENEPLSTK TIDTTAEQTS
     FRILEAKKGD KGRYKIVLQN KHGKAEGFIN LKVIDVPGPV RNLEVTETFD GEVSLAWEEP
     LTDGGSKIIG YVVERRDIKR KTWVLATDRA ESCEFTVTGL QKGGVEYLFR VSARNRVGTG
     EPVETDNPVE ARSKYDVPGP PLNVTITDVN RFGVSLTWEP PEYDGGAEIT NYVIELRDKT
     SIRWDTAMTV RAEDLSATVT DVVEGQEYSF RVRAQNRIGV GKPSAATPFV KVADPIERPS
     PPVNLTSSDQ TQSSVQLKWE PPLKDGGSPI LGYIIERCEE GKDNWIRCNM KLVPELTYKV
     TGLEKGNKYL YRVSAENKAG VSDPSEILGP LTADDAFVEP TMDLSAFKDG LEVIVPNPIT
     ILVPSTGYPR PTATWCFGDK VLETGDRVKM KTLSAYAELV ISPSERSDKG IYTLKLENRV
     KTISGEIDVN VIARPSAPKE LKFGDITKDS VHLTWEPPDD DGGSPLTGYV VEKREVSRKT
     WTKVMDFVTD LEFTVPDLVQ GKEYLFKVCA RNKCGPGEPA YVDEPVNMST PATVPDPPEN
     VKWRDRTANS IFLTWDPPKN DGGSRIKGYI VERCPRGSDK WVACGEPVAE TKMEVTGLEE
     GKWYAYRVKA LNRQGASKPS RPTEEIQAVD TQEAPEIFLD VKLLAGLTVK AGTKIELPAT
     VTGKPEPKIT WTKADMILKQ DKRITIENVP KKSTVTIVDS KRSDTGTYII EAVNVCGRAT
     AVVEVNVLDK PGPPAAFDIT DVTNESCLLT WNPPRDDGGS KITNYVVERR ATDSEVWHKL
     SSTVKDTNFK ATKLIPNKEY IFRVAAENMY GVGEPVQASP ITAKYQFDPP GPPTRLEPSD
     ITKDAVTLTW CEPDDDGGSP ITGYWVERLD PDTDKWVRCN KMPVKDTTYR VKGLTNKKKY
     RFRVLAENLA GPGKPSKSTE PILIKDPIDP PWPPGKPTVK DVGKTSVRLN WTKPEHDGGA
     KIESYVIEML KTGTDEWVRV AEGVPTTQHL LPGLMEGQEY SFRVRAVNKA GESEPSEPSD
     PVLCREKLYP PSPPRWLEVI NITKNTADLK WTVPEKDGGS PITNYIVEKR DVRRKGWQTV
     DTTVKDTKCT VTPLTEGSLY VFRVAAENAI GQSDYTEIED SVLAKDTFTT PGPPYALAVV
     DVTKRHVDLK WEPPKNDGGR PIQRYVIEKK ERLGTRWVKA GKTAGPDCNF RVTDVIEGTE
     VQFQVRAENE AGVGHPSEPT EILSIEDPTS PPSPPLDLHV TDAGRKHIAI AWKPPEKNGG
     SPIIGYHVEM CPVGTEKWMR VNSRPIKDLK FKVEEGVVPD KEYVLRVRAV NAIGVSEPSE
     ISENVVAKDP DCKPTIDLET HDIIVIEGEK LSIPVPFRAV PVPTVSWHKD GKEVKASDRL
     TMKNDHISAH LEVPKSVRAD AGIYTITLEN KLGSATASIN VKVIGLPGPC KDIKASDITK
     SSCKLTWEPP EFDGGTPILH YVLERREAGR RTYIPVMSGE NKLSWTVKDL IPNGEYFFRV
     KAVNKVGGGE YIELKNPVIA QDPKQPPDPP VDVEVHNPTA EAMTITWKPP LYDGGSKIMG
     YIIEKIAKGE ERWKRCNEHL VPILTYTAKG LEEGKEYQFR VRAENAAGIS EPSRATPPTK
     AVDPIDAPKV ILRTSLEVKR GDEIALDASI SGSPYPTITW IKDENVIVPE EIKKRAAPLV
     RRRKGEVQEE EPFVLPLTQR LSIDNSKKGE SQLRVRDSLR PDHGLYMIKV ENDHGIAKAP
     CTVSVLDTPG PPINFVFEDI RKTSVLCKWE PPLDDGGSEI INYTLEKKDK TKPDSEWIVV
     TSTLRHCKYS VTKLIEGKEY LFRVRAENRF GPGPPCVSKP LVAKDPFGPP DAPDKPIVED
     VTSNSMLVKW NEPKDNGSPI LGYWLEKREV NSTHWSRVNK SLLNALKANV DGLLEGLTYV
     FRVCAENAAG PGKFSPPSDP KTAHDPISPP GPPIPRVTDT SSTTIELEWE PPAFNGGGEI
     VGYFVDKQLV GTNEWSRCTE KMIKVRQYTV KEIREGADYK LRVSAVNAAG EGPPGETQPV
     TVAEPQEPPA VELDVSVKGG IQIMAGKTLR IPAVVTGRPV PTKVWTKEEG ELDKDRVVID
     NVGTKSELII KDALRKDHGR YVITATNSCG SKFAAARVEV FDVPGPVLDL KPVVTNRKMC
     LLNWSDPEDD GGSEITGFII ERKDAKMHTW RQPIETERSK CDITGLLEGQ EYKFRVIAKN
     KFGCGPPVEI GPILAVDPLG PPTSPERLTY TERTKSTITL DWKEPRSNGG SPIQGYIIEK
     RRHDKPDFER VNKRLCPTTS FLVENLDEHQ MYEFRVKAVN EIGESEPSLP LNVVIQDDEV
     PPTIKLRLSV RGDTIKVKAG EPVHIPADVT GLPMPKIEWS KNETVIEKPT DALQITKEEV
     SRSEAKTELS IPKAVREDKG TYTVTASNRL GSVFRNVHVE VYDRPSPPRN LAVTDIKAES
     CYLTWDAPLD NGGSEITHYV IDKRDASRKK AEWEEVTNTA VEKRYGIWKL IPNGQYEFRV
     RAVNKYGISD ECKSDKVVIQ DPYRLPGPPG KPKVLARTKG SMLVSWTPPL DNGGSPITGY
     WLEKREEGSP YWSRVSRAPI TKVGLKGVEF NVPRLLEGVK YQFRAMAINA AGIGPPSEPS
     DPEVAGDPIF PPGPPSCPEV KDKTKSSISL GWKPPAKDGG SPIKGYIVEM QEEGTTDWKR
     VNEPDKLITT CECVVPNLKE LRKYRFRVKA VNEAGESEPS DTTGEIPATD IQEEPEVFID
     IGAQDCLVCK AGSQIRIPAV IKGRPTPKSS WEFDGKAKKA MKDGVHDIPE DAQLETAENS
     SVIIIPECKR SHTGKYSITA KNKAGQKTAN CRVKVMDVPG PPKDLKVSDI TRGSCRLSWK
     MPDDDGGDRI KGYVIEKRTI DGKAWTKVNP DCGSTTFVVP DLLSEQQYFF RVRAENRFGI
     GPPVETIQRT TARDPIYPPD PPIKLKIGLI TKNTVHLSWK PPKNDGGSPV THYIVECLAW
     DPTGTKKEAW RQCNKRDVEE LQFTVEDLVE GGEYEFRVKA VNAAGVSKPS ATVGPVTVKD
     QTCPPSIDLK EFMEVEEGTN VNIVAKIKGV PFPTLTWFKA PPKKPDNKEP VLYDTHVNKL
     VVDDTCTLVI PQSRRSDTGL YTITAVNNLG TASKEMRLNV LGRPGPPVGP IKFESVSADQ
     MTLSWFPPKD DGGSKITNYV IEKREANRKT WVHVSSEPKE CTYTIPKLLE GHEYVFRIMA
     QNKYGIGEPL DSEPETARNL FSVPGAPDKP TVSSVTRNSM TVNWEEPEYD GGSPVTGYWL
     EMKDTTSKRW KRVNRDPIKA MTLGVSYKVT GLIEGSDYQF RVYAINAAGV GPASLPSDPA
     TARDPIAPPG PPFPKVTDWT KSSADLEWSP PLKDGGSKVT GYIVEYKEEG KEEWEKGKDK
     EVRGTKLVVT GLKEGAFYKF RVRAVNIAGI GEPGEVTDVI EMKDRLVSPD LQLDASVRDR
     IVVHAGGVIR IIAYVSGKPP PTVTWNMNER TLPQEATIET TAISSSMVIK NCQRSHQGVY
     SLLAKNEAGE RKKTIIVDVL DVPGPVGTPF LAHNLTNESC KLTWFSPEDD GGSPITNYVI
     EKRESDRRAW TPVTYTVTRQ NATVQGLIQG KAYFFRIAAE NSIGMGPFVE TSEALVIREP
     ITVPERPEDL EVKEVTKNTV TLTWNPPKYD GGSEIINYVL ESRLIGTEKF HKVTNDNLLS
     RKYTVKGLKE GDTYEYRVSA VNIVGQGKPS FCTKPITCKD ELAPPTLHLD FRDKLTIRVG
     EAFALTGRYS GKPKPKVSWF KDEADVLEDD RTHIKTTPAT LALEKIKAKR SDSGKYCVVV
     ENSTGSRKGF CQVNVVDRPG PPVGPVSFDE VTKDYMVISW KPPLDDGGSK ITNYIIEKKE
     VGKDVWMPVT SASAKTTCKV SKLLEGKDYI FRIHAENLYG ISDPLVSDSM KAKDRFRVPD
     APDQPIVTEV TKDSALVTWN KPHDGGKPIT NYILEKRETM SKRWARVTKD PIHPYTKFRV
     PDLLEGCQYE FRVSAENEIG IGDPSPPSKP VFAKDPIAKP SPPVNPEAID TTCNSVDLTW
     QPPRHDGGSK ILGYIVEYQK VGDEEWRRAN HTPESCPETK YKVTGLRDGQ TYKFRVLAVN
     AAGESDPAHV PEPVLVKDRL EPPELILDAN MAREQHIKVG DTLRLSAIIK GVPFPKVTWK
     KEDRDAPTKA RIDVTPVGSK LEIRNAAHED GGIYSLTVEN PAGSKTVSVK VLVLDKPGPP
     RDLEVSEIRK DSCYLTWKEP LDDGGSVITN YVVERRDVAS AQWSPLSATS KKKSHFAKHL
     NEGNQYLFRV AAENQYGRGP FVETPKPIKA LDPLHPPGPP KDLHHVDVDK TEVSLVWNKP
     DRDGGSPITG YLVEYQEEGT QDWIKFKTVT NLECVVTGLQ QGKTYRFRVK AENIVGLGLP
     DTTIPIECQE KLVPPSVELD VKLIEGLVVK AGTTVRFPAI IRGVPVPTAK WTTDGSEIKT
     DEHYTVETDN FSSVLTIKNC LRRDTGEYQI TVSNAAGSKT VAVHLTVLDV PGPPTGPINI
     LDVTPEHMTI SWQPPKDDGG SPVINYIVEK QDTRKDTWGV VSSGSSKTKL KIPHLQKGCE
     YVFRVRAENK IGVGPPLDST PTVAKHKFSP PSPPGKPVVT DITENAATVS WTLPKSDGGS
     PITGYYMERR EVTGKWVRVN KTPIADLKFR VTGLYEGNTY EFRVFAENLA GLSKPSPSSD
     PIKACRPIKP PGPPINPKLK DKSRETADLV WTKPLSDGGS PILGYVVECQ KPGTAQWNRI
     NKDELIRQCA FRVPGLIEGN EYRFRIKAAN IVGEGEPREL AESVIAKDIL HPPEVELDVT
     CRDVITVRVG QTIRILARVK GRPEPDITWT KEGKVLVREK RVDLIQDLPR VELQIKEAVR
     ADHGKYIISA KNSSGHAQGS AIVNVLDRPG PCQNLKVTNV TKENCTISWE NPLDNGGSEI
     TNFIVEYRKP NQKGWSIVAS DVTKRLIKAN LLANNEYYFR VCAENKVGVG PTIETKTPIL
     AINPIDRPGE PENLHIADKG KTFVYLKWRR PDYDGGSPNL SYHVERRLKG SDDWERVHKG
     SIKETHYMVD RCVENQIYEF RVQTKNEGGE SDWVKTEEVV VKEDLQKPVL DLKLSGVLTV
     KAGDTIRLEA GVRGKPFPEV AWTKDKDATD LTRSPRVKID TRADSSKFSL TKAKRSDGGK
     YVVTATNTAG SFVAYATVNV LDKPGPVRNL KIVDVSSDRC TVCWDPPEDD GGCEIQNYIL
     EKCETKRMVW STYSATVLTP GTTVTRLIEG NEYIFRVRAE NKIGTGPPTE SKPVIAKTKY
     DKPGRPDPPE VTKVSKEEMT VVWNPPEYDG GKSITGYFLE KKEKHSTRWV PVNKSAIPER
     RMKVQNLLPD HEYQFRVKAE NEIGIGEPSL PSRPVVAKDP IEPPGPPTNF RVVDTTKHSI
     TLGWGKPVYD GGAPIIGYVV EMRPKIADAS PDEGWKRCNA AAQLVRKEFT VTSLDENQEY
     EFRVCAQNQV GIGRPAELKE AIKPKEILEP PEIDLDASMR KLVIVRAGCP IRLFAIVRGR
     PAPKVTWRKV GIDNVVRKGQ VDLVDTMAFL VIPNSTRDDS GKYSLTLVNP AGEKAVFVNV
     RVLDTPGPVS DLKVSDVTKT SCHVSWAPPE NDGGSQVTHY IVEKREADRK TWSTVTPEVK
     KTSFHVTNLV PGNEYYFRVT AVNEYGPGVP TDVPKPVLAS DPLSEPDPPR KLEVTEMTKN
     SATLAWLPPL RDGGAKIDGY ITSYREEEQP ADRWTEYSVV KDLSLVVTGL KEGKKYKFRV
     AARNAVGVSL PREAEGVYEA KEQLLPPKIL MPEQITIKAG KKLRIEAHVY GKPHPTCKWK
     KGEDEVVTSS HLAVHKADSS SILIIKDVTR KDSGYYSLTA ENSSGTDTQK IKVVVMDAPG
     PPQPPFDISD IDADACSLSW HIPLEDGGSN ITNYIVEKCD VSRGDWVTAL ASVTKTSCRV
     GKLIPGQEYI FRVRAENRFG ISEPLTSPKM VAQFPFGVPS EPKNARVTKV NKDCIFVAWD
     RPDSDGGSPI IGYLIERKER NSLLWVKAND TLVRSTEYPC AGLVEGLEYS FRIYALNKAG
     SSPPSKPTEY VTARMPVDPP GKPEVIDVTK STVSLIWARP KHDGGSKIIG YFVEACKLPG
     DKWVRCNTAP HQIPQEEYTA TGLEEKAQYQ FRAIARTAVN ISPPSEPSDP VTILAENVPP
     RIDLSVAMKS LLTVKAGTNV CLDATVFGKP MPTVSWKKDG TLLKPAEGIK MAMQRNLCTL
     ELFSVNRKDS GDYTITAENS SGSKSATIKL KVLDKPGPPA SVKINKMYSD RAMLSWEPPL
     EDGGSEITNY IVDKRETSRP NWAQVSATVP ITSCSVEKLI EGHEYQFRIC AENKYGVGDP
     VFTEPAIAKN PYDPPGRCDP PVISNITKDH MTVSWKPPAD DGGSPITGYL LEKRETQAVN
     WTKVNRKPII ERTLKATGLQ EGTEYEFRVT AINKAGPGKP SDASKAAYAR DPQYPPGPPA
     FPKVYDTTRS SVSLSWGKPA YDGGSPIIGY LVEVKRADSD NWVRCNLPQN LQKTRFEVTG
     LMEDTQYQFR VYAVNKIGYS DPSDVPDKHY PKDILIPPEG ELDADLRKTL ILRAGVTMRL
     YVPVKGRPPP KITWSKPNVN LRDRIGLDIK STDFDTFLRC ENVNKYDAGK YILTLENSCG
     KKEYTIVVKV LDTPGPPVNV TVKEISKDSA YVTWEPPIID GGSPIINYVV QKRDAERKSW
     STVTTECSKT SFRVANLEEG KSYFFRVFAE NEYGIGDPGE TRDAVKASQT PGPVVDLKVR
     SVSKSSCSIG WKKPHSDGGS RIIGYVVDFL TEENKWQRVM KSLSLQYSAK DLTEGKEYTF
     RVSAENENGE GTPSEITVVA RDDVVAPDLD LKGLPDLCYL AKENSNFRLK IPIKGKPAPS
     VSWKKGEDPL ATDTRVSVES SAVNTTLIVY DCQKSDAGKY TITLKNVAGT KEGTISIKVV
     GKPGIPTGPI KFDEVTAEAM TLKWAPPKDD GGSEITNYIL EKRDSVNNKW VTCASAVQKT
     TFRVTRLHEG MEYTFRVSAE NKYGVGEGLK SEPIVARHPF DVPDAPPPPN IVDVRHDSVS
     LTWTDPKKTG GSPITGYHLE FKERNSLLWK RANKTPIRMR DFKVTGLTEG LEYEFRVMAI
     NLAGVGKPSL PSEPVVALDP IDPPGKPEVI NITRNSVTLI WTEPKYDGGH KLTGYIVEKR
     DLPSKSWMKA NHVNVPECAF TVTDLVEGGK YEFRIRAKNT AGAISAPSES TETIICKDEY
     EAPTIVLDPT IKDGLTIKAG DTIVLNAISI LGKPLPKSSW SKAGKDIRPS DITQITSTPT
     SSMLTIKYAT RKDAGEYTIT ATNPFGTKVE HVKVTVLDVP GPPGPVEISN VSAEKATLTW
     TPPLEDGGSP IKSYILEKRE TSRLLWTVVS EDIQSCRHVA TKLIQGNEYI FRVSAVNHYG
     KGEPVQSEPV KMVDRFGPPG PPEKPEVSNV TKNTATVSWK RPVDDGGSEI TGYHVERREK
     KSLRWVRAIK TPVSDLRCKV TGLQEGSTYE FRVSAENRAG IGPPSEASDS VLMKDAAYPP
     GPPSNPHVTD TTKKSASLAW GKPHYDGGLE ITGYVVEHQK VGDEAWIKDT TGTALRITQF
     VVPDLQTKEK YNFRISAIND AGVGEPAVIP DVEIVEREMA PDFELDAELR RTLVVRAGLS
     IRIFVPIKGR PAPEVTWTKD NINLKNRANI ENTESFTLLI IPECNRYDTG KFVMTIENPA
     GKKSGFVNVR VLDTPGPVLN LRPTDITKDS VTLHWDLPLI DGGSRITNYI VEKREATRKS
     YSTATTKCHK CTYKVTGLSE GCEYFFRVMA ENEYGIGEPT ETTEPVKASE APSPPDSLNI
     MDITKSTVSL AWPKPKHDGG SKITGYVIEA QRKGSDQWTH ITTVKGLECV VRNLTEGEEY
     TFQVMAVNSA GRSAPRESRP VIVKEQTMLP ELDLRGIYQK LVIAKAGDNI KVEIPVLGRP
     KPTVTWKKGD QILKQTQRVN FETTATSTIL NINECVRSDS GPYPLTARNI VGEVGDVITI
     QVHDIPGPPT GPIKFDEVSS DFVTFSWDPP ENDGGVPISN YVVEMRQTDS TTWVELATTV
     IRTTYKATRL TTGLEYQFRV KAQNRYGVGP GITSACIVAN YPFKVPGPPG TPQVTAVTKD
     SMTISWHEPL SDGGSPILGY HVERKERNGI LWQTVSKALV PGNIFKSSGL TDGIAYEFRV
     IAENMAGKSK PSKPSEPMLA LDPIDPPGKP VPLNITRHTV TLKWAKPEYT GGFKITSYIV
     EKRDLPNGRW LKANFSNILE NEFTVSGLTE DAAYEFRVIA KNAAGAISPP SEPSDAITCR
     DDVEAPKIKV DVKFKDTVIL KAGEAFRLEA DVSGRPPPTM EWSKDGKELE GTAKLEIKIA
     DFSTNLVNKD STRRDSGAYT LTATNPGGFA KHIFNVKVLD RPGPPEGPLA VTEVTSEKCV
     LSWFPPLDDG GAKIDHYIVQ KRETSRLAWT NVASEVQVTK LKVTKLLKGN EYIFRVMAVN
     KYGVGEPLES EPVLAVNPYG PPDPPKNPEV TTITKDSMVV CWGHPDSDGG SEIINYIVER
     RDKAGQRWIK CNKKTLTDLR YKVSGLTEGH EYEFRIMAEN AAGISAPSPT SPFYKACDTV
     FKPGPPGNPR VLDTSRSSIS IAWNKPIYDG GSEITGYMVE IALPEEDEWQ IVTPPAGLKA
     TSYTITGLTE NQEYKIRIYA MNSEGLGEPA LVPGTPKAED RMLPPEIELD ADLRKVVTIR
     ACCTLRLFVP IKGRPAPEVK WARDHGESLD KASIESTSSY TLLIVGNVNR FDSGKYILTV
     ENSSGSKSAF VNVRVLDTPG PPQDLKVKEV TKTSVTLTWD PPLLDGGSKI KNYIVEKRES
     TRKAYSTVAT NCHKTSWKVD QLQEGCSYYF RVLAENEYGI GLPAETAESV KASERPLPPG
     KITLMDVTRN SVSLSWEKPE HDGGSRILGY IVEMQTKGSD KWATCATVKV TEATITGLIQ
     GEEYSFRVSA QNEKGISDPR QLSVPVIAKD LVIPPAFKLL FNTFTVLAGE DLKVDVPFIG
     RPTPAVTWHK DNVPLKQTTR VNAESTENNS LLTIKDACRE DVGHYVVKLT NSAGEAIETL
     NVIVLDKPGP PTGPVKMDEV TADSITLSWG PPKYDGGSSI NNYIVEKRDT STTTWQIVSA
     TVARTTIKAC RLKTGCEYQF RIAAENRYGK STYLNSEPTV AQYPFKVPGP PGTPVVTLSS
     RDSMEVQWNE PISDGGSRVI GYHLERKERN SILWVKLNKT PIPQTKFKTT GLEEGVEYEF
     RVSAENIVGI GKPSKVSECY VARDPCDPPG RPEAIIVTRN SVTLQWKKPT YDGGSKITGY
     IVEKKELPEG RWMKASFTNI IDTHFEVTGL VEDHRYEFRV IARNAAGVFS EPSESTGAIT
     ARDEVDPPRI SMDPKYKDTI VVHAGESFKV DADIYGKPIP TIQWIKGDQE LSNTARLEIK
     STDFATSLSV KDAVRVDSGN YILKAKNVAG ERSVTVNVKV LDRPGPPEGP VVISGVTAEK
     CTLAWKPPLQ DGGSDIINYI VERRETSRLV WTVVDANVQT LSCKVTKLLE GNEYTFRIMA
     VNKYGVGEPL ESEPVVAKNP FVVPDAPKAP EVTTVTKDSM IVVWERPASD GGSEILGYVL
     EKRDKEGIRW TRCHKRLIGE LRLRVTGLIE NHDYEFRVSA ENAAGLSEPS PPSAYQKACD
     PIYKPGPPNN PKVIDITRSS VFLSWSKPIY DGGCEIQGYI VEKCDVSVGE WTMCTPPTGI
     NKTNIEVEKL LEKHEYNFRI CAINKAGVGE HADVPGPIIV EEKLEAPDID LDLELRKIIN
     IRAGGSLRLF VPIKGRPTPE VKWGKVDGEI RDAAIIDVTS SFTSLVLDNV NRYDSGKYTL
     TLENSSGTKS AFVTVRVLDT PSPPVNLKVT EITKDSVSIT WEPPLLDGGS KIKNYIVEKR
     EATRKSYAAV VTNCHKNSWK IDQLQEGCSY YFRVTAENEY GIGLPAQTAD PIKVAEVPQP
     PGKITVDDVT RNSVSLSWTK PEHDGGSKII QYIVEMQAKH SEKWSECARV KSLQAVITNL
     TQGEEYLFRV VAVNEKGRSD PRSLAVPIVA KDLVIEPDVK PAFSSYSVQV GQDLKIEVPI
     SGRPKPTITW TKDGLPLKQT TRINVTDSLD LTTLSIKETH KDDGGQYGIT VANVVGQKTA
     SIEIVTLDKP DPPKGPVKFD DVSAESITLS WNPPLYTGGC QITNYIVQKR DTTTTVWDVV
     SATVARTTLK VTKLKTGTEY QFRIFAENRY GQSFALESDP IVAQYPYKEP GPPGTPFATA
     ISKDSMVIQW HEPVNNGGSP VIGYHLERKE RNSILWTKVN KTIIHDTQFK AQNLEEGIEY
     EFRVYAENIV GVGKASKNSE CYVARDPCDP PGTPEPIMVK RNEITLQWTK PVYDGGSMIT
     GYIVEKRDLP DGRWMKASFT NVIETQFTVS GLTEDQRYEF RVIAKNAAGA ISKPSDSTGP
     ITAKDEVELP RISMDPKFRD TIVVNAGETF RLEADVHGKP LPTIEWLRGD KEIEESARCE
     IKNTDFKALL IVKDAIRIDG GQYILRASNV AGSKSFPVNV KVLDRPGPPE GPVQVTGVTS
     EKCSLTWSPP LQDGGSDISH YVVEKRETSR LAWTVVASEV VTNSLKVTKL LEGNEYVFRI
     MAVNKYGVGE PLESAPVLMK NPFVLPGPPK SLEVTNIAKD SMTVCWNRPD SDGGSEIIGY
     IVEKRDRSGI RWIKCNKRRI TDLRLRVTGL TEDHEYEFRV SAENAAGVGE PSPATVYYKA
     CDPVFKPGPP TNAHIVDTTK NSITLAWGKP IYDGGSEILG YVVEICKADE EEWQIVTPQT
     GLRVTRFEIS KLTEHQEYKI RVCALNKVGL GEATSVPGTV KPEDKLEAPE LDLDSELRKG
     IVVRAGGSAR IHIPFKGRPT PEITWSREEG EFTDKVQIEK GVNYTQLSID NCDRNDAGKY
     ILKLENSSGS KSAFVTVKVL DTPGPPQNLA VKEVRKDSAF LVWEPPIIDG GAKVKNYVID
     KRESTRKAYA NVSSKCSKTS FKVENLTEGA IYYFRVMAEN EFGVGVPVET VDAVKAAEPP
     SPPGKVTLTD VSQTSASLMW EKPEHDGGSR VLGYVVEMQP KGTEKWSIVA ESKVCNAVVT
     GLSSGQEYQF RVKAYNEKGK SDPRVLGVPV IAKDLTIQPS LKLPFNTYSI QAGEDLKIEI
     PVIGRPRPNI SWVKDGEPLK QTTRVNVEET ATSTVLHIKE GNKDDFGKYT VTATNSAGTA
     TENLSVIVLE KPGPPVGPVR FDEVSADFVV ISWEPPAYTG GCQISNYIVE KRDTTTTTWH
     MVSATVARTT IKITKLKTGT EYQFRIFAEN RYGKSAPLDS KAVIVQYPFK EPGPPGTPFV
     TSISKDQMLV QWHEPVNDGG TKIIGYHLEQ KEKNSILWVK LNKTPIQDTK FKTTGLDEGL
     EYEFKVSAEN IVGIGKPSKV SECFVARDPC DPPGRPEAIV ITRNNVTLKW KKPAYDGGSK
     ITGYIVEKKD LPDGRWMKAS FTNVLETEFT VSGLVEDQRY EFRVIARNAA GNFSEPSDSS
     GAITARDEID APNASLDPKY KDVIVVHAGE TFVLEADIRG KPIPDVVWSK DGKELEETAA
     RMEIKSTIQK TTLVVKDCIR TDGGQYILKL SNVGGTKSIP ITVKVLDRPG PPEGPLKVTG
     VTAEKCYLAW NPPLQDGGAN ISHYIIEKRE TSRLSWTQVS TEVQALNYKV TKLLPGNEYI
     FRVMAVNKYG IGEPLESGPV TACNPYKPPG PPSTPEVSAI TKDSMVVTWA RPVDDGGTEI
     EGYILEKRDK EGVRWTKCNK KTLTDLRLRV TGLTEGHSYE FRVAAENAAG VGEPSEPSVF
     YRACDALYPP GPPSNPKVTD TSRSSVSLAW SKPIYDGGAP VKGYVVEVKE AAADEWTTCT
     PPTGLQGKQF TVTKLKENTE YNFRICAINS EGVGEPATLP GSVVAQERIE PPEIELDADL
     RKVVVLRASA TLRLFVTIKG RPEPEVKWEK AEGILTDRAQ IEVTSSFTML VIDNVTRFDS
     GRYNLTLENN SGSKTAFVNV RVLDSPSAPV NLTIREVKKD SVTLSWEPPL IDGGAKITNY
     IVEKRETTRK AYATITNNCT KTTFRIENLQ EGCSYYFRVL ASNEYGIGLP AETTEPVKVS
     EPPLPPGRVT LVDVTRNTAT IKWEKPESDG GSKITGYVVE MQTKGSEKWS TCTQVKTLEA
     TISGLTAGEE YVFRVAAVNE KGRSDPRQLG VPVIARDIEI KPSVELPFHT FNVKAREQLK
     IDVPFKGRPQ ATVNWRKDGQ TLKETTRVNV SSSKTVTSLS IKEASKEDVG TYELCVSNSA
     GSITVPITII VLDRPGPPGP IRIDEVSCDS ITISWNPPEY DGGCQISNYI VEKKETTSTT
     WHIVSQAVAR TSIKIVRLTT GSEYQFRVCA ENRYGKSSYS ESSAVVAEYP FSPPGPPGTP
     KVVHATKSTM LVTWQVPVND GGSRVIGYHL EYKERSSILW SKANKILIAD TQMKVSGLDE
     GLMYEYRVYA ENIAGIGKCS KSCEPVPARD PCDPPGQPEV TNITRKSVSL KWSKPHYDGG
     AKITGYIVER RELPDGRWLK CNYTNIQETY FEVTELTEDQ RYEFRVFARN AADSVSEPSE
     STGPIIVKDD VEPPRVMMDV KFRDVIVVKA GEVLKINADI AGRPLPVISW AKDGIEIEER
     ARTEIISTDN HTLLTVKDCI RRDTGQYVLT LKNVAGTRSV AVNCKVLDKP GPPAGPLEIN
     GLTAEKCSLS WGRPQEDGGA DIDYYIVEKR ETSHLAWTIC EGELQMTSCK VTKLLKGNEY
     IFRVTGVNKY GVGEPLESVA IKALDPFTVP SPPTSLEITS VTKESMTLCW SRPESDGGSE
     ISGYIIERRE KNSLRWVRVN KKPVYDLRVK STGLREGCEY EYRVYAENAA GLSLPSETSP
     LIRAEDPVFL PSPPSKPKIV DSGKTTITIA WVKPLFDGGA PITGYTVEYK KSDDTDWKTS
     IQSLRGTEYT ISGLTTGAEY VFRVKSVNKV GASDPSDSSD PQIAKEREEE PLFDIDSEMR
     KTLIVKAGAS FTMTVPFRGR PVPNVLWSKP DTDLRTRAYV DTTDSRTSLT IENANRNDSG
     KYTLTIQNVL SAASLTLVVK VLDTPGPPTN ITVQDVTKES AVLSWDVPEN DGGAPVKNYH
     IEKREASKKA WVSVTNNCNR LSYKVTNLQE GAIYYFRVSG ENEFGVGIPA ETKEGVKITE
     KPSPPEKLGV TSISKDSVSL TWLKPEHDGG SRIVHYVVEA LEKGQKNWVK CAVAKSTHHV
     VSGLRENSEY FFRVFAENQA GLSDPRELLL PVLIKEQLEP PEIDMKNFPS HTVYVRAGSN
     LKVDIPISGK PLPKVTLSRD GVPLKATMRF NTEITAENLT INLKESVTAD AGRYEITAAN
     SSGTTKAFIN IVVLDRPGPP TGPVVISDIT EESVTLKWEP PKYDGGSQVT NYILLKRETS
     TAVWTEVSAT VARTMMKVMK LTTGEEYQFR IKAENRFGIS DHIDSACVTV KLPYTTPGPP
     STPWVTNVTR ESITVGWHEP VSNGGSAVVG YHLEMKDRNS ILWQKANKLV IRTTHFKVTT
     ISAGLIYEFR VYAENAAGVG KPSHPSEPVL AIDACEPPRN VRITDISKNS VSLSWQQPAF
     DGGSKITGYI VERRDLPDGR WTKASFTNVT ETQFIISGLT QNSQYEFRVF ARNAVGSISN
     PSEVVGPITC IDSYGGPVID LPLEYTEVVK YRAGTSVKLR AGISGKPAPT IEWYKDDKEL
     QTNALVCVEN TTDLASILIK DADRLNSGCY ELKLRNAMGS ASATIRVQIL DKPGPPGGPI
     EFKTVTAEKI TLLWRPPADD GGAKITHYIV EKRETSRVVW SMVSEHLEEC IITTTKIIKG
     NEYIFRVRAV NKYGIGEPLE SDSVVAKNAF VTPGPPGIPE VTKITKNSMT VVWSRPIADG
     GSDISGYFLE KRDKKSLGWF KVLKETIRDT RQKVTGLTEN SDYQYRVCAV NAAGQGPFSE
     PSEFYKAADP IDPPGPPAKI RIADSTKSSI TLGWSKPVYD GGSAVTGYVV EIRQGEEEEW
     TTVSTKGEVR TTEYVVSNLK PGVNYYFRVS AVNCAGQGEP IEMNEPVQAK DILEAPEIDL
     DVALRTSVIA KAGEDVQVLI PFKGRPPPTV TWRKDEKNLG SDARYSIENT DSSSLLTIPQ
     VTRNDTGKYI LTIENGVGEP KSSTVSVKVL DTPAACQKLQ VKHVSRGTVT LLWDPPLIDG
     GSPIINYVIE KRDATKRTWS VVSHKCSSTS FKLIDLSEKT PFFFRVLAEN EIGIGEPCET
     TEPVKAAEVP APIRDLSMKD STKTSVILSW TKPDFDGGSV ITEYVVERKG KGEQTWSHAG
     ISKTCEIEVS QLKEQSVLEF RVFAKNEKGL SDPVTIGPIT VKELIITPEV DLSDIPGAQV
     TVRIGHNVHL ELPYKGKPKP SISWLKDGLP LKESEFVRFS KTENKITLSI KNAKKEHGGK
     YTVILDNAVC RIAVPITVIT LGPPSKPKGP IRFDEIKADS VILSWDVPED NGGGEITCYS
     IEKRETSQTN WKMVCSSVAR TTFKVPNLVK DAEYQFRVRA ENRYGVSQPL VSSIIVAKHQ
     FRIPGPPGKP VIYNVTSDGM SLTWDAPVYD GGSEVTGFHV EKKERNSILW QKVNTSPISG
     REYRATGLVE GLDYQFRVYA ENSAGLSSPS DPSKFTLAVS PVDPPGTPDY IDVTRETITL
     KWNPPLRDGG SKIVGYSIEK RQGNERWVRC NFTDVSECQY TVTGLSPGDR YEFRIIARNA
     VGTISPPSQS SGIIMTRDEN VPPIVEFGPE YFDGLIIKSG ESLRIKALVQ GRPVPRVTWF
     KDGVEIEKRM NMEITDVLGS TSLFVRDATR DHRGVYTVEA KNASGSAKAE IKVKVQDTPG
     KVVGPIRFTN ITGEKMTLWW DAPLNDGCAP ITHYIIEKRE TSRLAWALIE DKCEAQSYTA
     IKLINGNEYQ FRVSAVNKFG VGRPLDSDPV VAQIQYTVPD APGIPEPSNI TGNSITLTWA
     RPESDGGSEI QQYILERREK KSTRWVKVIS KRPISETRFK VTGLTEGNEY EFHVMAENAA
     GVGPASGISR LIKCREPVNP PGPPTVVKVT DTSKTTVSLE WSKPVFDGGM EIIGYIIEMC
     KADLGDWHKV NAEACVKTRY TVTDLQAGEE YKFRVSAING AGKGDSCEVT GTIKAVDRLT
     APELDIDANF KQTHVVRAGA SIRLFIAYQG RPTPTAVWSK PDSNLSLRAD IHTTDSFSTL
     TVENCNRNDA GKYTLTVENN SGSKSITFTV KVLDTPGPPG PITFKDVTRG SATLMWDAPL
     LDGGARIHHY VVEKREASRR SWQVISEKCT RQIFKVNDLA EGVPYYFRVS AVNEYGVGEP
     YEMPEPIVAT EQPAPPRRLD VVDTSKSSAV LAWLKPDHDG GSRITGYLLE MRQKGSDFWV
     EAGHTKQLTF TVERLVEKTE YEFRVKAKND AGYSEPREAF SSVIIKEPQI EPTADLTGIT
     NQLITCKAGS PFTIDVPISG RPAPKVTWKL EEMRLKETDR VSITTTKDRT TLTVKDSMRG
     DSGRYFLTLE NTAGVKTFSV TVVVIGRPGP VTGPIEVSSV SAESCVLSWG EPKDGGGTEI
     TNYIVEKRES GTTAWQLVNS SVKRTQIKVT HLTKYMEYSF RVSSENRFGV SKPLESAPII
     AEHPFVPPSA PTRPEVYHVS ANAMSIRWEE PYHDGGSKII GYWVEKKERN TILWVKENKV
     PCLECNYKVT GLVEGLEYQF RTYALNAAGV SKASEASRPI MAQNPVDAPG RPEVTDVTRS
     TVSLIWSAPA YDGGSKVVGY IIERKPVSEV GDGRWLKCNY TIVSDNFFTV TALSEGDTYE
     FRVLAKNAAG VISKGSESTG PVTCRDEYAP PKAELDARLH GDLVTIRAGS DLVLDAAVGG
     KPEPKIIWTK GDKELDLCEK VSLQYTGKRA TAVIKFCDRS DSGKYTLTVK NASGTKAVSV
     MVKVLDSPGP CGKLTVSRVT QEKCTLAWSL PQEDGGAEIT HYIVERRETS RLNWVIVEGE
     CPTLSYVVTR LIKNNEYIFR VRAVNKYGPG VPVESEPIVA RNSFTIPSPP GIPEEVGTGK
     EHIIIQWTKP ESDGGNEISN YLVDKREKKS LRWTRVNKDY VVYDTRLKVT SLMEGCDYQF
     RVTAVNAAGN SEPSEASNFI SCREPSYTPG PPSAPRVVDT TKHSISLAWT KPMYDGGTDI
     VGYVLEMQEK DTDQWYRVHT NATIRNTEFT VPDLKMGQKY SFRVAAVNVK GMSEYSESIA
     EIEPVERIEI PDLELADDLK KTVTIRAGAS LRLMVSVSGR PPPVITWSKQ GIDLASRAII
     DTTESYSLLI VDKVNRYDAG KYTIEAENQS GKKSATVLVK VYDTPGPCPS VKVKEVSRDS
     VTITWEIPTI DGGAPVNNYI VEKREAAMRA FKTVTTKCSK TLYRISGLVE GTMYYFRVLP
     ENIYGIGEPC ETSDAVLVSE VPLVPAKLEV VDVTKSTVTL AWEKPLYDGG SRLTGYVLEA
     CKAGTERWMK VVTLKPTVLE HTVTSLNEGE QYLFRIRAQN EKGVSEPRET VTAVTVQDLR
     VLPTIDLSTM PQKTIHVPAG RPVELVIPIA GRPPPAASWF FAGSKLRESE RVTVETHTKV
     AKLTIRETTI RDTGEYTLEL KNVTGTTSET IKVIILDKPG PPTGPIKIDE IDATSITISW
     EPPELDGGAP LSGYVVEQRD AHRPGWLPVS ESVTRSTFKF TRLTEGNEYV FRVAATNRFG
     IGSYLQSEVI ECRSSIRIPG PPETLQIFDV SRDGMTLTWY PPEDDGGSQV TGYIVERKEV
     RADRWVRVNK VPVTMTRYRS TGLTEGLEYE HRVTAINARG SGKPSRPSKP IVAMDPIAPP
     GKPQNPRVTD TTRTSVSLAW SVPEDEGGSK VTGYLIEMQK VDQHEWTKCN TTPTKIREYT
     LTHLPQGAEY RFRVLACNAG GPGEPAEVPG TVKVTEMLEY PDYELDERYQ EGIFVRQGGV
     IRLTIPIKGK PFPICKWTKE GQDISKRAMI ATSETHTELV IKEADRGDSG TYDLVLENKC
     GKKAVYIKVR VIGSPNSPEG PLEYDDIQVR SVRVSWRPPA DDGGADILGY ILERREVPKA
     AWYTIDSRVR GTSLVVKGLK ENVEYHFRVS AENQFGISKP LKSEEPVTPK TPLNPPEPPS
     NPPEVLDVTK SSVSLSWSRP KDDGGSRVTG YYIERKETST DKWVRHNKTQ ITTTMYTVTG
     LVPDAEYQFR IIAQNDVGLS ETSPASEPVV CKDPFDKPSQ PGELEILSIS KDSVTLQWEK
     PECDGGKEIL GYWVEYRQSG DSAWKKSNKE RIKDKQFTIG GLLEATEYEF RVFAENETGL
     SRPRRTAMSI KTKLTSGEAP GIRKEMKDVT TKLGEAAQLS CQIVGRPLPD IKWYRFGKEL
     IQSRKYKMSS DGRTHTLTVM TEEQEDEGVY TCIATNEVGE VETSSKLLLQ ATPQFHPGYP
     LKEKYYGAVG STLRLHVMYI GRPVPAMTWF HGQKLLQNSE NITIENTEHY THLVMKNVQR
     KTHAGKYKVQ LSNVFGTVDA ILDVEIQDKP DKPTGPIVIE ALLKNSAVIS WKPPADDGGS
     WITNYVVEKC EAKEGAEWQL VSSAISVTTC RIVNLTENAG YYFRVSAQNT FGISDPLEVS
     SVVIIKSPFE KPGAPGKPTI TAVTKDSCVV AWKPPASDGG AKIRNYYLEK REKKQNKWIS
     VTTEEIRETV FSVKNLIEGL EYEFRVKCEN LGGESEWSEI SEPITPKSDV PIQAPHFKEE
     LRNLNVRYQS NATLVCKVTG HPKPIVKWYR QGKEIIADGL KYRIQEFKGG YHQLIIASVT
     DDDATVYQVR ATNQGGSVSG TASLEVEVPA KIHLPKTLEG MGAVHALRGE VVSIKIPFSG
     KPDPVITWQK GQDLIDNNGH YQVIVTRSFT SLVFPNGVER KDAGFYVVCA KNRFGIDQKT
     VELDVADVPD PPRGVKVSDV SRDSVNLTWT EPASDGGSKI TNYIVEKCAT TAERWLRVGQ
     ARETRYTVIN LFGKTSYQFR VIAENKFGLS KPSEPSEPTI TKEDKTRAMN YDEEVDETRE
     VSMTKASHSS TKELYEKYMI AEDLGRGEFG IVHRCVETSS KKTYMAKFVK VKGTDQVLVK
     KEISILNIAR HRNILHLHES FESMEELVMI FEFISGLDIF ERINTSAFEL NEREIVSYVH
     QVCEALQFLH SHNIGHFDIR PENIIYQTRR SSTIKIIEFG QARQLKPGDN FRLLFTAPEY
     YAPEVHQHDV VSTATDMWSL GTLVYVLLSG INPFLAETNQ QIIENIMNAE YTFDEEAFKE
     ISIEAMDFVD RLLVKERKSR MTASEALQHP WLKQKIERVS TKVIRTLKHR RYYHTLIKKD
     LNMVVSAARI SCGGAIRSQK GVSVAKVKVA SIEIGPVSGQ IMHAVGEEGG HVKYVCKIEN
     YDQSTQVTWY FGVRQLENSE KYEITYEDGV AILYVKDITK LDDGTYRCKV VNDYGEDSSY
     AELFVKGVRE VYDYYCRRTM KKIKRRTDTM RLLERPPEFT LPLYNKTAYV GENVRFGVTI
     TVHPEPHVTW YKSGQKIKPG DNDKKYTFES DKGLYQLTIN SVTTDDDAEY TVVARNKYGE
     DSCKAKLTVT LHPPPTDSTL RPMFKRLLAN AECQEGQSVC FEIRVSGIPP PTLKWEKDGQ
     PLSLGPNIEI IHEGLDYYAL HIRDTLPEDT GYYRVTATNT AGSTSCQAHL QVERLRYKKQ
     EFKSKEEHER HVQKQIDKTL RMAEILSGTE SVPLTQVAKE ALREAAVLYK PAVSTKTVKG
     EFRLEIEEKK EERKLRMPYD VPEPRKYKQT TIEEDQRIKQ FVPMSDMKWY KKIRDQYEMP
     GKLDRVVQKR PKRIRLSRWE QFYVMPLPRI TDQYRPKWRI PKLSQDDLEI VRPARRRTPS
     PDYDFYYRPR RRSLGDISDE ELLLPIDDYL AMKRTEEERL RLEEELELGF SASPPSRSPP
     HFELSSLRYS SPQAHVKVEE TRKDFRYSTY HIPTKAEAST SYAELRERHA QAAYRQPKQR
     QRIMAEREDE ELLRPVTTTQ HLSEYKSELD FMSKEEKSRK KSRRQREVTE ITEIEEEYEI
     SKHAQRESSS SASRLLRRRR SLSPTYIELM RPVSELIRSR PQPAEEYEDD TERRSPTPER
     TRPRSPSPVS SERSLSRFER SARFDIFSRY ESMKAALKTQ KTSERKYEVL SQQPFTLDHA
     PRITLRMRSH RVPCGQNTRF ILNVQSKPTA EVKWYHNGVE LQESSKIHYT NTSGVLTLEI
     LDCHTDDSGT YRAVCTNYKG EASDYATLDV TGGDYTTYAS QRRDEEVPRS VFPELTRTEA
     YAVSSFKKTS EMEASSSVRE VKSQMTETRE SLSSYEHSAS AEMKSAALEE KSLEEKSTTR
     KIKTTLAARI LTKPRSMTVY EGESARFSCD TDGEPVPTVT WLRKGQVLST SARHQVTTTK
     YKSTFEISSV QASDEGNYSV VVENSEGKQE AEFTLTIQKA RVTEKAVTSP PRVKSPEPRV
     KSPEAVKSPK RVKSPEPSHP KAVSPTETKP TPTEKVQHLP VSAPPKITQF LKAEASKEIA
     KLTCVVESSV LRAKEVTWYK DGKKLKENGH FQFHYSADGT YELKINNLTE SDQGEYVCEI
     SGEGGTSKTN LQFMGQAFKS IHEKVSKISE TKKSDQKTTE STVTRKTEPK APEPISSKPV
     IVTGLQDTTV SSDSVAKFAV KATGEPRPTA IWTKDGKAIT QGGKYKLSED KGGFFLEIHK
     TDTSDSGLYT CTVKNSAGSV SSSCKLTIKA IKDTEAQKVS TQKTSEITPQ KKAVVQEEIS
     QKALRSEEIK MSEAKSQEKL ALKEEASKVL ISEEVKKSAA TSLEKSIVHE EITKTSQASE
     EVRTHAEIKA FSTQMSINEG QRLVLKANIA GATDVKWVLN GVELTNSEEY RYGVSGSDQT
     LTIKQASHRD EGILTCISKT KEGIVKCQYD LTLSKELSDA PAFISQPRSQ NINEGQNVLF
     TCEISGEPSP EIEWFKNNLP ISISSNVSIS RSRNVYSLEI RNASVSDSGK YTIKAKNFRG
     QCSATASLMV LPLVEEPSRE VVLRTSGDTS LQGSFSSQSV QMSASKQEAS FSSFSSSSAS
     SMTEMKFASM SAQSMSSMQE SFVEMSSSSF MGISNMTQLE SSTSKMLKAG IRGIPPKIEA
     LPSDISIDEG KVLTVACAFT GEPTPEVTWS CGGRKIHSQE QGRFHIENTD DLTTLIIMDV
     QKQDGGLYTL SLGNEFGSDS ATVNIHIRSI
//
